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Introduction and outline of thesis 
FUO: report on 53 patients in a Dutch university hospital 
General Introduction 
Already in the fourth century B.C. Hippocrates and others in the Hippocratic 
collection (Corpus Hippocraticum) recognized fever disclosed by palpation, as 
an important feature of disease. It was not until 1592 that Galileo 
constructed a technically imperfect thermometer (probably the first), but he 
did not see the medical application for the device. Santorio, however, in the 
17th century was greatly interested in measuring body temperature and 
constructed ingenious but cumbersome thermometric instruments. A useful 
thermometer was not developed until 1717 by Gabriel Daniel Fahrenheit and 
it was Herman Boerhaave in Holland and his students De Haen and Van 
Swieten in Vienna who started measuring body temperature in patients. 
Despite their efforts, it took another century until clinical thermometry 
became a part of daily practice. Karl August Wunderlich, in 1868, clearly 
established by measuring temperature in 25,000 individuals that abnormality 
of temperature was a cardinal sign of disease and normality of temperature a 
sign of health 13. Within a couple of decades, doctors started to use fever as 
a sign of disease and learned to use body temperature measurements for 
diagnosis as well as for judgement of the course of the disease. 
Although fever represented a clinical sign, recognized to indicate an 
underlying illness with mostly apparent cause amendable to treatment or 
related to a self-limiting illness, in some patients prolonged fever appeared to 
occur without an obvious cause. Fevers proved to be the presenting or sole 
manifestation of many common and exotic disorders, and these fevers of 
unknown origin turned out to be one of the greatest challenge of diagnostic 
skills of general internists. One of the earliest papers on prolonged fever in 
the USA was published by Cabot in 1907 under the title of The Three Long 
Continued Fevers of New England 4. According to these early reports on fever 
of obscure origin, although already recognized as a clinical problem and 
despite of an universal interest, the subject was seldom dealt with as an 
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independent topic in a comprehensive way 5. The first series on this subject 
published in the early twenties lacked an uniform definition 5 1 4 which made it 
hard to compare data and extrapolate data to individual patients with fever of 
unknown origin (FUO). It was not until 1961 that Petersdorf and Beeson 
introduced a definition of FUO, making possible epidemiological^ comparable 
studies on this subject. In this landmark paper 1S, Petersdorf and Beeson 
presented 100 patients with FUO, defined as: illness of more than three 
weeks' duration with rectal temperature of 38 3°C (101 °F) or higher on at 
least three occasions, with no diagnosis reached after one week of inpatient 
investigation. Many retrospective 1 6 2 5 and a few prospective 263° studies of 
patients with FUO had been performed using this definition. Other series used 
different criteria 3 1 4 2, and their results were more difficult to interpret. A 
recently revised definition, excluding immunocompromised patients 2 9 4 3 4 4 , 
had not been employed in major series. 
Because of the diversity of diseases able to bring about longstanding fever, it 
remained difficult to construct diagnostic algorithms that cover the complete 
spectrum of FUO. Attempts had been undertaken to outline diagnostic 
approaches 4 5 5 \ but these algorithms were never based on scientific data on 
the utility of different investigations under various conditions and therefore 
hard to extrapolate to the individual patient with FUO. In general, two groups 
of patients with FUO could be identified, a group with potentially diagnostic 
clues (PDCs) and a group without PDCs. The importance of PDCs was 
emphasized in many reviews on FUO: the clinician was advised to stick to 
"Sutton's " Law: "to go were the money is" 4 5 4 6 5 2 5 4 (щ other words: look for 
Willie Sutton was a notorious gentleman bank robber who spent most of his adult years in 
prison and was released from jail for the last time in 1969 after which he assisted the Federal 
Banking System in order to prevent bank robberies A statement Willie once made to a 
reporter when asked why he robbed banks, was "Why, that's where the money is" Dr 
William Dock, a distinguished clinician and teacher of New York Downstate Medical Center in 
Brooklyn deplored the tendency to carry out a battery of unnecessary "routine" 
examinations, so he formulated "Sutton's Law", which recommended that physicians 
proceed immediately to a specific diagnostic procedure 
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PDCs), but this procedure was never prospectively evaluated. To prevent 
unnecessary investigations in patients without PDCs, who pose the most 
difficult diagnostic puzzle, there was a need for prospective studies on the 
diagnostic utility of modern microbiological, histological and imaging 
techniques under various circumstances. 
Outline of the thesis 
At the start of the study few recent data were available from North-Western 
Europe. Before starting a multicenter prospective study, we wanted to obtain 
a better insight into FUO in the Netherlands. Firstly, a retrospective study was 
performed in the University Hospital Nijmegen over the period August 1988 
until January 1992. We studied diagnostic outcome and workup of 53 
patients wi th FUO. These data are described in Chapter 2. Because the use of 
diagnostic techniques seemed extensive and a standardized diagnostic 
protocol had to be developed for the prospective study, we performed an in-
depth inquiry into the diagnostic work up of patients wi th FUO among 
selected internists in all university hospitals in the Netherlands. With help of 
these data, described in Chapter 3 and data available in the literature, a 
standardized diagnostic protocol was developed. This protocol was approved 
by each internal medicine staff of all Dutch university hospitals and by all 
local ethical committees. 
Scintigraphic methods are widely used in patients wi th FUO. A relatively new 
technique, used in our hospital is indium 111 -labeled polyclonal human IgG 
(111ln-lgG) scintigraphy. We retrospectively studied 24 patients with FUO seen 
at our university hospital in whom the technique was used. Also the literature 
on the utility of scintigraphic techniques in patients wi th FUO was reviewed. 
This study is described in Chapter 4 . 
From January 1992 until January 1994 the multicenter prospective study 
was performed. A total of 167 immunocompetent patients fulfilling classical 
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we used fixed epidemiologic entry criteria, a method which had not been 
used before in FUO studies. First, all records of non-immunocompromised 
patients were reviewed for FUO criteria once a week. Second, and as an 
additional check, all blood cultures orders were reviewed weekly at the 
microbiological laboratory. After thus having identified all patients with fever, 
we applied the FUO criteria. By combining these t w o methods, we minimized 
the chance of missing patients fulfilling FUO criteria. Details on the diagnostic 
outcome are described in Chapter 5. 
By prospective study of PDCs, the screening value of many investigations 
could be retrieved. In patients without PDCs or only misleading PDCs the 
standardized diagnostic protocol was used. Data on the diagnostic yield of 
this protocol and other investigations, as well as the influence of many 
parameters on the chance of finding a diagnosis are described in Chapter 6. 
One major question we had at the onset of the prospective study was if 
measurements of concentrations of the pyrogenic cytokines interleukin-1/? (IL-
1/?), tumor-necrosis-factor-σ (TNFo), interleukin-6 (IL-6) and the anti­
inflammatory cytokine IL-1 receptor antagonist (IL-1 ra) in the circulation, and 
cytokine production capacity of blood cells measured as ex-vivo production of 
these cytokines using a whole blood system, were of diagnostic value. This 
study is described in Chapter 7. 
Since scintigraphic methods are widely used to exclude or demonstrate local 
inflammatory and infectious diseases in patients with FUO, we performed a 
prospective study on the utility of 1 1 1 ln-lgG scintigraphy in patients with and 
without indices of inflammation. The results of this study is described in 
Chapter 8. 
With use of the data recovered in this study and the personal experience with 
many patients with FUO, in Chapter 9 a proposal for future diagnostic workup 
of patients with FUO is presented. Not every step in this procedure has 
scientific basis, but in general it will help physicians with the challenging 
workup in this group of patients. 
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Abstract 
Background and methods: Data on patients with fever of unknown origin 
(FUO) show that the problem of FUO differs, depending on place and time. In 
order to obtain a better insight into FUO in the Netherlands, we performed a 
retrospective study in our University Hospital. 
Results: We studied 53 patients fulfilling FUO criteria. Infection was found in 
11 patients (21%), neoplasms in 10 cases (19%), non-infectious 
inflammatory diseases in 12 patients (23%). In 16 patients (30%) no 
diagnosis could be made. In 12 patients fever subsided. In 4 patients fever 
persists with a median follow-up of 14.5 years. In all 5 patients without 
directional clues no diagnosis could be made. In 21 patients (57%) the 
diagnosis was found by non-invasive methods, in 16 patients (43%) invasive 
methods were necessary. A median of 54 investigations were done in all 
patients. 
Conclusions: The spectrum of FUO is changing. The proportion of patients in 
whom no diagnosis can be made is growing. The presence of directional 
clues seems to be an important issue, which other series often do not 
mention. Their importance should be studied in a larger, prospective study. 
The use of sophisticated diagnostic techniques seems to be extensive. 
Because very little is known about the diagnostic yield of many of those 
techniques, a prospective study on this aspect is needed. 
Introduction 
Despite all advanced diagnostic techniques available nowadays, fever of 
unknown origin (FUO) remains a diagnostic challenge. Many series of patients 
with classical FUO, according to Petersdorf's criteria 1 (i.e. febrile illness of 
more than 3 weeks duration, fever of 38.3 °C or higher on at least 3 
occasions and uncertain diagnosis after 1 week of study in a hospital) have 
18 
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been published 1"10. 
When studying these data it is obvious that the problem of FUO differs 
depending on place and time. The composition of the groups varies and 
several other factors, (i.e. geographic area, changes in diagnostic procedures, 
changes in disease pattern, hospital setting) can be held responsible for this. 
At the time of this study, few recent data were available from North-Western 
Europe. Only the study by Knockaert et al. 10 originates from this part of the 
world. In order to obtain a better insight into FUO in our area, we performed a 
retrospective study in our University hospital. 
Materials and Methods 
Using the registration system for patients admitted to our department from 
August 1988 to January 1992, 111 charts of patients, admitted because of 
fever, were reviewed. Of these, only 27 patients fulfilled the criteria of 
Petersdorf. The registration systems for diagnosis at discharge was also 
checked for patients wi th fever of unknown origin. Of 132 patients only 2 
had classical FUO. Other patients were retrieved by examining all charts of 
patients submitted to ¡ndium-111 labeled polyclonal immunoglobulin G 
scintigraphy (5 patients) 11 or by checking temperature lists and microbiology 
consultation lists (19 patients). The risk of missing patients and selection is 
less due to the use of more searching techniques. 
Final diagnoses reported in this study were made by the authors upon critical 
revision of the data and diagnosis mentioned in medical records. 
For every patient we checked the presence and usefulness of directional clues 
(i.e. diagnostic abnormalities, which pointed to certain possible diagnoses and 
enabled the attending physician to order specific investigations). This clues 
varied from clues in the history (e.g. tropical trips) to abnormalities on 
physical examination (e.g. pleural effusion, hepatosplenomegaly, lymphoma). 
19 
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Fig. 2.1. Distribution of duration of fever before hospitalization in 53 patients 
with FUO. Duration of fever was calculated according to Petersdorf, using 
the start of the febrile illness as the first day. With recurrent fever, the 
summation of febrile days is given. 
lymphadenopathy). In patients without such clues, all diagnostic testing had 
to be performed in a blind fashion. Diagnostic procedures were studied and 
counted in each patient. 
Recurrent fever in this study was defined as repeated bouts of fever wi th 
fever-free intervals of at least 2 weeks and apparent remission of the 
underlying disease.Data were statistically analyzed and groups of patients 
compared wi th use of Fisher's exact test. A P-value of < .05 was considered 
significant. 
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Table 2.1. The diagnostic categories of 53 cases of FUO. 
CATEGORY NO. OF CASES (% OF TOTAL) 
Infection 
Persistent yersiniosis 
Spondylitis [Streptococcus pyogenus) 
Tuberculous spondylitis 
Endocarditis (culture negative) 
Central venous catheter infection 
Salmonellosis 
Chronic meningococcaemia 
Cytomegalovirus infection 
Neoplasm 
Hodgkin's disease 
Angioimmunoblastic lymphadenopathy 
Acute myelogenous leukemia 
Renal cell carcinoma 
Metastasis of lungcancer in the ileum 
Colonic carcinoma 
Non-infectious inflammatory diseases 
Non-classifiable inflammatory disease 
Periarteritis nodosa 
Systemic lupus erythematosus 
Polymyalgia rheumatica 
Adult-onset Still's disease 
Inflammatory bowel disease 
Sarcoidosis 
Focal proliferative glomerulonephritis 
Miscellaneous 
Pulmonary embolism 
Mixed cryoglobulinemia 
Factitious fever 
No diagnosis 
Spontaneous recovery 
Persistent fever 
11 (21%) 
3 
2 
2 
1 
1 
1 
3 
1 
1 
1 
1 
3 
1 
1 
2 
1 
1 
12 
4 
10 (19%) 
12 (23%) 
4 ( 8%) 
16 (30%) 
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Table 2.2. The diagnostic categories of 18 patients with recurrent fever. 
CATEGORY NO. OF PERIODS OF 
FEVER IN EACH PATIENT 
NO. OF CASES 
(% OF TOTAL) 
Infection 
Salmonella bacteremia 
Persistent yersiniosis (3 cases) 
Chronic meningococcemia 
Neoplasm 
Non-infectious inflammatory diseases 
Non-classifiable inflammatory disease 
Inflammatory bowel disease 
Miscellaneous 
Pulmonary embolism 
Mixed cryoglobulinemia 
No diagnosis 
2 
3, 4 and >5 
3 
>5 
3, >5 and >5 
2 
2 
5 (28%) 
0 
4 (22%) 
2 (11%) 
7 (39%) 
Results 
Clinical features 
A total of 53 patients was retrieved (25 men and 28 women); median age of 
51 years, range, 19-80 years). Eighteen patients had some form of recurrent 
fever. Nine patients per year were retrieved in 1988 and 1989; in 1990 and 
1991, 17 and 18 were found, respectively. Twenty-eight patients (53%) had 
already been investigated by internists in other hospitals and came for a 
second opinion. Seven patients (13%) were seen by us in consultation at 
other departments or already admitted because of non-febrile diseases. 
The median duration of hospitalization was 23 days (range 5 to 171 days), in 
21 patients (40%) the duration of hospitalization exceeded 4 weeks. Five 
patients were admitted in other hospitals and seen at the outpatients' 
department in our hospital. Fig. 2.1 presents the duration of fever before 
admission to the hospital (median duration, 40 days). 
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Table 2.3. Diagnostic categories of 22 patients with FUO of > 180 days 
CATEGORY NO OF CASES (% OF TOTAL) 
Infection 
Endocarditis 
Persistent yersiniosis 
Neoplasm 
Hodgkin's disease 
Acute myelogenous leukemia 
Angioimmunoblastic lymphadenopathy 
Non-infectious inflammatory diseases 
Non classifiable inflammatory disease 
Polymyalgia rheumatica 
Systemic lupus erythematosus 
Inflammatory bowel disease 
Focal proliferative glomerulonephritis 
No diagnosis 
Spontaneous recovery 
Persistent fever 
1 
1 
1 
1 
1 
2 
1 
1 
3 
1 
5 
4 
2 ( 9%) 
3 (14%) 
8 (36%) 
9 (41 %) 
Diagnosis and outcome 
In our series, infection was the cause of fever in 11 patients (21%). 
Neoplasms accounted for 10 cases (19%) and non-infectious inflammatory 
diseases for 12 cases (23%) (Table 2.1). In 16 (30%) patients no diagnosis 
could be made. In 12 patients fever subsided spontaneously after a duration 
of median 115 days (range 28 days-38 months) In 4 patients fever (periods) 
persisted and no diagnosis could be made until now (median duration 14.5 
years, range 1.6-25.8 years). These 4 patients all had some form of recurrent 
fever. 
In 7 patients the diagnosis was made during follow-up after discharge, 
because of new emerging facts (endocarditis, lupus erythematosus, 
angioimmunoblastic lymphadenopathy, leukemic transformation in 
myelofibrosis, Hodgkin's disease, ulcerative colitis, Crohn's disease). 
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Tab/e 2.4. Laboratory procedures used to establish a final diagnosis in 37 
FUO patients. 
DIAGNOSTIC METHOD NO OF CASES (%) 
Non-invasive 
Serology or bacteriolog 11 (30%) 
Radiology 2 ( 5%) 
Endoscopy 3 ( 8%) 
Clinical course/ response to treatment 5 (14%) 
Invasive 
Biopsy 12(32%) 
Explorative laparotomy 4(11 %) 
Some patients received non-steroidal anti-inflammatory drugs. This was not 
done as part of a protocol and thus, evaluation was not possible. 
In 5 patients, no directional clues were present and all diagnostic testing was 
performed in a blind fashion. In no patient in this group was a diagnosis 
made. In contrast, no diagnosis was made in 11 (23%) of 48 patients with 
directional clues (P < .01). In 23 patients (48%) with a clue, the clue was 
misleading. In 18 patients, some form of recurrent fever was present (Table 
2.2). No diagnosis could be made in 7 (39%) of these 18 patients. This 
finding is not significantly different (P = .16) from 35 patients with 
continuous fever, in which no diagnosis could be made in 9 cases (26%). 
In 22 patients, duration of fever before diagnosis or recovery was longer than 
a half year (Table 2.3). In 9 patients no diagnosis could be made (41%). This 
is not significantly different from the number of diagnoses made in patients 
with shorter duration of fever (P = .13). 
Diagnostic procedures 
Of the 37 patients in w h o m a final diagnosis was established, diagnosis was 
established by non-invasive methods in 21 (57%). 
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Table 2.5. Frequency of investigations performed in 53 patients with FUO. 
FREQUENCY (%) INVESTIGATIONS 
100 ESR, hemoglobin, platelet, total leukocytes, creatinine, chest radiograph 
> 9 0 Liver chemistry, total serum protein, albumin, urine protein and urinalysis, differentiation of 
leukocytes, blood cultures 
> 8 0 Electrolytes, serum protein fractions, urine culture, antinuclear antibodies 
> 7 0 Fecal cultures, abdominal ultrasonography. 
> 6 0 Immunoelectrophoresis, fecal blood, rheumatoid factor, Cytomegalovirus serology. 
> 5 0 Creatine kinase, angiotensin-converting enzyme, complement C3 and C4, PPD, Hepatitis В 
serology, abdominal CT. 
> 4 0 AntidsDNA, ENA, ANCA, serology for syphilis, respiratory virus infections, hepatitis A, 
Epstein Barr virus, brucellosis, and toxoplasmosis, l n ln- lgG scintigraphy 
> 3 0 Iron, iron-binding capacity, thyroid function, hemostasis tests, sputum culture, ASO, 
serology for Chlamydia infection, yersiniosis and borrehosis, bone marrow cytology, liver 
biopsy, transthoracic echocardiography, X-ray of sinuses. 
>25 Haptoglobin, specific cultures, bone marrow cultures, serology for Q fever and HIV, CRP, 
skin biopsy, X-ray of spine, "'In-WBC scintigraphy. 
> 2 0 Amylase, serology for Mycoplasma, X-ray colon, thoracic CT, coloscopy 
>15 Vitamin B12, folate, ferritin, culture of throat, culture of bronchoalveolar lavage, CSF 
culture, Widal test, cryoglobulin, blood smear examination on malaria, serology for 
hepatitis C, X-ray series of small bowel, ventilation/perfusion scintigraphy, cerebral CT, 
intravenous pyelography, lung, bone and skin-muscle biopsy, bronchoscopy. 
> 1 0 Urate, cholesterol, immunoglobulin D, prostatic phosphate, anti-mitochondrial antibody, 
lymph node biopsy, specific biopsies, temporal biopsy, gastroscopy, dental radiography, 
pelvic ultrasonography. 
< 1 0 σ-Fetoprotein, IgE, vitamin E, porphyrin, CEA, cultures of skin, liver, cervix, pleural fluid, 
and intravenous lines, serology for leptospirosis, gonorrhoea, Campylobacter infection, 
amoebiasis, legionellosis, schistosomiasis, cat-scratch disease, histoplasmosis, 
schistosomiasis, trypanosomiasis, rickettsiosis, lysozyme, anti-smooth muscle antibody, 
renal biopsy, biopsy of pleura, rectum, ileum, and colon. X-ray of stomach, ERCP, 
laparotomy, laparoscopy, thoracoscopy, mediastinoscopy, specific CT and MRI, EMG, 
oesophageal echocardiography. 
Abbreviations: ANCA = anticytoplasmatic antigen, ASO = antistreptolysin O-test, CEA = carcino-
embryonic antigen, CRP = C-reactive protein, CSF = cerebrospinal fluid, CT = computerized tomography, 
EMG = electromyography, ENA = extractable nuclear antigen, ERCP = endoscopic retrograde cholangio­
pancreatography, ESR = erythrocyte sedimentation rate, HIV = human immunodeficiency virus, lnln-lgG 
= indium-111 -labeled immunoglobulin G; "Ίη-WBC = indium-111 -labeled white blood cells, MRI = 
magnetic resonance imaging, PPD = purified protein derivative (tuberculin skin test) 
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The diagnosis was made by invasive methods in 16 patients (43%), mostly 
by biopsies (Table 2.4). 
A median of 54 investigations (range, 23-83) was performed in all patients, 
there was no significant difference between patients with or without 
directional clues. There was no significant difference in patients with true or 
misleading clues. Table 2.5 shows the frequency of specific investigations 
performed. 
Discussion 
Most striking in our series, is the large proportion of patients in whom no 
diagnosis could be made. This is in agreement with the findings of Knockaert 
et al. 10. There are several possible explanations. Firstly, a high percentage 
(53%) of cases in our series, had undergone investigations elsewhere, before 
referral to our hospital. In most other, older series exact data on referral 
pattern are lacking b 5 ·7 ·9 . It is likely that by selection more patients are 
encountered in referral centers, who are difficult to diagnose and have a 
lower chance of reaching a final diagnosis. Secondly, wi th the advent of 
advanced diagnostic techniques, certain disease entities that used to be 
found in patients with FUO (e.g., hepatic-biliary diseases, abdominal 
abscesses, liver and kidney tumors, lymphoma and mediastinal or hilar 
abnormalities) can now be established more easily within one week of 
admission or even at the outpatient department. This leaves us with a group 
of patients, fulfilling classical criteria, in whom a diagnosis is much more 
difficult to make. 
As in nearly all series of FUO, infection was a frequently established 
diagnosis, but, as expected, our study revealed no abscesses or hepatic 
biliary diseases. Tuberculosis and endocarditis were rare causes of FUO in 
accordance with the series of Larson 3 and Knockaert 10. Remarkable is the 
fact that the diagnosis of persistent Yersinia enterocolitica infection, was 
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made in 3 patients. This was made possible by use of sensitive and specific 
immunoblotting techniques. The most often used Yersinia agglutination 
reaction is often negative in chronic Yersinia infection 12,13, and thus this 
diagnosis may have been missed in other series. 
Compared with other series from university hospitals 1 5 , we found a low 
percentage of tumors as the cause of fever. In their study, Knockaert et al. 10 
found an even lower percentage (7%) of neoplasms. As expected, tumors of 
the alimentary tract (colonic cancer) and some hematological malignancies 
(Hodgkin's disease and angioimmunoblastic lymphadenopathy) remain difficult 
to diagnose and therefore remain a cause of FUO, because of lack of 
localizing symptoms or difficulty in obtaining appropriate biopsies. 
Most series of FUO distinguish a category of diseases called "collagen 
disorders", which also includes vasculitis and so called autoimmune diseases. 
Since collagen is involved in only a few of these disorders, and an 
autoimmune nature is often difficult to prove, we would prefer a category 
named non-infectious inflammatory diseases (NIIDs). This category would 
also include inflammatory bowel disease and sarcoidosis, diseases usually 
listed under "miscellaneous disorders". It should be noted that some of the 
diseases now categorized as "non-infectious inflammatory" may actually turn 
out to have an infectious etiology (as recently demonstrated for Whipple's 
disease). NIIDs that are accompanied by fever rather often classify as FUO; 
fever may precede more typical manifestations or serological evidence by 
weeks or months. A number of these diseases, e.g., adult-onset Still's 
disease, polymyalgia rheumatica and mixed connective tissue disease, can 
only be made by exclusion and prolonged observation may be necessary. 
Some of these disorders have symptoms in common with paraneoplastic 
syndromes. In contrast to Knockaert et al. 10 who reported 8 .5% of temporal 
arteritis, we did not encounter this diagnosis in our series; one of the patients 
with polymyalgia rheumatica and one patient wi th a non-classifiable NMD 
could have had temporal arteritis, but biopsies were not performed in these 
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t w o patients. Inflammatory bowel disease can present very atypical during 
many years, with few abdominal complaints and therefore remain important 
causes of FUO and recurrent fever. 
The presence or absence of directional clues which we consider an important 
issue, is not explicitly mentioned in most previous series q 6 8 ' 1 0 . Kazanjian 1 4 
states that 9 of 86 patients with FUO (10%) had no directional clue, 
Wanvarie et al. э mention that 3 of 25 (12%) patients wi th FUO had no clues, 
and Deal 7 describes this in 11 of 34 cases (32%). In the absence of 
directional clues, we find that the likelihood of reaching a diagnosis is very 
low. Wanvarie et al. also noted this in their series. Their series and ours are 
small and retrospective, and because sometimes it is difficult to deduce in 
retrospective, which clues were directional for the attending physician, this 
should be studied in a larger prospective study. 
The chances of reaching a diagnosis in patients with continuous fever (74%) 
seems somewhat higher than in patients with some form of recurrent fever 
(61%), although the difference is not significant. Knockaert et al. also noted 
the fact that it is harder to reach a diagnosis in the latter group 1 5. Neoplasms 
were not found to cause recurrent fever in our series and only in 4 % of 45 
cases of recurrent fever in Knockaert's series 1 5. Although the data are limited 
and more information on this subgroup is needed, it seems that this group of 
patients with FUO could be followed as outpatients, without invasive 
diagnostic procedures, after clinical observation of one attack of fever. 
In 22 patients (42%) the duration of fever was longer than 180 days. In this 
group fewer infections were found (9%) and more patients wi th no diagnosis 
(41%). The difference in diagnostic categories between this group and the 
group of patients in whom duration of fever was less than 180 days was not 
significant. Barbado et al. found in 110 patients wi th FUO 15 patients (14%) 
with prolonged FUO, in 4 of these patients (27%) no diagnosis could be made 
1 6
. In another series in 133 patients with FUO, this was the case in 2 8 % 2. 
Because we wanted to get an insight into the diagnostic strategies, we 
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studied the investigations performed in patients wi th FUO. Many 
investigations were apparently ordered in a blind manner, without specific 
directional clues pointing to the diagnosis sought In contrast, some 
commonly performed investigations (e g , blood cultures, serum protein 
fractions, antinuclear antibodies) were not performed in all patients. Although 
the diagnostic yield of most microbiological, immunohistological and imaging 
techniques in patients with FUO is unknown, the use of these investigations 
seems abundant A thorough prospective study is needed to investigate the 
various diagnostic yields An additional question is, in which subgroups of 
patients with FUO certain investigations are useful. Because of the diversity 
of patients wi th FUO, prospective studies are needed that either are large 
enough or focus on certain subgroups Only wi th this information can justified 
algorithms be made. 
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Inquiry into the diagnostic workup of patients with FUO 
Abstract 
Background: The utility of algorithms in patients wi th fever of unknown origin 
(FUO) has not yet been determined. Before starting a prospective study on 
the utility of a staged diagnostic protocol in patients wi th FUO, we performed 
an inquiry among selected internists in each university hospital in the 
Netherlands to obtain insight into their diagnostic approaches of FUO. 
Methods: Nineteen of 24 internists filled out a questionnaire. The first part 
consisted of a description of a patient with FUO having few potentially 
diagnostic clues and questions on the workup of this patient with FUO. In the 
second part a multiple choice form had to be filled out specifying the clinical 
situations in which one would order in general each of the 182 investigations 
mentioned. 
Results: Regarding the first part, a median of 6 (2 -16) possible diagnoses 
were mentioned. Many investigations would be ordered on the basis of this 
differential diagnosis. Regarding the second part, 38 investigations were 
ordered as screening procedure by more than 5 0 % of these internists. A 
median of 49 investigations were ordered as screening procedure per internist 
and 103 investigations on suspicion for a possible diagnosis only. 
Conclusions: Many investigations were used as screening procedures in the 
diagnostic process of patients wi th FUO. A two-staged diagnostic protocol 
was developed based on retrospective analysis of diagnostic management 
and data from this study. The diagnostic utility of this protocol will be tested 
in a large prospective multicenter study. 
Introduction 
Fever of unknown origin (FUO) has been defined by Petersdorf and Beeson 1 
as a febrile illness of more than 3 weeks duration, fever of 38.3°C or higher 
on at least three occasions and uncertain diagnosis after 1 week of diagnostic 
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workup ¡η a hospital. Despite many studies on this subject 1 6 and a variety of 
diagnostic methods available currently, the diagnostic workup in this group of 
patients remains a challenge. 
Because of the diversity of causes of longstanding fever, it is difficult to 
construct algorithms that cover the complete spectrum of FUO. In the past 
some attempts were undertaken to outline diagnostic approaches 7"13. None of 
these algorithms had scientific basis but merely were a proposal of an 
experienced physician. Although such guidance is of importance, it is difficult 
to extrapolate to the individual patient with FUO. Should all the examinations 
mentioned in staged protocols be done when no potentially diagnostic clues 
(PDCs) are present? What is the diagnostic yield of these investigations under 
various circumstances? Which patients have a greater risk to have a 
dangerous disease and is it possible to select the patients with benign fever? 
Before starting a prospective study on FUO, in which we wanted to use a 
staged diagnostic protocol, we performed a retrospective analysis of the 
diagnostic workup in 53 patients with FUO, presenting from 1988 to 1992 in 
our university hospital. Data on this study have been published 14. Because of 
the abundant use of diagnostic techniques in this study, we did an inquiry 
among internists to find out their approach in FUO. 
Methods 
In each of the eight university hospitals in the Netherlands, three general 
internists were asked to fill out a questionnaire on diagnostic techniques 
potentially useful in patients with FUO. These diagnostic techniques had been 
all performed in the patients with FUO retrospectively studied by us 14. Of 
these 24 internists, 19 filled out the questionnaire. Thirteen were working at 
general internal wards and had been registered for at least 5 years as 
internist. Six internists were licensed for the sub-specialty of infectious 
diseases (ID-physicians). 
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Number of internists 
10 
9 
0-5 6-10 11-15 >15 
Number of diagnoses 
Fig. 3.1. Number of diagnoses per internist (median 6). 
The questionnaire consisted of two parts. In the first part, a case report was 
given, describing one of our patients with FUO. We asked the participants to 
propose a diagnostic workup after stating a differential diagnosis of the 
following case. 
A 52-year-old man is hospitalized because of fever up to 39 °C existing for more than 
three months. Occasionally, the fever is accompanied by chills. His medical history 
reveals fatigue for over one year; during the last year he lost 4 kgs in weight. In addition 
there are slight complaints of pollakisuna without strangury or urine abnormalities. He is a 
pigeon-fancier, but none of the pigeons has been ill. he has not travelled to tropical areas; 
there are neither arthralgia nor skin abnormalities and the rest of his medical history also 
is unremarkable. On examination he had an anaemic, grayish skin and a slightly enlarged 
spleen. Laboratory findings (leucocyte and platelet count, total serum protein, liver 
function tests, creatinine kinase, urinary analysis, fecal occult blood, creatinine, PPD, 
antinuclear antibody, rheumatoid factors) were normal, except for a sedimentation rate of 
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38 mm/h and a hemoglobin of 7.5 mmol/l. The X-ray of the chest was normal. Abdominal 
ultrasonography revealed a slightly enlarged spleen with a length of 14 cm and diffuse 
hepatomegaly. 
Question 1: Which diagnoses would you consider at the moment of presentation? 
Question 2: In view of diagnoses considered, which investigations would you perform? 
Question 3: If you do not favor any diagnosis, which investigations would you perform 
as a screening procedure at presentation? 
Question 4. If these investigations do not yield a diagnosis and the patient remains ill, 
which investigations would you perform in a later stage' 
In the second part, we asked the participants to specify the clinical situations 
in which they would order each of 182 investigations. For each item there 
were seven possible answers (Table 3.1). To facilitate interpretation, we 
summarized these answers and subdivided the answers in t w o groups. The 
first group of answers concerned investigations that were ordered as a 
screening procedure in patients without the presence of potentially diagnostic 
clues (PDCs) by the majority of internists; the threshold for these 
investigations can be considered low. The second group of investigations was 
ordered only when indicated by the presence of PDCs by the majority of 
internists; thus the threshold for the latter can be considered higher. 
Data were statistically analyzed and compared with use of Mann-Whitney U 
statistics. A Ρ value of < .05 (two-sided) was considered to be significant. 
Results 
Question 1. With regard to the case presented, the number of potential 
diagnoses mentioned per internist was median 6 (range 2 - 1 6 ) (fig. 3.1). 
There was no significant difference between generalists and ID-physicians. 
The potential diagnoses most often mentioned as answer to question 1 were 
malignant lymphoma (n = 18) and extrapulmonary tuberculosis (n = 14). 
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Table 3.1. Question asked on 182 investigations with a possible role in 
diagnostic process of patients with FUO. 
Question: Which of the investigations listed here would you order in a patient with FUO and at 
what stage of the diagnostic phase. 
Answers: 
1. Always, in the first phase at presentation during the first week of admission or at first 
presentation in patients with fever lasting longer than 3 weeks. 
2. When routine studies after 1 week yield no diagnosis. 
3. When no diagnosis has been established after one month of negative studies. 
4. When no diagnosis has been made after several months. 
5. When minor clues to a specific disease are present, also with low suspicion. 
6. When major clues to a specific disease are present only, with high suspicion only. 
7. Never, not even when clues to a specific disease are present. 
Also mentioned often were: solid tumor (n = 8), endocarditis (n = 8), bird 
fancier's lung (n = 8), Cytomegalovirus infection (n = 7), vasculitis (n = 7), 
psittacosis (n = 6), brucellosis (n = 5), infectious mononucleosis (n = 5), 
sarcoidosis (n = 4), toxoplasmosis (n = 3), persistent yersiniosis (n = 3) and 
malaria (n = 3). A variety of other diseases was mentioned only once or 
twice: parasitic infections, Q-fever, temporal arteritis, hyperthyroidism, 
polyarteritis nodosa, stomach cancer, colon cancer, prostatitis, Crohn's 
disease, colitis, leishmaniasis, syphilis, Human Immunodeficiency Virus 
infection, adult-onset Still's disease, pulmonary embolism. 
Question 2. Based on the diagnoses considered, all internists would perform a 
series of investigations in the first stage of the diagnostic process. The 
investigations most commonly mentioned were abdominal CT (n = 11), bone 
marrow aspiration for cytology and culture (n = 10), serology for Epstein-Ban 
virus and Cytomegalovirus, Immunoglobulin E and serum precipitinagainst 
pigeon proteins (n = 7), serology for Brucella spp. (n = 5), for Chlamydia 
psittaci, Yersinia enterocolitica, and bone biopsy (n = 4 ) . 
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Table 3.2. Investigations ordered as screening procedure in the absence of 
PDCs by majority of internists 050%) within one month of diagnostic 
workup. 
Biochemical: 
Calcium; phosphate; amylase; thyroxine; thyroid stimulating hormone; immune electrophoresis of 
serum and urine; Bence Jones in urine; C-reactive protein; angiotensin converting enzyme; 
antinuclear antigen; antidsDNA; complement; cryoglobulin; anticytoplasmatic antibodies; test for 
rheumatoid factor; circulating immune complexes; 
Microbiology: 
blood cultures cultured for more than 1 week; blood, urine and gastric contents for cultures for 
Mycobacterium tuberculosis; bone marrow culture for Mycobacteria, Brucella spp.; fecal 
examination for worms and eggs; serology for T. pallidum, Cytomegalovirus, Epstein Barr virus, 
hepatitis В virus, Mycoplasma pneumoniae. Yersinia enterocolitica. Toxoplasma gondii; anti­
streptolysin O-test; repeated PPD; Paul Bunnel test; 
Histology: 
bone marrow aspiration; bone biopsy; 
Imaging procedures: 
abdominal CT; fundoscopy by ophthalmologist; X-ray sinus, teeth, ultrasonography of pelvis and 
echocardiogrphy 
Also mentioned often were: culture of expressed prostate secretion, fecal 
cultures, angiotensin converting enzyme and skin-muscle biopsy (n = 3). 
Other investigations would be performed only once or twice: C-reactive 
protein, serology for Mycoplasma pneumoniae, Rickettsiae, respiratory 
viruses, Treponema pallidum, Toxoplasma gondii and Hepatitis В virus, serum 
immune electrophoresis, anemia analysis, complement profile, circulating 
immune complexes, pulmonary function tests, serum calcium, CT of the 
chest, repeated blood cultures, mycobacterial cultures of urine and stomach 
contents, repeated urine analysis including microscopic evaluation of urine, 
cryoglobulin, lysis centrifugation blood cultures, triglycerides, transesophageal 
echocardiography, scintigraphic techniques (Gallium-67, Technetium-95m 
37 
Inquiry into the diagnostic workup of patients with FUO 
bone scintigraphy, indium-111-white blood cell), serum T4, intravenous 
pyelography, gastroscopy, funduscopy, liver biopsy, arteriography. 
With regard to the third question, 14 of the 19 internists would not perform 
any screening investigations in the first stage of the diagnostic process 
because of the presence of PDCs. The other 5 internists would perform a 
variety of investigations, each of which was only mentioned once or twice. 
Question 4. Investigations most often ordered in a later diagnostic phase as a 
screening procedure were: liver biopsy (n = 10), abdominal CT (η = 8), CT 
of the chest, bone biopsy, bone marrow aspiration and culture (n = 4), 
repeated history and physical examination and X-ray of the colon (n = 3). 
Two internists (ID-physicians) would not do any investigations at this stage of 
the diagnostic process. Other investigations were mentioned once or twice: 
specific precipitin against bird antigens, Immunoelectrophoresis, serology for 
human immunodeficiency virus, stools for worms and cysts, blood cultures 
during high fever, anergy tests, complement state, serum immunoglobulin D, 
serology for Borrelia burgdorfii, Coxiella. burnetii, hepatitis virus A and B, 
s c i n t i g r a p h i c imaging t e c h n i q u e s i n c l u d i n g bone s c i n t i g r a p h y , 
echocardiography, CT of the brain and pituitary gland, coloscopy, 
ventilation/perfusion scintigraphy, bronchoscopy, gastroscopy, temporal 
biopsy, X-ray of the ileum, investigation of ear, nose and throat, 
splenectomy. 
The response to the second part of the questionnaire yielded a series of 
investigations to be performed by the majority of internists as screening 
procedures in patients without clues to possible diagnoses (Table 3.2), 
investigations ordered because of clues pointing to possible diagnoses are 
listed in Table 3.3. 
A median of 49 (range, 13 - 102) investigations were ordered as a screening 
procedure and a median of 103 (range, 19 - 120) investigations only on 
suspicion for a possible diagnosis (no significant differences between 
generalists and ID-physicians). 
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Table 3.3. Investigations ordered only in the presence of PDCs by majority of 
internists (>50%) 
Biochemical 
haptoglobin; vitamin B12; total iron concentration; iron binding capacity; trace elements; Cortisol, 
catecholamine; specific IgE; extractable nuclear antigens; antibodies against cardiolipin, 
thyroglobulin, parietal cells, intrinsic factor, mitochondria, smooth muscle, heart muscle, tubular 
basal membrane, glomerular basal membrane, liver cell membrane, 
Microbiological 
blood smear for malaria; cerebrospinal fluid culture, liver biopsy culture, serology for hepatitis 
A,B,C virus, respiratory viruses, Human Immunodeficiency Virus, Poliovirus, Mumps virus, 
Dengue, Mycoplasma pneumoniae, Salmonella spp, Borrelia burgdorfii, Coxiella burnetii, 
Rickettsia spp, Brucella, Chlamydia psittac/, Leptospira, Legionella, Schistosoma spp, 
Leishmania, Toxocara, Entamoeba, Aspergillus, Listeria monocytogenes, cryptococcal antigen, 
Histology 
temporal artery biopsy; skin muscle, fascia biopsy; peripheral lung biopsy; lymph node biopsy; 
enteric biopsy; rectal biopsy; lip biopsy; skin biopsy; cytology on cerebrospinal fluid; pleural 
biopsy or puncture; 
Imaging procedures 
thoracic and brain CT; bone scintigraphy; thyroid scintigraphy; ventilation and perfusion lung 
scintigraphy, gallium lung scintigraphy; X-ray of stomach, spine, ileum, pelvis, colon, hands, 
feet, breasts, urinary tract, lymphography, angiography of mesenterial vessels, ultrasonography 
of prostrate, echocardiography, endoscopy of lungs, colon, bladder, stomach, biliary tract 
Additional investigations 
continuous temperature measurements, diagnostic laparotomy 
Discussion 
This study was undertaken to obtain more insight into the diagnostic 
approach of FUO used by internists in university hospitals in the Netherlands. 
In our retrospective study on FUO 14 we could not allways retrieve the 
reasons for ordering the large array of tests. It appeared that many studies 
were done as screening procedures without the presence of specific clues to 
exclude diseases which could possibly cause FUO. 
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Table 3.4. Diagnostic protocol for FUO of which validity will be examined 
prospectively. 
A. Obligatory investigations performed in all patients. 
ESR; hemoglobin, mean cellular volume; platelet count; leukocyte count and differentiation 
creatinine; sodium; potassium, protein, protein fractions, alkaline phosphatase, aminotransferase, 
LDH, creatine Phosphokinase, ANA, rheumatoid factors, urinary analysis, feces for occult blood, 
blood cultures aerobic and anaerobic (n = 3); tuberculin skin test, urine-, feces-, and sputum 
culture when indicated; chest X-ray; ultrasonography of upper abdomen, 
B. Phase 1 of standardized diagnostic protocol in patients without PDCs. 
Pulse/rectal temperature measurement by observer, fundoscopy by an ophthalmologist Calcium, 
phosphate, urate, amylase and TSH/T4, Immunoelectrophoresis serum and urine, CRP, ACE, 
ANCA, anti-dsDNA, ASO, cryoglobulin, C3, C4, CH50, serology for Cytomegalovirus, Epstein-
Barr virus. Mycoplasma, Brucella, Toxoplasma, Borrelia, Coxiella, Treponema, Yersinia, blood 
cultures incubating for more than 1 week, stools for worms, eggs, cysts, blood cultures, gastric 
fluid, urine cultures for tuberculosis, bone marrow aspiration for cytology and culture for 
Mycobacteria, Brucella, Yersinia, ln-111-lgG scintigraphy, X-Ray of sinus and teeth, 
ultrasonography of pelvis 
C. Phase 2 of standardized diagnostic protocol in patients without PDCs. 
(performed when phase 1 does not reveal PDCs or diagnosis) 
hepatitis В serology, anergy tests, liver biopsy for histology and culture for Mycobacteria, 
bacteria and fungi, repeated chest X-ray, IgD in serum, bone biopsy for histology and culture for 
Mycobacteria, Brucella and bacteria, echocardiography, CT of abdomen, CT of chest, X-Ray of 
colon and temporal artery biopsy in patients over 55 years 
Abbreviations: ACE = Angiotensin-Converting enzyme, ANA = antinuclear factor, ANCA = Antineutrophil 
cytoplasmic autoantibodies, ASO = antistreptolysin 0 test, С = complement, CH50 = total hemolytic 
complement, CRP = C-reactive peptide; CT = computer tomography, dsDNA = double-stranded 
deoxyribonucleic acid, ESR = erythrocyte sedimentation rate, IF = immunofluorescence, ln-111 IgG = 
lndium-111-labeled polyclonal human Immunoglobulin G, LDH = lactate dehydrogenase, PDCs = 
potentially diagnostic clues, PPD = purified protein derivative, T4 = Thyroxine, TSH = Thyroid-stimulating 
hormone 
In the present study, we found that in a case like the presented one, 
internists on average mention 6 diagnostic possibilities. Despite some 
agreement, there is also remarkable divergence of opinion regarding the 
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differential diagnosis and the diagnostic approach. Apparently, most internists 
tend to give an overview of causes of FUO and with help of this list 
investigations are ordered. Although, according to reports in literature 1 5 , 1 1 
patients with FUO without PDCs should probably have a different diagnostic 
approach than those with PDCs, it is our impression that this distinction ii 
not made by these internists. Despite of the fact that the case we selectee 
for the questionnaire had very few PDCs, many possible diagnoses wert 
mentioned. In the abscence of PDCs it seems unlikely that investigations fo 
some of these diseases are useful. This is for instance true fo 
Cytomegalovirus infection; all patients wi th Cytomegalovirus infectior 
described in some series on FUO had lymphocytosis and atypical lymphocyte: 
in the peripheral blood smear 1 3 . Also, patients without a heart murmur ar< 
not likely to have endocarditis 1 , s. Finally, without any blood disorders it i; 
very unlikely that a bone marrow aspiration will lead to a diagnosis. Ir 
patients with FUO finally diagnosed as having leukemia, all patients hac 
anemia or leukopenia 2'3. 
When looking at Table 3.2 and 3.3, it is obvious that many investigations ar< 
ordered in patients with FUO as screening procedures, without knowledge о 
the diagnostic yield of these investigations in that particular setting. This wai 
of approach in daily practice is a reflection of many papers on FUO, in whicr 
also the presence of PDCs is not taken into account when final diagnosis anc 
outcome are discussed. This is remarkable since many authors of review 
papers on FUO and of chapters in textbooks put forward Suttton's law (i.e 
the search for PDCs) in the approach of the patient 7 B · 1 7 - 1 9 . The problem wit ! 
algorithms as proposed in literature is the fact that they cannot b< 
extrapolated to the highly heterogeneous group of patients with FUO 7"13. 
In this study we found that many investigations are used as screeninc 
procedures in the diagnostic process of patients with FUO whereas th< 
diagnostic yield of these techniques in this setting has not been established 
The use of diagnostic protocols and algorithms has been validated neither 
4 ' 
Inquiry into the diagnostic workup of patients with FUO 
We developed a standardized diagnostic protocol based on a retrospective 
analysis of diagnostic management 14 and data from this study. This staged 
protocol (Table 3.4) consists of an obligatory part used in the first week of 
admission and a two-staged diagnostic part only to be used in patients 
without potentially diagnostic clues (PDCs). A prospective study on the 
diagnostic yield of this staged screening diagnostic protocol is in progress. 
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Utility of scintigraphic methods in patients with FUO 
Abstract 
Background: We assessed the utility of scintigraphy with ¡ndium-111 -labeled 
polyclonal human IgG (111ln-lgG) scintigraphy in patients with fever of 
unknown origin (FUO) that fulfilled the criteria of temperature of 38.3 C° or 
more on at least three occasions for at least 3 weeks and no diagnosis during 
one week of hospital admission. We compared the utility of this technique 
wi th results of scintigraphic techniques reported in the literature. 
Methods: Data for all patients seen at our university hospital in whom 111 ln-
IgG scanning was performed were analyzed and checked for the criteria for 
FUO. The literature on the utility of scintigraphic techniques in patients wi th 
FUO was reviewed. 
Results: We studied 24 patients wi th FUO. In 13 patients, focal i n l n - lgG 
accumulation was observed. In nine of those, the positive n 1 ln- lgG scintigram 
led to the final diagnosis; in the other four patients (17%), the scintigraphic 
findings were not helpful. In the 11 patients wi th negative 111 In-IgG scans, 
extensive diagnostic workup produced no infection as the final diagnosis in 
nine patients, one had an abscess in a renal cyst that was detected several 
months later, and in the other the cause of fever was an infected intravenous 
line. The overall sensitivity and specificity of 1 l1 ln-lgG scintigraphy were 8 1 % 
and 6 9 % , respectively. Positive predictive value was 6 9 % and negative 
predictive value was 8 2 % . 
Conclusion: Our results show that 111ln-lgG scintigraphy contributed to the 
diagnostic process in patients wi th FUO. A positive scan increased the 
likelihood of finding the cause of the fever, and a negative scan ruled out an 
inflammatory component wi th a high degree of certainty. These data compare 
favorably wi th data in literature concerning other radiopharmaceuticals; a 
larger prospective evaluation of this technique is indicated. 
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Introduction 
Fever of unknown origin (FUO) has been defined by Petersdorf and Beeson ] 
as a febrile illness of more than 3 weeks' duration, documented temperature 
of 38.3 C° or higher on at least three occasions, and uncertain diagnosis 
after 1 week of diagnostic workup in the hospital. Currently, a variety of 
diagnostic imaging procedures, including radiography, magnetic resonance 
imaging, ultrasonography, and scintigraphy, are potentially useful in patients 
with FUO. 
With regard to scintigraphic imaging, gallium 67 2"9, white blood cells (WBCs) 
labeled with indium-111 ( l l 1 ln) 10'12, and, most recently, technetium (Tc99m)-
labeled BW250/183, an anti-granulocyte monoclonal antibody of murine 
origin 13, has been applied in patients wi th FUO to detect infectious and other 
inflammatory foci . A positive scintigram enhances the likelihood of 
establishing a final diagnosis 8. 
A relatively new and potentially useful technique for this indication is 111 ln-
labeled polyclonal human IgG (111ln-lgG) scintigraphy. Recently, the utility of 
11l ln-lgG scintigraphy in the evaluation of various types of focal inflammation 
and infection has been studied. Reports have been published in the literature 
on bone and joint infections 14,15, abdominal 16, pulmonary 17, and vascular 1S 
lesions. This technique is also applicable in granulocytopenic patients 19. 
Since 111ln-lgG is a convenient and safe radiopharmaceutical, comparing 
favorably wi th other scintigraphic techniques, we studied its diagnostic utility 
in patients wi th FUO. 
Material and methods 
Patients 
Records of all patients who underwent 111ln-lgG scintigraphy in our hospital 
were reviewed for FUO \ Twenty-four patients (11 women and 13 men; 
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mean age 51 years, median 52 years) fulfilled the Petersdorf and Beeson 
criteria for FUO. From our studies of FUO carried out during the same period, 
we found that 4 5 % of the patients with FUO had undergone n i l n - lgG 
scintigraphy. All patients underwent full biochemical and appropriate further 
investigations, including extensive microbiological methods, which failed to 
establish a diagnosis within 1 week of admission. These investigations varied 
from patient to patient; no protocol was fol lowed. The median fol low-up of 
these patients was 216 days (range, 2 to 1500 days). The final diagnosis 
was made by the patients' physicians and checked by the first author. 
Radiopharmaceutical 
Human nonspecific polyclonal IgG (Sandoglobulin, Sandoz AG, Nürnberg, 
Germany) was conjugated to diethylenetriamine pentaacetic bicyclic 
anhydride (bicyclic DTPA) according to the method described by Hnatowich 
et al. 20 and labeled with n i l n chloride (Medgenix Diagnostics, Fleurus, 
Belgium. Labeling efficiency was always greater than 95%. A dose of 1 to 2 
mg of IgG labeled with 75 MBq 111ln was injected intravenously. 
Imaging procedures 
Exclusion criteria for 111ln-lgG scintigraphy were agammaglobulinemia, 
selective IgA deficiency, and a history of severe adverse reactions after 
intravenous or intramuscular administration of human IgG. Pregnant or 
lactating women were also excluded from this study. Scintigraphic images 
were obtained wi th a gamma camera (Siemens Orbiter, Siemens Ine, Hoffman 
Estates, III.) connected to an image processor (Scintiview, Siemens Ine). All 
images were collected in digital format in a 256 χ 256 matrix. A medium-
energy parallel-hole collimator (173 KeV peak, 1 5 % symmetric window; 247 
KeV peak, 1 5 % symmetric window) was used. 1 1 1 ln-lgG images were 
acquired 4, 2 4 , and 48 hours after injection for a preset time of 5, 7.5, and 
10 minutes, respectively. At least once, 24 hours after injection, spot views 
of the total body were obtained. 
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Table 4.1. Characteristics patients according to results of 1"/n-lgG scans 
Ptn/ 
Age,γ 
1/81 
2/67 
3/23 
4/65 
5/63 
6/33 
7/4B 
8/46 
9/63 
ESR 
(mm) 
93 
132 
40 
140 
90 
70 
72 
136 
20 
Clinical data 
Arthritis of knee, 
heart murmur 
Lumbar pain 
Lymphadenopathy, 
L* 
11 4 
8 5 
12 7 
abdominal pain, arthritis 
No abdominal 
complaints 
No abdominal 
26 5 
5 7 
complaints, steroids 
Hecurrent pain 7 6 
abdomen, no diarrhea 
Polyarthritis, 
pleural effusion 
Thoracic pain, 
pleural effusion 
Polyarthritis, 
diarrhea 
5 4 
6 6 
1 0 9 
localization uptake 
fever 
duration(wks) 
final diagnosis 
TRUE POSITIVE SCANS 
4 
8 
7 
22 
3 
7 
8 
11 
20 
Right knee 
Left hip, back 
Right lower abdomen 
Right lower abdomen 
Right lower abdomen 
Ascending colon 
Both lungs 
left hip, knee 
Right lung 
No activity kidney 
Tuberculous arthritis 
Spondylitis,arthritis 
with Streptococcus, 
Crohn's disease 
Ileum metastasis of 
surgically cured lung 
Abscess with E coli 
after appendicitis 
Ulcerative colitis 
Inflammatory lung 
disease, C-negative 
periostitis 
Pleural empyema, 
additional 
studies* 
puncture,С 
B,C,X 
Ρ acnes 
coloscopy 
X, CT,S,PE 
cancer 
US,S 
X, PE 
coloscopy 
Open lung В 
US,C,B,CT 
DSA.blood 
CT,X,B,US,C 
spondylitis {St aureus) 
Hydronephrosis in 
colon cancer, 
US, X, S, PE 
coloscopy 
E coli in urine 
FALSE POSITIVE SCANS 
10/49 50 Fatigue, recurrent 8 1 
fever for 5 у 
11/61 120 Nonspecific pain 8 5 
right hip s г 
12/25 75 Abdominal pam, 3 9 
extreme weight loss 
13/44 1 2 Dyspnea, heart 1 3 4 
murmur, s r 
53 Both hips 
7 Right hip 
Aseptic necrosis hips, X, Te bone 
no diagnosis scan,US,В 
No diagnosis S, С 
4 Nose, left axilla SLE, non-specific 
lymphadenopathy axilla 
23 Ascending colon No diagnosis 
В, CT, blood 
blood, C, 
(continued) 
Abbreviations: US indicates ultrasound, CT, computed tomography, B, biopsy, C, culture, S, surgery, MR, 
magnetic resonance imaging, X, x-ray, BM, bone marrow aspiration, PE, pathologic examination, DSA, 
digital subtraction angiography, and Tc, technetium, s r, spontaneous recovery, I e , Leukocytes (x109/l) 
# Investigations performed to verify the diagnosis are shown in boldface For true positive scans, all 
additional investigations were performed for verification 
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Table 4.1. Characteristics of patients according to results of "Ίη-lgG scans1 
(continued) 
Ptn/ 
Age.V 
ESR 
(mm) 
Clinical data 
localization uptake 
fever final diagnosis 
duration(wks) 
additional 
studies* 
FALSE NEGATIVE SCANS 
23/54 
24/68 
14/25 
15/77 
16/62 
17/52 
18/46 
19/63 
20/53 
21/35 
22/27 
93 
71 
89 
112 
96 
4 0 
140 
112 
14 
5 
4 
Heart murmur, 
kidney transplant, 
renal cysts 
Scleroderma, 
heart murmur, 
Heart murmur 
Indonesian travel 
Cough, diarrhea, 
Fatigue, s.r. 4 mo. 
Fatigue, weight loss 
pigeon fancier, 
s r after 10 mo 
Myalgia of legs 
fatigue, anorexia 
Fatigue, lumbar pain 
transient diarrhea 
s г. after 4 mo 
Persistent, recurrent 
fever > 4 yr 
Tick bite, recurrent 
fever with headache 
s.r. after 1 yr 
Fatigue, s r 10 mo 
11.7 
14 5 
6.1 
7.4 
10.0 
5.5 
5 5 
11.1 
4 6 
4.4 
7.1 
5 
5 
None 
None 
Infected renal cyst 
culture - after use 
of several antibiotics 
Central catheter 
infection 
TRUE NEGATIVE SCANS 
6 
17 
13 
12 
30 
3 
88 
51 
18 
Equivocal (pelvis) 
None 
None 
Equivocal (right 
lower abdomen) 
Equivocal (lungs) 
None 
None 
None 
Equivocal (colon) 
Salmonella sepsis, 
Hodgkin's disease 
lung cancer 
No diagnosis 
No diagnosis 
Acute leukemia 
No diagnosis 
No diagnosis 
B,X,blood,C 
No diagnosis 
No diagnosis 
S,C 
CT,X,US,C 
blood 
X, blood.C 
S, В 
BM, CT, с, 
US, blood 
X, B, CT, 
US,C 
CT, US, BM 
Bone biopsy 
US, CT,X, 
B,blood,С 
MR, CT, US, 
CT, X, В, С, 
blood, US 
US, blood.C, 
coloscopy, 
Abbeviations: US indicates ultrasound; CT, computed tomography; B, biopsy; C, culture; S, surgery; MR, 
magnetic resonance imaging; X, x-ray; BM, bone marrow aspiration; PE, pathologic examination; DSA, 
digital subtraction angiography; and Tc, technetium; s г., spontaneous recovery, I e , Leukocytes (x109/l) 
№ Investigations performed to verify the diagnosis are shown in boldface For true positive scans, all 
additional investigations were performed for verification 
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Fig. 4.1. Patient No. 2: abnormal uptake in the left hip and back due to 
spondylitis. 
Single-photon-emission computed tomography images were recorded when 
necessary for more definite localization in three dimensions of areas with 
increased uptake. All images were interpreted by three observers, "blinded" 
to the results of the verification procedures. Disagreements were resolved by 
consensus opinion. Hyperemic non-inflamed lesions may initially show some 
uptake but no further accumulation of 111 In-IgG with time 21. These scans 
were interpreted as equivocal and not pathologic. An 1 l1 ln-lgG scan was 
interpreted as positive only if consistent, focally increasing accumulation 
could be noted over time. An 111ln-lgG scintigram was considered "true 
positive" only when this imaging procedure was considered helpful in 
diagnosis. The results of the scintigraphic findings were verified by clinical, 
radiographic and ultrasonographic methods and preferably by microbiological 
methods. 
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Fig.4.2. Patient No. 3: abnormal uptake in the right lower abdomen due to 
Crohn's disease. 
Statistics 
Differences between groups were analyzed by the Mann-Whitney U test or 
Student's f test, when necessary. 
Results 
In 13 (54%) of 24 patients, focal accumulation of activity increasing with 
time was observed. In nine patients (38%), scintigraphy was diagnostically 
helpful (Table 4.1); in eight of these, inflammatory or infectious foci were 
identified as cause of the fever (Figure 4.1 and Figure 4.2). In four other 
patients (17%), a positive 111ln-lgG scintigram did not lead to the final 
diagnosis. Table 4.1 also shows the data for the remaining 11 patients, in 
whom a negative or equivocal 111ln-lgG scintigram was obtained. In six of 
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those patients, extensive workup disclosed no diagnosis; follow-up from the 
start of fever varied from 224 to 929 days (median, 515 days). In two 
patients a neoplasm most probably was the cause of fever, and one patient 
had positive blood cultures with Salmonella paratyphi serotype A. The two 
remaining patients had infections as the cause of the fever despite negative 
IgG scintigraphy; one had an infected renal cyst, diagnosed 3 months after 
the negative 1l1ln-lgG scan, and the other an infected central venous catheter. 
If we considered results of i n ln-lgG scintigraphy as true positive only when 
this imaging procedure led to the diagnosis, sensitivity of this technique was 
8 1 % , specificity was 69%, and positive and negative predictive value was 
69% and 82%, respectively. 
Comparison of the erythrocyte sedimentation rate of patients with positive 
scans (mean ± SD, 80.8 ± 43.0 mm/h) with that of patients with negative 
scans (mean ± SD, 70.5 ± 47.5 mm/hr) yielded no significant difference. 
Likewise, WBC counts of patients with positive scans (mean ± SD, 9.9 ± 
5.7 χ 109/L) and patients with negative scans (mean ± SD, 8.0 ± 3.3 χ 109/L) 
did not differ significantly. 
Comparison of the groups with positive and negative l11ln-lgG scans showed 
that a positive scan significantly increased the likelihood of reaching a 
diagnosis; in 10 (77%) of 13 patients with a positive scan, a final diagnosis 
was made, compared with only five (45%) of 11 patients with a negative 
scan (P < .05). 
Discussion 
From this study, it can be concluded that n i ln-lgG scintigraphy is a promising 
technique in the workup of patients with FUO, as indicated by an overall 
sensitivity of 82% and specificity of 69%. These results compare favorably 
with data in literature dealing with other radiopharmaceutical (Table 4.2). 
53 
Utility of scintigraphic methods in patients with FUO 
Table 4.2. Reports on diagnostic value of scintigraphy in patients with FUO* 
YEAR/SCAN SCAN RESULT, N0.(%) Sensitivity Specificity 
SOURCE N TP (%) FP (%) TN (%) FN (%) % % Remarks 
1990 /Ga 67 49 8(16) 17(35) Abstract 
Nakamura et al2 
1990 /Ga 67 56 23(41) 10(17) 19(35) 4 ( 7 ) 85% 65% Selected group, 
Misaki et al3 abstract 
1 9 7 9 / G a 6 7 61 47(77) 3 ( 5 ) 11(18) 0 ( 0 ) 100% 79% no criteria FUO 
Hilson and Maisey4 (postoperative) 
1975 /Ga 67 42 9(21) 5(11) 25(61) 3 ( 7 ) 75% 83% Selected group 
Teates and Hunter5 no criteria FUO 
1991 /Ga 67 36 17(47) 0 ( 0 ) 15(42) 4(11) 80% 100% Retrospective, 
Suga et al6 other criteria FUO 
1975 /Ga 67 22 12(54) 5(22) 3(15) 2 ( 9 ) 86% 38% Postoperative pts 
Habibian et al7 no definition FUO 
1991 /Ga 67 54 14(26) 8(15) 28(51) 4 ( 7 ) 78% 78% Selected group 
Knockaert et al8 FUO criteria 
1982 /Ga 67 40 10(25) 9(23) 18(45) 3 ( 7 ) 77% 67% FUO criteria 
Larson et al23 selected group, 
1994 /Ga 67 145 42(29) 40(28) 54(37) 9 ( 6 ) 82% 57% FUO criteria 
Knockaert et al9 selected group 
1987 / , 1 1 l n WBC 32 7(21) 4(13) 21(66) 0 ( 0 ) 100% 84% FUO criteria 
Schmidt et al10 selected group 
1 9 8 7 / ' " I n WBC 68 19(28) 7(10) 40(59) 2 ( 3 ) 90% 85% Other criteria FUO 
Syrjälä et al11 selected group 
1979 / 1 1 , l n WBC 13 3(24) 1 ( 7 ) 9(69) 0 ( 0 ) 100% 90% No criteria FUO 
Me Dougall et al12 without PDCs 
1 9 9 0 / 1 l , l n WBC 28 5(18) 5(18) 18(64) 2 ( 7 ) 7 1 % 86% FUO criteria 
Davies and Garvie24 retrospective 
1993/Tca-NCA 34 8(24) 1 ( 3 ) 13(38) 12(35) 40% 92% FUO criteria 
Becker et al13 retrospective 
present/ ' " I n IgG 24 9(38) 4(17) 9(38) 2 ( 8 ) 8 1 % 69% FUO criteria 
study retrospective 
* FUO indicates fever of unknown origin; FUO criteria are criteria for FUO according to Petersdorf; TP, true 
positive; FP, false negative; TN, true negative; FN, false negative; Ga 67, gallium citrate Ga 67; l11ln, 
indium-111, Tc, technetium; WBC white blood cells; and a-NCA, anti-nonspecific cross-racting antigen. 
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Most scintigraphic studies in FUO have been performed with gallium citrate 
(Ga 67) 2 β , ° ' 2 2 and 1 1 ,ln-WBCs 1 0 1 2 · 2 3 . For scintigraphic studies with Ga 67, 
sensitivity ranged from 7 5 % to 1 0 0 % and specificity varied widely, ranging 
from 3 8 % to 1 0 0 % . For 111ln-WBC scintigraphy, sensitivity and specificity 
appeared to be much higher, ranging from 90 to 1 0 0 % and 8 4 % to 8 6 % , 
respectively. When these data are compared, 1 1 1ln-WBC scintigraphy seemed 
to perform somewhat better than Ga 67 scintigraphy and 1 1 1 ln-lgG 
scintigraphy. However, many studies did not adhere to the classic criteria for 
FUO formulated by Petersdorf and Beeson 4 7 U U I some even include 
postoperative patients with fever, who often have a localized abscess 4 7 . 
Those results cannot be extrapolated to those patients with classic FUO, 
making comparison of these data somewhat hazardous. Moreover, in other 
studies, only a selection of patients with FUO was included 3.s.e,io,ii,i3.22.24_ 
Knockaert et al. B found in patients wi th FUO that a positive Ga 67 scintigram 
increased the chances of reaching a final diagnosis; 7 7 % of patients with 
positive scans in contrast to 3 4 % of those with negative scans were given a 
final diagnosis. This is in agreement wi th our findings wi th the use of 1 1 1 l n -
IgG: a final diagnosis was made in 10 (77%) of 13 patients with a positive 
scan and in five (45%) of 11 patients with a negative scan. In previous 
experience with more than 1000 patients studied with 1 1 1 ln-lgG for a variety 
of indications , 4 , 2 \ this technique had a high diagnostic yield, and in 
comparison with Ga 67 and , n ln-WBC scintigraphy, it has many advantages. 
First, unlike Ga 67 and Tc99m hexamethylpropyleneamine oxime-labeled 
WBCs, 1 1 1ln-lgG is not secreted in the normal bowel, leading to better 
detection of abdominal infections or inflammation. In addition, the radiation 
burden of Ga 67 is higher than that of 1 1 T ln-lgG, i.e. an effective dose 
equivalent of 27 and 15 mSv, respectively 2 1 , 2 5 . In chronic infection, 
sensitivity of labeled WBC scintigraphy might be limited by the absence of 
granulocyte influx in this type of infection 2 6 . In a prospective comparative 
study in subacute infections, with the use of 1 1 1ln-WBC and 1 1 1 ln-lgG 
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scintigraphy, Oyen et al. 17 found a higher diagnostic accuracy of 111ln-lgG 
scintigraphy. The need to draw blood and label leukocytes makes 111ln-WBC 
and 99mTc-WBC scintigraphy more time-consuming, complicated, and costly 
then 111ln-lgG scintigraphy. It takes 3 hours to prepare the 
radiopharmaceutical, and not every department of nuclear medicine has the 
facilities to label leukocytes. Of major concern are the handling of blood and 
the possibility of administering the cells to the wrong patient 27. There is a 
limitation to the use of all scintigraphic techniques, including 111ln-lgG: lesions 
in organs with relatively high physiological uptake, e.g. liver, heart, spleen, 
and kidneys, can be missed. Because of the advantages and the high 
diagnostic yield, 111ln-lgG scintigraphy may become the first choice in 
scintigraphic investigations in patients with FUO. Since the current study, like 
almost all studies on scintigraphic methods in FUO, was retrospective, the 
exact role in the exact role of 111 In-IgG scintigraphy in the diagnostic process 
of patients with FUO is unknown. Prospective studies are necessary to 
provide such additional information. 
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Introduction 
Fever of unknown origin (FUO) is an intriguing medical problem. Petersdorf 
and Beeson 1 defined FUO as an illness characterized by rectal temperature of 
38 .3°C or higher on at least three occasions, evolving during at least 3 
weeks, wi th no diagnosis reached after 1 week of inpatient investigation. 
Many retrospective 2"12 and a few prospective 13"17 studies of patients wi th 
FUO have been performed using this definition. Other series that have 
appeared used different criteria 18"29, and their results are more difficult to 
interpret. A more recently revised definition, excluding immunocompromised 
patients 16'30'31, has not been employed in major series yet. 
The spectrum of diseases causing FUO not only seems to be determined by 
geographical factors, but also appears to change wi th time. In recent series, 
the proportion of patients in whom no diagnosis is made, has been found 
increased as compared to older series 12,16. In addition, comparison is 
troublesome because on the one hand most studies do not use uniform 
epidemiological entry criteria, thus possibly introducing unintended bias, on 
the other hand differences in diagnostic work up can influence the outcome. 
Consequently, the use of uniform entry criteria and continuous audit for 
completeness are necessary and a standardized diagnostic workup is 
preferable. 
To update information on FUO and entertain these new ideas, we conducted 
a prospective, two-year study on patients wi th FUO in all 8 Dutch university 
hospitals, in which we excluded immunocompromised patients and used a 
standardized protocol to minimize diversity in diagnostic management. This 
protocol was based on retrospective analysis of diagnostic management 10, 
and an in-depth inquiry into diagnostic management, among internists in the 8 
Dutch university hospitals 32. 
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Methods 
The present study was undertaken from January 1992 to January 1994. 
Since we wanted to enroll all admitted patients fulfilling criteria for FUO, 
without any unintended selection bias, two very broad initial selection criteria 
were used. Firstly, all records of non-immunocompromised patients with fever 
on the internal medicine wards in all 8 university hospitals in the Netherlands, 
were reviewed for the Petersdorf and Beeson criteria for FUO once a week 
(illness characterized by rectal temperature of 38.3°C or higher on at least 
three occasions, evolving during at least 3 weeks, with no diagnosis reached 
after 1 week of inpatient investigation). Total bed capacity of each of the 8 
university hospitals ranged from 715 to 1260 beds. As immunocompromised 
patients were considered patients with neutropenia for at least 1 week, 
within 3 months before the onset of fever (WBC < 1.0 χ 109/l and/or 
granulocytes < 0.5 χ 109/l), H.I.V. positive patients, patients with known 
hypogammaglobulinemia (IgG < 50%) and patients using the equivalent of 
more than 10 mg prednisone for at least 2 weeks. Secondly, and as an 
additional check, all blood culture orders were reviewed weekly at the 
microbiological laboratory and the records of all patients in whom blood 
culture were ordered were reviewed. The latter procedure was added because 
in a retrospective study 10 we had found that in all patients with FUO blood 
cultures were performed. After thus having identified all patients with fever, 
we applied the Petersdorf and Beeson criteria1, as described before. By 
combining these two methods, we minimized the chance of missing patients 
fulfilling FUO criteria. 
The study was approved by all local ethic committees. After informed 
consent, patients were included in our FUO protocol, which consisted of a 
standardized pre-coded history and standardized thorough physical 
examination. A number of additional investigations at least had to be 
performed in the first week of admission (Table 5.1). 
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Table 5.1. Obligatory investigations performed in all patients. 
Sedimentation rate; hemoglobin; mean cellular volume; platelet count; leukocyte count and 
differential count; creatinine; sodium; potassium; protein; protein fractions; alkaline phosphatase; 
aminotransferase; lactate dehydrogenase; creatine Phosphokinase; antinuclear antibodies; 
rheumatoid factors; urinary analysis; feces for occult blood; blood cultures aerobic and 
anaerobicfn = 3); tuberculin skin test; urine-, feces-, and sputum culture when indicated; chest 
X-ray; ultrasonography of upper abdomen; 
Much weight was given to the presence or absence of potentially diagnostic 
clues (PDCs), defined as all localizing signs, symptoms, and abnormalities 
potentially pointing towards a possible diagnosis, and the use of these PDCs 
in the diagnostic process. Misleading PDCs are defined as PDCs eventually 
not leading to the definite diagnosis. History, physical examination, laboratory 
and technical investigations, the presence of PDCs and their use in the 
diagnostic process were prospectively registered in a structured data 
collection form. If PDCs were present, investigations that were considered 
appropriate, were performed. If PDCs were absent or misleading only, 
patients underwent a standardized diagnostic protocol (Table 5.2). Within 1 
week of inclusion in the study, every patient was seen by the first author in 
order to streamline the management of the patients. 
The final diagnosis was established by the attending physician and the first 
author. Definite diagnoses were established by positive serology, cultures or 
histology. In some patients probable diagnoses were established by excluding 
other diseases or by the response to specific therapy or by studying the 
course of the disease. 
A long follow-up was deemed indispensable for all patients in whom a final 
definite diagnosis could not be made. A final follow-up was therefore per­
formed more than 2 years later in March 1996, by analysis of the records of 
the patients, and telephone-calls to the treating physicians and patients. 
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Table 5.2. diagnostic protocol performed in patients without PDCs. 
Phase 1. 
Pulse/rectal temperature measurement by observer, fundoscopy by an ophthalmologist Calcium, 
phosphate, urate, amylase and TSH/T4, Immunoelectrophoresis serum and urine, CRP, ACE, 
ANCA, anti-dsDNA, ASO, cryoglobulin, C3, C4, CH50, serology for Cytomegalovirus, Epstem-
Barr virus. Mycoplasma, Brucella, Toxoplasma, Borrelia, Coxiella, Treponema, Yersinia, blood 
cultures incubating for more than 1 week, stools for worms, eggs, cysts, blood cultures, gastric 
fluid, urine cultures for tuberculosis, bone marrow aspiration for cytology and culture for 
Mycobacteria, Brucella, Yersinia, ln-111-lgG scintigraphy, X-Ray of sinus and teeth, 
ultrasonography of pelvis 
Phase 2. (performed when phase 1 does not reveal PDCs or diagnosis) 
hepatitis В serology, anergy tests, liver biopsy for histology and culture for Mycobacteria, 
bacteria and fungi, repeated chest X-ray, IgD in serum, bone biopsy for histology and culture for 
Mycobacteria, Brucella and bacteria, echocardiography, CT of abdomen, CT of chest, X-Ray of 
colon and temporal artery biopsy in patients over 55 years 
Abbreviations- ACE = Angiotensin-Converting enzyme, ANA = antinuclear factor, ANCA = Antineutrophil 
cytoplasmic autoantibodies, ASO = antistreptolysin 0 test, С = complement, CH50 = total hemolytic 
complement, CRP = C-reactive peptide, CT = computer tomography, dsDNA = double-stranded 
deoxyribonucleic acid, ESR = erythrocyte sedimentation rate, IF = immunofluorescence, ln-111-lgG = 
lndium-111-labeled polyclonal human Immunoglobulin G, LDH = lactate dehydrogenase, PDCs = 
potentially diagnostic clues, PPD = purified protein derivative, T4 = Thyroxine, TSH = Thyroid-stimulating 
hormone 
Recurrent fever was defined in this study as at least two episodes of fever, 
with intervals of at least 48 hours without fever. 
Statistics 
Data were statistically analyzed and groups of patients compared with use of 
Fisher's exact test. A Ρ value of < .05 (two-sided) was considered to be 
significant. 
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Results 
Clinical features. 
During the two-year period of study, 167 patients (80 males, 87 females) met 
the criteria of FUO. The median age was 53 years (range 1 6 - 8 7 years), 46 
patients (28%) were older than 65 years. Of these patients, 139 patients 
were found by reviewing weekly the records of all patients with fever, in all 
of these patients blood cultures were done. By means of blood culture 
surveys an additional 28 patients were retrieved that fulfilled FUO criteria and 
were not recognized as such when checking the records. 
Sixty-five (39%) patients were referred by general practitioners and 64 (38%) 
had already undergone extensive investigations before referral to a university 
hospital, whereas 7 patients (4%) were referred by other departments within 
the university hospitals and 31 patients (19%) were already known with 
other non-febrile conditions at the university department. The proportion of 
patients in whom no diagnosis could be made was slightly lower, albeit not 
significantly, for patients referred by general practitioners (26%) than for 
secondarily referred patients (33%). If we consider the 117 patients wi th a 
diagnosis, a diagnosis was established after a median of 60.5 days from the 
onset of fever (range 21 - 1,584 days) in those referred by general 
practitioners, whereas in patients referred by non-university hospitals it took a 
median of 166 days (range 22 - 3,347 days) (P = .005). 
Median overall fol low-up after admission was 854 days (range 10 - 3,387 
days). In 30 patients (18%) fol low-up was less than 0.5 years. Fifteen of 
these 30 patients died within this period, only one of them without a 
diagnosis. In the other 15 patients, diagnosis was proven in 14 patients. One 
patient wi th probably venous thrombosis as cause of her fever could not be 
traced during fol low-up. The median follow-up of 50 patients without a 
diagnosis and 48 patients wi th a probable diagnosis was 1080 days (range 
15 days - 3387 days). In only 3 of these 98 patients follow-up was less than 
1 year. Median duration of hospitalization was 27 days (range 7 - 295 days). 
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Median duration of fever in the group of 117 patients in whom a diagnosis 
was made was 78.5 days (range 21 - 8,804 days). Of the 50 (30%) patients 
in whom no diagnosis was made, 37 patients recovered spontaneously after 
a median of 190 days (range 30 - 13,844 days). Thirteen patients remained 
febrile and these patients had a median duration of fever of 1021 days (range 
481 - 5,281 days). Except for one patient, patients wi th persistent fever all 
had some form of recurrent fever. 
Recurrent fever was present in 56 patients. In 28 of these patients (50%) no 
diagnosis could be established, in contrast to 22 out of 111 patients (20%) 
with continuous fever (P < .0001). 
In 67 patients the fever lasted longer than 6 months. In 37 patients (55%) no 
diagnosis could be made, contrasting to 18 out of 100 patients (18%) with 
fever shorter than 6 months (P < .0001). 
Diagnosis and outcome. 
In 117 patients in whom a diagnosis was made, diagnostic phase in the 
university hospital (after referral) took a median of 33 days (range 1 - 1,297 
days). In 42 patients the diagnosis was made after discharge during fol low-up 
because of new emerging facts. Of the 167 patients in this series, 20 
patients died during fol low-up, in 18 of them a diagnosis was made; in 4 not 
until after autopsy. All but 1 patient succumbed to the disease responsible for 
the FUO. Infections were found in 43 (26%) patients, neoplasms in 21 (13%) 
and non-infectious inflammatory diseases in 40 patients (24%) (Table 5.3). 
INFECTIONS. 
In 4 patients, abscesses were the cause of fever. In the first two patients this 
were liver abscesses caused by Escherichia coli (E. coli), Proteus mirabilis and 
Bacteroides fragilis in the first patient, in the second patient the abscess was 
culture negative at autopsy after empirical antibiotic therapy. The delay of 
diagnosis in these patients was due to inconclusive ultrasound examinations. 
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In one patient, the second ultrasonography revealed multiple abscesses in the 
liver, in the other patient a biopsy of the liver yielded the diagnosis. In the last 
two patients pelvic abscesses were the cause of fever, in the first patient by 
Peptococcus spp., in the second by E. coli and Streptococcus milleri. In these 
patients the delay was due to failure to order pelvic ultrasonography due to 
the absence of lower abdominal pain. There were two patients wi th pleural 
empyema. In one, the chest radiography was wrongly interpreted resulting in 
a delay in the diagnosis. Scintigraphy and thoracal computer tomography led 
to the diagnosis and culture of pleural fluid grew Peptococcus spp. In the 
second patient pleural fluid cultures were sterile, but pleural biopsies yielded 
Actinomyces spp. 
In 5 patients urinary tract infection turned out to be the cause of fever; two 
of them received antibiotics for other presumed infections at the time of the 
first urine culture. In both patients, urine cultures yielded K. pneumoniae 
eventually. In one patient recurrent prostatitis was suggested by transrectal 
sonography and culture of prostatic secretion yielded K. pneumoniae. In one 
patient chronic xanthogranulomatous pyelonephritis wi th obstruction of the 
ureter was demonstrated by abdominal CT, blood- and urine cultures 
remained negative. In the f i f th patient balanitis accompanied the urinary 
infection and cultures grew E. coli; after circumcision fever subsided. 
Endocarditis was found in 4 patients. Culture-negative endocarditis occurred 
in two patients, and the diagnosis was not made until autopsy by histology. 
In one of these two patients echocardiography had been negative, in the 
other echocardiography was not performed, because of the presence of 
mislaeding PDCs. In the third patient, cultures became positive for 
Streptococcus bovis when empiric antibiotic therapy was stopped. In the 
fourth patient, blood cultures were not drawn in the referring hospital and 
empirical antibiotics were given. Because of deterioration the patient was 
referred to our hospital and two days later blood cultures yielded 
Staphylococcus aureus. 
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Tab/e 5.3. Final diagnoses in 767 patients with fever of unknown origin. 
CATEGORY NO. OF CASES (% OF TOTAL) 
Infection 
Bacterial: 
abscess / lung empyema* (1 pt with urinary tract infection 
urinary tract infections* 
endocarditis* 
atypical or recurrent pneumonia* 
tuberculosis* 
other bacterial infections* 
Viral: 
Cytomegalovirus infection 
other viral infections* 
Fungal: 
disseminated cryptococcal infection 
Neoplasm 
Hematologic* 
Solid* 
Non-infectious inflammatory diseases 
"Collagen diseases " 
adult onset Still's disease* 
mixed cryoglobulinemia 
other* 
"Vasculitis syndromes" 
temporal arteritis 
other* 
"Granulomatous diseases " 
inflammatory bowel diseases 
sarcoidosis 
other* 
Drugfever 
Factitious fever 
Miscellaneous* 
No diagnosis 
spontaneous recovery 
persistent fever 
also) 6 
5 
4 
6 
3 
12 
5 
2 
1 
14 
7 
6 
5 
8 
4 
10 
2 
2 
3 
37 
13 
43 (26) 
21 (13) 
40 (24) 
19 111) 
14(8) 
7 14) 
3(2") 
2 (1) 
8 (5) 
50 (30) 
* = see results 
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In six patients a clinical picture of pneumonia was present. In all X-rays of the 
chest showed segmental infiltrates consistent wi th bronchopneumonia. In 
three patients bronchoscopy wi th culture of bronchial fluid and serology for 
respiratory viruses. Chlamydia, Legionella, Mycoplasma pneumoniae and 
Coxiella burnetii were negative and thus no causative micro-organism could 
be found. The first patient had also mediastinal lymphadenopathy and some 
pleural effusion and had already received extensive antibiotic therapy 
(cephalosporin, amoxicillin, flucloxacillin and tobramycin) elsewhere without 
disappearance of fever. After referral, he recovered spontaneously after a 
total of eight weeks of fever. The second patient had received doxycycline, 
amoxicill in, gentamicin, cephazolin and erythromycin without improvement of 
his condition. Isoniazid, rifampin and pyrazinamide was given for 6 weeks 
without effect and stopped when cultures for tuberculosis remained negative. 
He recovered spontaneously over a 6-month period hereafter. The third 
patient was treated with penicillin, erythromycin and rifampin for four weeks, 
after this period temperature was below 38 °C, antibiotic therapy was 
stopped and patient recovered further during the next two weeks. In the 
fourth patient wi th pneumonia, H. influenzae and Stenotrophomonas 
maltophilia were cultured first. After antibiotic therapy with cefuroxime fever 
persisted. A second culture after stopping therapy revealed Moraxella 
cattarrhalis and antibiotic therapy with amoxicillin-clavulanate was successful. 
In the f i f th patient Pseudomonas aeruginosa was cultured. She was treated 
with ceftazidime intravenously but fever persisted. Because of a history of 
tuberculosis in the far past she was then treated wi th isoniazid, pyrazinamide 
and rifampin wi thout result. Repeated bronchoscopic examination and culture 
of bronchial fluid yielded Pseudomonas aeruginosa again. After prolonged 
therapy wi th ciprofloxacin she recovered after several weeks of therapy. In 
the sixth patient wi th pneumonia H. influenzae and Stenotrophomonas 
maltophilia were cultured. Erythromycin had already been given empirically 
without any effect and ciprofloxacin was added. By then Klebsiella 
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pneumoniae was cultured from the urine also. We concluded that this patient 
had two different infections as cause of the FUO. It took more than 20 days 
for her to recover and temperature to normalize. 
Tuberculosis was proved in 3 patients by culture. In the first patient 
pericardial puncture revealed the diagnosis. In the second patient a positive 
PPD and erythema nodosum suggested tuberculosis but no localization 
seemed present after inclusion. A somatostatin scintigraphy was performed 
which showed activity in the axillary region. An ultrasonographic biopsy of 
enlarged axillary lymph nodes showed acid-fast bacilli. Cultures grew 
Mycobacterium tuberculosis. The third patient had a recent history with 
breast cancer and bone metastasis and lymphangitis carcinomatosis was 
suspected. Corticosteroids were administered empirically. Because of 
deterioration and in accordance with the diagnostic protocol, sputum cultures 
for tuberculosis were performed, which showed acid-fast bacilli. Cultures 
grew M. tuberculosis eventually. 
Cytomegalovirus infection was proved in 5 patients by serology (a four-fold 
elevation of IgG titer); in all patients lymphocytosis and atypical lymphocytes 
in the blood smear were found initially but misleading PDCs delayed the 
diagnostic process. 
Other bacterial infections included persistent Yersinia enterocolitica infection 
(n = 2), diverticulitis (n = 2), recurrent sinusitis, cholangitis, adnexitis, 
bacterial meningitis in ventriculo-peritoneal drain with E. coli, typhoid fever, 
occult dental infection, secondary syphilis and infected central venous device 
with Staphylococcus epidermidis and aureus. 
NEOPLASMS. 
In 14 patients hematological malignancies were found. Hodgkin's disease was 
the cause of fever in 5 patients. In two patients, the diagnostic process was 
delayed, because their fever was erroneously attributed to previously 
diagnosed diseases (systemic lupus erythematosus and sarcoidosis). In two 
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others there was no lymphadenopathy and diagnosis was made by bone 
biopsy. In the f i f th patient there was only mediastinal localization of 
Hodgkin's disease and diagnostic workup took more than one week. 
In 4 patients non-Hodgkin's lymphomas were the cause of fever. In one 
patient very small abdominal lymph nodes found eventually by abdominal CT 
established the diagnosis, three years after successful allogenic bone marrow 
transplantation. Positive yersinia serology (Western blot) delayed diagnostic 
laparotomy in a second patient wi th abdominal lymphadenopathy. The third 
patient had a 3-year history of recurrent fever. Only misleading PDCs were 
present during first admission in the university hospital and because fever 
subsided, the standardized diagnostic protocol was not used. During the next 
episode of fever, anemia developed and bone biopsy revealed non-Hodgkin's 
lymphoma. The fourth patient had a 18-year history of progressive 
polyneuropathy, telangiectasis, muscle weakness, hepatomegaly and 
lymphadenopathy. Despite a large series of extensive investigations a 
diagnosis was never established. She had never been febrile before inclusion 
into our study when a malignant T-cell tumor was identified. Other 
hematological malignancies were angioimmunoblastic lymphoma (n = 2), 
acute leukemia, acute myelofibrosis and gamma-heavy-chain disease 
(Franklin's disease). 
In 7 patients a variety of solid tumors were responsible for the fever. Primary 
tumors were found in 2 patients, one wi th breast cancer and one wi th 
stomach cancer. Metastasis of breast cancer (n = 2), larynx cancer and 
adenocarcinoma of unknown origin were found in 4 other patients. In the 
seventh patient necrosis of a dermoid tumor in Gardner's syndrome was 
responsible for the fever. 
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NON-INFECTIOUS INFLAMMATORY DISEASES. 
"Collagen diseases" 
A diagnosis of adult-onset Still's disease was made in 6 patients. All patients 
met the Medsger and Christy criteria for adult-onset Still's disease 33, but the 
diagnosis was made after prolonged observation and exclusion of other 
diseases only. Other collagen diseases found in this series were mixed 
cryoglobulinemia (n = 5), systemic lupus erythematosus (n = 2), reactive 
arthritis (n = 2), polymyalgia rheumatica (n = 1), relapse of rheumatoid 
arthritis (n = 1), dermatomyositis (n = 1) and relapse polymyositis (n = 1). 
"Vasculitis syndromes" 
Temporal arteritis was found in 4 patients. Other vasculitis syndromes found 
in our series were hypersensitivity vasculitis (n = 3), poly-angiitis overlap 
syndrome (n = 2), Wegener's disease (n = 2), and Schnitzler's disease 
(urticarial vasculitis with monoclonal IgM), vasculitis accompanying 
rheumatoid arthritis and polyarteritis nodosa each in one patient. 
"Granulomatous diseases" 
In 2 patients granulomatous hepatitis and in 1 patient granulomatous myositis 
was found without underlying disease as cause of the fever. 
MISCELLANEOUS DISEASES 
The miscellaneous group encompassed aseptic meningitis without underlying 
disorders (Mollaret's meningitis) (n = 2), pseudogout (n = 2), gout, venous 
thrombosis, hyperthyroidism and allergic pneumonitis after radiation therapy 
each in one patient. 
Diagnostic process. 
PDCs were present in 162 (97%) patients. The ten most common PDCs were 
(number of patients between brackets): relevant diseases in past (131), 
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weight loss (93), relevant operation in past (68), headache (62), myalgia (58), 
diarrhea (50), vertigo (48), arthralgia (48), heart murmur (41), pulmonary 
abnormalities (38). These PDCs led to the diagnosis in 101 patients (62%). In 
48 of these 101 patients also misleading PDCs were present. No clues were 
present in 5 patients and in two of them no diagnosis was made. There was a 
small but not significant difference in reaching the diagnosis between patients 
with clues (73%) or patients without clues (60%). In 16 patients diagnoses 
were made with the help of the standardized diagnostic protocol (Table 6.3). 
More detailed information on PDCs and the utility of the diagnostic protocol is 
found in Chapter 6. 
Discussion 
In this prospective multi center study of 167 patients, FUO was due to 
infection in 26% of cases, neoplasms in 12%, non-infectious inflammatory 
diseases (NIIDs) in 24% and miscellaneous causes in 8%, whereas the 
diagnosis was not established in 30% despite every effort being made. This is 
in agreement with the findings of our retrospective study in a single 
institution 10 and those of other recent series 12,16 but in contrast to other 
reports (Table 5.4). There are a number of possible explanations for this 
phenomenon. First, 38% patients were referred after undergoing extensive 
investigations elsewhere, which seems comparable to Knockaert et al (28%). 
In most series of FUO exact data on referral pattern are lacking L7 '9 ·1 1 .™,^ 
One could speculate that more difficult-to-diagnose cases are referred, with a 
lower chance of reaching a final diagnosis. In our series however, the number 
of patients without a diagnosis was only slightly higher in the referred group. 
It is more likely that the introduction of advanced diagnostic techniques had a 
major impact. In many patients that would have been formerly classified as 
having FUO because of difficulty in reaching a diagnosis, a diagnosis 
nowadays is likely to be established before they meet the criteria for FUO. 
72 
Chapter 5 
Table 5.4. Diagnostic categories in major series on FUO (%). 
DIAGNOSTIC 
CATEGORY 
Infection 
Neoplasm 
Non-infectious 
inflammatory diseases 
"Collagen diseases" 
"Vasculitis syndromes" 
"Granulomatous diseases" 
Drugfever 
Factitious fever 
Miscellaneous 
No diagnosis 
1 3LDER MAJOR SERIES 
Petersdorf 
1961 1 
N = 100 
36 
19 
19 
1 
3 
15 
7 
(13) 
(2) 
(4) 
Larson 
198214 
N = 105 
30 
31 
15 
(5I 
(4) 
(8I 
0 
3 
8 
13 
Barbado 
19846 
N = 133 
32 
20 
16 
(3) 
111) 
(2) 
0 
4 
7 
21 
NEW SERIES 
Knockaert 
1992'6 
N = 199 
22.7 
7.0 
23.1 
(8 5) 
(10.61 
(4.0) 
3.0 
3.5 
15.1 
25.6 
present 
study 
N = 167 
25.7 
12.6 
24.0 
(11.4) 
I8.4I 
(4.2) 
1.8 
1.2 
4.8 
29.9 
This is especially true for disease-entities such as endocarditis, abdominal 
abscesses and malignant lymphoma that can be diagnosed easily by 
ultrasonography, a technique that is being used very early in the diagnostic 
process nowadays. This leaves us with a group of patients fulfilling classical 
criteria, in whom a diagnosis is much more difficult to make and who have 
mostly self-limiting or benign fevers. 
There has also been a shift in diseases that cause fever. For instance, in non-
immunocompromised patients, tuberculosis has become relatively rare. Many 
infections in our series were due to common micro-organisms. Petersdorf and 
Beeson ' excluded these diseases because they represented common entities. 
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It is, however, important for attending doctors to realize that FUO can be 
caused by such common diseases and micro-organisms which might be 
concealed by misleading PDCs or the use of antibiotics. 
Compared to other series from university hospitals1,8,12, tumors are not a 
common cause of FUO. This is in accordance with our retrospective survey 
and one other recent series11,16. This could be the result of the widespread 
use of advanced diagnostic techniques such as ultrasonography early in the 
diagnostic process for instance ultrasonography, computer tomography and 
serological techniques. As expected, some hematological malignancies remain 
difficult to diagnose because of lack of localizing symptoms. Metastases can 
be very small, while causing FUO and other paraneoplastic symptoms 34. The 
diagnostic process in patients wi th a history of malignancy, should be 
focussed on recurrence of the tumor. In contrast to other series, we used a 
dual method for case finding. In this way, all patients that presented with 
FUO were retrieved. It is of interest, that three of the six prospectively 
conducted studies on FUO did not mention the way in which cases were 
retrieved 1-14'17, whereas in the other three studies their methods still show a 
degree of selection bias 614 ,15, because no control system was used that 
could avoid missing patients fulfilling FUO criteria. Of course, serious 
selection bias cannot be prevented in retrospective studies. 
In accordance with the suggestions made by Durack and Street 30 and 
Petersdorf 31, we excluded immunocompromised patients wi th FUO, because 
these patients show an entirely different spectrum of diseases causing fever. 
One of the criteria for FUO is admission in hospital for one week, without a 
diagnosis being established. This is a time-related criterium, which may cause 
important differences, as it is dependent of the experience of the doctor, the 
facilities and differences in management between countries or even hospitals. 
The differences that can be caused by these criteria make comparison 
between different series difficult. In our opinion, the recommendation of 
Knockaert et al. 16 and Durack and Street 30 to shorten this period to three 
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days is not really an improvement for several reasons. First, a better way to 
reduce bias is to change from a time-criterium to a quality-criterium that 
requires a number of investigations to have been performed. We have used 
such a list (Table 5.1). One could add directional investigations based on 
PDCs, performed within the first week of admission. Second, a major reason 
to classify patients with FUO as such, is to indicate that we deal with a 
difficult or potentially difficult problem. In that context, maintaining the 
criterium of one week of clinical analysis seems appropriate to us, but 
perhaps in this context a difference in admission policy between the 
Netherlands and the USA plays a role. Third, it is our experience that three 
days is often too short to exclude diseases that are easy to diagnose, 
because the results of cultures and serology often take more than 2-3 days. It 
can be concluded that even if the criteria are adapted, comparison of series of 
patients with FUO remains troublesome. Geographic factors 4 , 5 r 9, age 
distribution of the study population 2Э, referral pattern, hospital setting 8'15, 
time and duration of study (changes in disease pattern and diagnostic 
management) have influence on the distribution of diagnostic categories. 
Selection bias augments when patients with FUO presenting at the 
outpatients' department are included; prospective case finding is much harder 
to realize and standardized diagnostic protocols are more difficult to 
implement. Howver, it would be very interesting to study this group of 
patients with a standardized protocol. 
The median duration of hospitalization and of diagnostic phase were 27 days 
and 33 days, respectively. These figures are in accordance with figures 
presented by Knockaert et al. 16 (25 and 19 days, respectively) and by our 
retrospective study 10 (a median of 23 days of hospitalization). In most other 
major series no such data are presented. In a review on patients with FUO in 
community hospitals, Kazanjian found that it took a median of 19 days to 
establish a diagnosis after a median duration of hospitalization of 11 days 8. It 
is possible that the difference between these data indicates a difference 
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between degree of difficulty of both patient groups. 
The chance of reaching a diagnosis in patients with recurrent fever and fever 
lasting longer than six months is relatively low. This was also found by 
Knockaert et al. 35. 
Nomenclature of the group of patients not having infections or neoplasms has 
not been similar in series on FUO. Terms like rheumatic diseases, multisystem 
diseases 1β, dyscollagenosis 2 5 , collagen diseases 1·3'4·11, collagen vascular 
diseases ^13·14·17·36, connective tissue diseases 7 · 9 1 5 , inflammatory disorders 3 0 
are used. Most series of FUO distinguish a category of diseases labeled as 
collagen disorders, which includes vasculitis and autoimmune diseases. Since 
only in few of these disorders, collagen is involved and an autoimmune nature 
is often difficult to prove, we would break a lance for using in future the term 
non-infectious inflammatory diseases (NIIDs). This category could also include 
granulomatous disorders, like inflammatory bowel disease and sarcoidosis, 
usually listed under miscellaneous disorders. A subdivision as presented by us 
in Table 5.3 and 5.4 still makes comparison to older series possible. NIIDs 
that are accompanied by fever often classify as FUO. In these diseases, fever 
may precede more typical manifestations or serological evidence by months. 
Moreover, many of these diseases can only be made by exclusion or after 
prolonged observation. 
Summary and conclusions 
All internal medicine wards in all 8 university hospitals in the Netherlands 
participated in this prospective study on FUO during a two-year period from 
January 1992 until January 1994 in order to update information on the 
spectrum of diseases causing FUO. 
We used fixed epidemiological entry criteria to achieve completeness of 
enrolment and avoid unintended selection bias. After entry, 
immunocompetent patients were included using criteria for FUO according to 
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Petersdorf and Beeson. A standardized diagnostic protocol was used and 
potentially diagnostic clues (PDCs) and their use in the diagnostic process 
were prospectively registered Thus, the criteria of classic FUO were adjusted 
to modern times immunocompromised patients were excluded and the time-
critenum "1 week in hospital without a diagnosis" was replaced by a quahty-
critenum stating that certain investigations had to be performed and PDCs 
had to be fol lowed adequately for at least 1 week, without certain diagnosis 
A total of 167 immunocompetent patients wi th FUO were thus retrieved, of 
whom 43 (26%) had infections, 21 (13%) neoplasms and 40 (24%) non-
infectious inflammatory diseases. In 50 patients (30%) no diagnosis was 
made, of whom 37 recovered spontaneously. 
This study confirms the changing spectrum of diseases causing FUO. Indeed, 
as shown by another recent study the group of patients wi th FUO, in whom 
no diagnosis can be made is extending, mostly it concerns self-limiting or 
benign fevers. Others have suggested that this trend is not taken place 31. We 
did not place patients wi th diseases of unknown origin in the "non-diagnosis" 
group and indeed made presumptive diagnoses when necessary 
Nevertheless, the category of undiagnosed fevers augments. We believe that 
this higher percentage of undiagnosed cases can be attributed to the 
increased use of advanced diagnostic techniques attendant on an increase of 
self-limited illnesses within the group of patients meeting criteria for FUO. 
Newer microbiological techniques (such as 16 S ribosomal RNA amplification) 
may be needed as an approach in the relatively large proportion of patients in 
whom we now fail to make a diagnosis Because of an ongoing development 
in diagnostic techniques and the prospective influence on the spectrum of 
diseases causing FUO, studies on this subject should be performed regularly 
to update information on this subject. Because of an expected increase of 
evaluations for FUO on an outpatient basis, this group of patients should be 
included in future studies. In order to avoid unwanted selection bias, fixed 
epidemiological entry criteria should be used to ensure completeness of 
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enrolment. To shorten the period of collecting data, multicentric studies can 
be done using standardized diagnostic protocols. 
In patients wi th recurrent fever or fever lasting longer than 6 months, the 
chance of reaching a diagnosis is significantly lower and especially in these 
patients one should exercise the greatest caution to avoid abundant and 
extensive diagnostic procedures. 
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Diagnostic procedures in patients with FUO 
Introduction 
The diagnostic workup of patients with fever of unknown origin (FUO) 
remains a challenge despite many studies on this subject ' 1 6 and a variety of 
diagnostic methods available currently, FUO has been defined by Petersdorf 
and Beeson 9 as a febrile illness of more than three weeks duration, fever of 
38.3°C (101 °F) or higher on at least three occasions and uncertain diagnosis 
after one week of in-hospital diagnostic workup Recently, this definition has 
been modernized by excluding immunocompromised patients like patients 
with neutropenia or AIDS 17. 
A large number of diseases have been reported to cause FUO, which makes it 
difficult to construct algorithms covering the complete spectrum of FUO. 
Some attempts have been made in the past to outline diagnostic approaches 
18 2
*. Although of importance, it is impossible to extrapolate these algorithms 
to the individual patient wi th FUO. Many relevant questions remain when 
studying these algorithms. Should one perform all examinations mentioned in 
the staged protocol in patients without potentially diagnostic clues (PDCs)? 
What is the diagnostic yield of all these investigations under various circum-
stances7 Which patients are at risk to have life-threatening disease7 Is it 
possible to distinguish patients with benign fevers7 
Based on data retrieved in retrospective analysis of investigations performed 
in patients wi th FUO 10 and a questionnaire on the use of diagnostic 
techniques in patients with FUO among Dutch internists 2S we developed a 
staged standardized diagnostic protocol. This protocol was used in a 
prospective study on FUO performed during a two-year period in all university 
hospitals in the Netherlands 25. In this study all investigations, the indications 
for these investigations and the results were registered prospectively to 
recover their utility under various conditions. 
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Methods 
In all 8 university hospitals in the Netherlands, all immunocompetent patients 
fulfilling criteria for FUO according to Petersdorf and Beeson 9 were enrolled 
in this study. By reviewing records of all patients wi th fever and by checking 
all records of all patients in whom blood cultures were ordered on internal 
medicine wards, we tried to prevent unintended selection bias. 
After informed consent, patients were included in our FUO protocol, which 
consisted of a standardized coded history and a standardized thorough 
physical examination. A number of additional investigations (Table 6.1) had to 
be performed in the first week of examination, if an explanatory diagnosis 
was not established. Much weight was given to the presence or absence of 
potentially diagnostic clues (PDCs, defined as all localizing signs, symptoms, 
and abnormalities potentially pointing towards a diagnosis), and the use of 
these PDCs in the diagnostic process. PDCs derived from history, physical 
examination and additional investigations and a diagnostic workup based on 
these clues had to be registered in the protocol form. If PDCs were present, 
appropriate investigations were performed; the indication to perform such 
investigations and the entity thus searching for, had to be registered. In the 
absence of PDCs, patients underwent a staged standardized diagnostic 
protocol (Table 6.1). Patients did not have to remain admitted; after inclusion, 
all investigations of this protocol could be performed on an outpatient basis. 
The patient's condition was the major reason for a longer stay in hospital. 
The standardized diagnostic protocol ended (a) when a definite diagnosis was 
made, (b) when PDCs appeared during the diagnostic process, (c) when 
empiric treatment was started or (d) when fever subsided. 
The final diagnosis was established by the attending physician and the first 
author. Diagnoses were established by serology, culture and histology 
preferably, but sometimes by exclusion of other diseases or response to 
therapy and disease course. 
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Table 6.1. Diagnostic protocol 
Obligatory investigations performed in all patients. 
Sedimentation rate; hemoglobin; mean cellular volume; platelet count, leukocyte count and 
differential count; creatinine; sodium, potassium, protein; protein fractions, alkaline phosphatase, 
aminotransferase; lactate dehydrogenase, creatine Phosphokinase, antinuclear antibodies, 
rheumatoid factors, urinary analysis, feces for occult blood, blood cultures aerobic and 
anaerobicfn = 3); tuberculin skin test; urine-, feces-, and sputum culture when indicated, chest 
X-ray; ultrasonography of upper abdomen; 
Phase 1 of standardized diagnostic protocol in patients without PDCs. 
Pulse/rectal temperature measurement by observer, fundoscopy by an ophthalmologist Calcium, 
phosphate, urate, amylase and TSH/T4, Immunoelectrophoresis serum and urine, CRP, ACE, 
ANCA, anti dsDNA, ASO, cryoglobulin, C3, C4, CH50, serology for Cytomegalovirus, Epstein-
Barr virus. Mycoplasma, Brucella, Toxoplasma, Borrelia, Coxiella, Treponema, Yersinia, blood 
cultures incubating for more than 1 week, stools for worms, eggs, cysts, blood cultures, gastric 
fluid, urine cultures for tuberculosis, bone marrow aspiration for cytology and culture for 
Mycobacteria, Brucella, Yersinia, ln-111-lgG scintigraphy, X-Ray of sinus and teeth, 
ultrasonography of pelvis 
Phase 2 of standardized diagnostic protocol in patients without PDCs. 
(performed when pase 1 does not reveal PDCs or diagnosis) 
hepatitis В serology, anergy tests, liver biopsy for histology and culture for Mycobacteria, 
bacteria and fungi, repeated chest X-ray, IgD in serum, bone biopsy for histology and culture for 
Mycobacteria, Brucella and bacteria, echocardiography, CT of abdomen, CT of chest, X-Ray of 
colon and temporal artery biopsy in patients over 55 years 
Abbreviations: TSH = Thyroid-stimulating hormone, T4 = Thyroxine, CRP = C-reactive peptide, ACE = 
Angiotensin-Converting enzyme, ANCA = Antineutrophil cytoplasmic autoantibodies, dsDNA = double-
stranded deoxyribonucleic acid, ASO = antistreptolysin О test, С = complement, CH50 = total hemolytic 
complement, ln-111-lgG = lndium-111 -labeled polyclonal human Immunoglobulin G, PPD = purified protein 
derivative, IF = immunofluorescence, CT = computer tomography, PDCs = potentially diagnostic clues, 
Follow-up was performed by analysis of the records of the patients, by 
telephone-calls with attending physicians and individual patients; last follow-
up was performed in March 1996 for patients with uncertain or no diagnosis. 
In this study, periodic fever was defined as at least two episodes of fever 
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with intervals of at least 48 hours without fever. 
Results of investigations were coded as normal or abnormal. Abnormal tests 
were subdivided in true positive (directly contributing to the diagnosis), false 
positive (misleading), equivocal (abnormal but not providing any convincing 
evidence or not leading to the cause of FUO). Normal tests were coded as 
true negative or false negative. Because mostly a golden standard was not 
available specificity and sensitivity could only be calculated assuming that 
negative results were "true negative" when further investigation or the final 
diagnosis did not contradict these results. The indications of the 
investigations were registered and coded also. 
Most investigations were performed in each university hospital by the locally 
standard applied method, because the scale of this study did not allow us to 
centralize these measurements and investigations. However, all immunoblots 
for Yersinia enterocolitica were performed by the Department of Medical 
Microbiology, University Hospital Nijmegen (Head: Prof.dr. J.A.A. Hoogkamp-
Korstanje) 2 6 '2 8. Interpretation of the immunoblot was as fol lows: IgA negative 
and IgG positive for at least 2 bands: infection in the past which was 
considered equivocal. IgA positive for at least 1 band and IgG positive for at 
least 2 bands: recent or persistent infection, and this is considered a positive 
test. IgA positive for 1 band and IgG positive for 1 band or IgA and IgG 
weakly positive for 1 or more bands: infection in past or beginning infection, 
repeat necessary; when unchanged this result was considered equivocal. All 
other microbiological serology was only considered positive in the presence of 
a four-fold elevation of IgG titer. In the presence of IgM but no four-fold 
elevation, the test was considered equivocal. 
Statistical analysis 
Comparisons between groups were performed with Fisher's exact test (for 
the 2 * 2 - tables) and the Mann - Whitney - U test, Ρ values of .05 or less 
were considered significant, N.S. is an abbreviation of non-significant. 
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Table 6.2. Potential diagnostic clues (PDCs) in the diagnostic process. 
PATIENTS WITH DIAGNOSIS 
(N = 117) 
helpful PDCs only 
misleading and 
helpful PDCs 
misleading PDCs only 
no PDCs 
53 
48 
13 
3 
PATIENTS WITHOUT DIAGNOSIS 
(N = 50) 
Spontaneous recovery persistent fever 
(N = 37) (N = 13) 
35 13 
2 0 
TOTAL 
53 
48 
61 
5 
Table 6.3. Diagnoses in 16 patients without PDCs or with misleading PDCs 
in whom the standardized diagnostic protocol was useful. 
DIAGNOSTIC CLUES FINAL DIAGNOSIS DECISIVE DIAGNOSTIC PROCEDURE 
NONE(N = 3) 
bacterial endocarditis 
polyarteritis nodosa 
mixed cryoglobulinemia 
blood cultures not performed without 
antibiotics in the referring hospital 
fundoscopy * 
cryoglobulin positive * 
MISLEADING 
(N = 13) 
polyangntis overlap syndrome 
temporal arteritis (n = 3) 
chronic yersiniosis (n = 2) 
dental root infection 
Hodgkin's disease 
factitious fever (n = 2) 
drug fever (n = 3) 
CT of thorax (revealed aneurysms) * 
temporal biopsy * 
positive serology, reaction therapy * 
radiography of teeth *, 
defervescence after extraction 
bone biopsy * 
searching for fraudulence 
after exclusion other causes, 
defervescence after cessation therapy 
= investigation performed in accordance to the diagnostic protocol 
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Logistic regression was applied to select variables that might predict whether 
a diagnosis would be made or not. Variables admitted in this analysis were 
most obligatory investigations (sedimentation rate; hemoglobin; mean cellular 
volume; platelet count; leukocyte count and differential count; serum urea 
nitrogen; creatinine; sodium; potassium; protein; protein fractions; alkaline 
phosphatase; aminotransferase; lactate dehydrogenase; urinary analysis; 
antinuclear antibodies; blood cultures; Chest X-ray and abdominal 
ultrasound), fever pattern, referral pattern, specific or non-specific history and 
physical examination, age, sex, presence of night sweat. For the 8 university 
hospitals 7 dummy variables were introduced. Logistic regression could only 
be applied to those patients that had "known" values for all admitted 
variables. In patients wi th known values for the selected variables, but wi th 
missing values for one or more of the other admitted variables, it was verified 
whether the regression equation was valid. 
Results 
Of 167 patients meeting the criteria for FUO during the two-year period of 
study, in only 117 a diagnosis could be made. In 43 patients (26%) infections 
were found, in 21 neoplasms (13%), in 40 patients (24%) non-infectious 
inflammatory diseases (NIIDs) (see Chapter 5). A total of 10855 
investigations in 167 patients were performed. 
1. UTILITY OF THE SCREENING DIAGNOSTIC PROTOCOL 
All data on history and physical examination were entered in a database. 
PDCs that were most common were the following (present in more than 10 
patients): relevant diseases in past (131), relevant operation in past (68), 
headache (62), myalgia (58), diarrhea (50), vertigo (48), arthralgia (48), 
changed bowel habits (42), nausea (42), heart murmur (41), pulmonary 
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abnormalities (38), pain in back (38), sore throat (37), abdominal complaints 
(37), dysuria (30), sensory dysfunction (28), arthritis (27), hepatomegaly 
(26), mastopathy or other palpable breast abnormalities (22), contact with 
tuberculosis (21), visual complaints (21), tropical trip in recent past (21), 
struma (20), splenomegaly (17), cold intolerance (17), neurological 
abnormalities (17), insect bite (15), jaundice in past (15), dental intervention 
(15), hearing loss (15), heat intolerance (15), cervical lymphadenopathy (13), 
buccal aphthae (13), genital infection in the past (12), generalized 
lymphadenopathy (11), and abnormal vaginal discharge (10). Other PDCs 
were found by various investigations in the first week of admission. 
After one week of admission, PDCs were present in 162 (97%) patients 
(Table 6.2). In 114 out of 162 patients with PDCs (70%) and in 3 out of 5 
(60%) patients without PDCs a diagnosis was made (Fisher's exact test, 
N.S.). Not in all 66 patients (Table 6.2) without PDCs or misleading PDCs 
only, the first phase (Table 6.1) was completed. Some investigations were 
not performed because new PDCs appeared or fever subsided. A total of 43 
patients completed the first phase, 15 of them also completed the second 
part. Exact data on the amount of investigations performed as screening 
procedure in the absence of PDCs can be found in Table 6.4 and 6.5. In 14 
(33%) of the 43 patients who completed the first phase of the protocol, no 
diagnosis could be made, which is not different from the 124 patients not 
undergoing the diagnostic protocol (29%). In 10 of 43 patients (23%) the 
protocol proved useful (Table 6.3). 
2. UTILITY OF INVESTIGATIONS IN DIAGNOSTIC PROCESS OF FUO. 
Chemical investigations 
The obligatory chemical investigations (Table 6.1) were performed in more 
than 95% of all patients except for serum proteins fractions (145), fecal 
occult blood (109) and creatine Phosphokinase (135). None of the chemical 
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investigations revealed the diagnosis, although some contributed somewhat 
to the diagnosis: in one patient wi th hyponatremia, meningitis proved to be 
the cause of the fever. In four patients wi th elevated creatinine further 
investigations revealed mixed cryoglobulinemia (n = 2), systemic lupus 
erythematosus (n = 1) and pyelonephritis wi th ureteral obstruction (n = 1) 
as cause of the fever. In six patients wi th abnormal liver chemistry, 
abnormalities in the liver explaining the fever were found (localization of 
malignant lymphoma and Hodgkin lymphoma; CMV (n = 2); hepatitis C; liver 
metastasis of adenocarcinoma). However, in 50% of our patients wi th FUO 
non-specific disturbances of liver chemistry were found. Fecal occult blood 
never was helpful in our patient group and false positive in 10% of cases. In 
one patient, hypercalcemia led to the diagnosis of bone metastasis of breast 
cancer. Urate was elevated in one patient in whom gout presented as FUO. 
Creatine Phosphokinase was elevated in two patients (relapse polymyositis 
and dermatomyositis wi th interstitial lung fibrosis) and false positive in one 
patient, in whom a dental infection was the cause of fever. Anemia, present 
in 127 patients, was normocytic in most patients. In 37 patients MCV was 
abnormal, in none of the 17 patients with microcytic anemia gastrointestinal 
abnormalities were responsible for the fever. 
Immunological serology (Table 6.4) 
Antinuclear antibodies were helpful in establishing the diagnoses systemic 
lupus erythematosus (n = 2), relapse of mixed cryoglobulinemia and relapse 
of polymyositis). The presence of rheumatoid factors was helpful in 
establishing the fol lowing diagnoses: relapse of polymyositis, relapse of 
mixed cryoglobul inemia and vascul i t is in rheumato id ar thr i t is . 
Immunoelectrophoresis of the serum was helpful in establishing the diagnosis 
relapse of mixed cryoglobulinemia, Schnitzler's disease and gamma-heavy 
chain disease. In one patient wi th abnormalities on the chest X-ray 
angiotensin converting enzyme (ACE) was helpful in finding sarcoidosis. 
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Table 6.4. Diagnostic utility of immunological and microbiological serology 
and culture techniques. 
INVESTIGATIONS 
ANA * 
Rf * 
IEF of serum * 
ACE * 
ANCA * 
antidsDNA 
cryoglobulin 
anti-ENA 
complement profile 
ASO test 
Y.enterocolitica 
immunoblot * 
blood cultures 
fecal cultures 
sputum cultures 
PPD skin test 
No. of 
patients 
l + PDCs/PDCe) 
145 (30+115) 
124(26 + 981 
105 (16 + Θ9) 
90(14 + 76) 
98 (10 + 88) 
89 (16 + 73) 
68 (6 + 62) 
62 (26 + 36) 
95 (13 + 82) 
78(9 + 691 
117(9 + 108) 
167 (87 + 801 
92 (37 + 55) 
51 (38 + 13) 
83 121+62) 
patients 
helpful 
2 (7%) 
1 (4%) 
1 (6%) 
1 (7%) 
1 (10%) 
2 (13%) 
3 (50%) 
2 (8%) 
0 
0 
0 
6 (7%) 
0 
4(10%) 
2 (10%) 
+ PDCs 
FP 
4(13%) 
1 (4%) 
3(19%) 
3 21%) 
2 (20%) 
0 
0 
0 
0 
0 
1 (10%) 
0 
0 
3(8%) 
0 
patients 
helpful 
2 (2%) 
1 (1%) 
2 (2%) 
0 
2 (2%) 
0 
2 (3%) 
0 
0 
0 
3 (3%) 
2 (3%) 
0 
0 
0 
-PDCs 
FP 
17 (15%) 
1 (1%) 
2(2%) 
5 (7%| 
6(7%) 
2 (3%) 
0 
0 
0 
0 
11 (10%) 
2 (3%) 
0 
0 
0 
Overall 
sens 
NC 
NC 
NC 
NC 
NC 
NC 
NC 
NC 
NC 
NC 
100 
% 
NC 
NC 
NC 
NC 
spe 
с 
NC 
NC 
NC 
NC 
NC 
NC 
NC 
NC 
NC 
NC 
83 
% 
NC 
NC 
NC 
NC 
Abbreviations: * = see results for detailed information; ACE = angiotensin converting enzyme; ANA = 
antinuclear antibodies; ANCA = anti-neutrophil cytoplasmatic antibody; antidsDNA = antibody to double-
stranded (native) DNA; ASO = antistreptolysin О; ENA = extractable nuclear antigen; IEF = 
Immunoelectrophoresis, NC = not calculated; PDCs = potentially diagnostic clues; Rf = rheumatoid 
factors; sens = sensitivity; spec = specificity; Y = Yersinia; 
In one patient with histologically proven sarcoidosis, ACE was false negative. 
Anti-neutrophil cytoplasmatic antibody (ANCA) helped establishing the 
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diagnoses polyarteritis nodosa (n = 1) and Wegener's disease (n = 2) and 
was false positive in patients with the following final diagnoses: relapse of 
cryoglobulinemia, ulcerative colitis, lung empyema with Actinomyces spp., 
hypersensitivity vasculitis, chronic pyelonephritis in ureter obstruction, 
sarcoidosis and in t w o patients without diagnosis who recovered 
spontaneously wi thout signs of vasculitis. 
Endocrinological investigations 
In one patient who had diarrhea and weight loss, thyroid stimulating hormone 
(TSH) and thyroxine (T4) proved the diagnosis hyperthyroidism. In four 
patients TSH was down-regulated but hyperthyroidism was excluded by 
further testing and final diagnoses were: recurrent urinary tract infections, 
chronic pseudomonal infection of the lungs, hypersensitivity vasculitis and no 
diagnosis. Plasma Cortisol (n = 16), carcino-embryogenic antigen (n = 11) 
and σ-foeto protein (n = 16) did not help in finding diagnoses. 
Microbiological serology. (Table 6.4) 
In all patients wi th cytomegalovirus infection, atypical lymphocytosis was 
present. Serology for Epstein Barr virus (n = 92), Mycoplasma pneumoniae 
(n = 99), Brucella spp. (n = 73), Toxoplasma gondii (n = 85), Borrelia 
burgdorferi (n = 72), Coxiella burnetii (n = 78), Chlamydia psittaci (n = 62), 
HIV (n = 38), Influenza virus (n = 44), Leptospira spp. (n = 12), Respiratory 
syncytial virus (n = 36), Rubella virus (n = 11) did not help in establishing 
diagnoses in this study. In one of 56 patients serology for parainfluenza virus 
was positive; this patient also had right-sided heart failure and no other cause 
for the fever could be found, she recovered without specific therapy within 
five weeks. In one of 19 patients a positive Widal test for Salmonella typhi 
was helpful in establishing the diagnosis, although cultures (blood, stools, 
urine) remained negative after empirically started antibiotics before admission 
to the hospital. Because of the clinical picture and course we concluded that 
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she did have had typhoid fever. 
In 117 patients serology for Yersinia enterocolitica was performed using the 
¡mmunoblotting technique as described. In 57 patients serology was negative; 
equivocal results were obtained in 44 patients and positive serology in 15 
patients, of whom in three the test was considered true positive: after 6 
weeks of treatment with ciprofloxacin fever resolved, serology became 
negative and no other cause for the fever could be found; after a follow-up of 
more than three years these 3 patients remained afebrile. In 12 patients the 
test was considered false positive: treatment of more than 6 weeks with 
doxycycline and ciprofloxacin had no effect on the fever and in most of them 
other causes for fever were found: malignant lymphoma (n = 2), right 
adnexitis, urinary tract infection, relapse of rheumatoid arthritis, mixed 
cryoglobulinemia, non-classifiable granulomatous myositis, factitious fever, 
sarcoidosis, and no diagnosis (n = 3). 
Culture techniques (Table 6.4) 
Aerobic and anaerobic blood cultures, being obligatory investigations of our 
diagnostic protocol were performed in all patients. In eight patients (5%) 
these cultures contributed more or less in establishing the diagnosis: 
endocarditis in two patients, abscesses in three patients, an infected central 
venous device, Pseudomonas spp. bacteremia in pneumonia and diverticulitis. 
In 19 patients false positive blood cultures were found growing coagulase-
negative staphylococci (n = 10), Streptococcus viridans (n = 3), 
Mycobacterium kansasii, Corynebacterium spp., Propionibacterium spp. an 
anaerobic Gram-negative rod, an aerobic sporulating rod and Enterobacter 
cloacae combined with Bacillus spp. each in one patient. Blood cultures from 
a patient with ischemic colitis as later complication and stomach cancer as 
cause of FUO grew Bacteroides fragilis; we consider these results equivocal. 
Urinary cultures (n = 134) were helpful in establishing the diagnosis in five 
patients. None of the 69 patients with a normal urinary sediment turned out 
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to have an urinary infection. In five patients the test was considered false 
positive. After treating the assumed urinary tract infection adequately, 
bacteriuria disappeared whereas the fever remained unchanged. In 24 
patients bacteriuria was found with less than 106 micro-organisms/ml, in none 
of them there were signs of an urinary tract infection. 
In 92 patients fecal cultures for Salmonella spp., Campylobacter jejuni, 
Shigella spp. and Yersinia enterocolitica were performed and in none of them 
cultures were positive. In one patient the clinical course combined wi th a 
positive Widal test suggested salmonellosis as cause of the FUO. Cultures 
probably remained negative because of empirically started antibiotics before 
admission. 
None of the cultures of blood, urine and gastric fluid for Mycobacterium 
tuberculosis was positive, and none of the other cultures for other micro-
organisms performed without PDCs in accordance to the diagnostic protocol 
contributed to the diagnosis. 
Other cultures contributing to diagnosis were performed because PDCs were 
present for infection (i.e. culture of liver biopsy in a patient wi th cryptococcal 
infection; cerebrospinal fluid in Spitz-Holter drain and hyponatremia; lymph 
node in tuberculous lymphoma; pleural fluid in actinomycosis, line tip in 
infected venous device; pericardium biopsy in tuberculous pericarditis). 
Imaging techniques (Table 6.5) 
In six patients without PDCs for chest diseases a chest X-ray helped to 
establish the fol lowing diagnoses: Hodgkin's disease, malignant lymphoma, 
recurrent pneumonia combined wi th urinary tract infection, disseminated 
cryptococcosis, systemic lupus erythematosus and sarcoidosis. In one patient 
with pleural empyema a normal chest X-ray was found, scintigraphic and CT 
techniques revealed the diagnosis, when assuming all others to be true 
negative overall sensitivity and specificity can be calculated (Table 6.5). 
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Table 6.5. Diagnostic utility of imaging techniques and histological 
investigations. 
INVESTIGATIONS 
chest X-ray * 
abdominal US * 
pelvic US 
X-ray sinuses 
X-ray teeth 
abdominal CT * 
chest CT * 
US heart * 
X-ray colon * 
X-ray ileum * 
111ln-lgG scan 
Ga-67 scan 
bone scan * 
BM aspiration * 
liver В * 
BM В * 
temporal В 
enteric В 
skin В * 
skin-muscle В * 
colonic В 
No. of 
patients 
f + PDCs/PDCs) 
167 (51 + 116) 
158 (47 + 111) 
28 ( 9 + 1 9 ) 
82 (19 + 631 
47 (6 + 41) 
8 4 ( 5 1 + 3 4 ) 
45 ( 3 0 + 1 5 ) 
66 (33 + 33) 
29 (16 + 13) 
24 (16 + 8) 
5 8 ( 3 5 + 23) 
27 (5 + 22) 
28 (17 + 11) 
7 4 ( 4 0 + 34) 
3 4 ( 2 5 + 9) 
49 (23 + 26) 
26 (7 + 19) 
13 (7 + 6) 
25 (23 + 2) 
2 9 ( 1 7 + 12) 
11 ( 1 1 + 0 ) 
patients 
helpful 
12 ( 2 4 % ) # 
7 ( 1 5 % | 
2 (22%) 
0 
0 
12 (24%)# 
12 (40%) 
6 ( 1 8 % ) # 
3 19%| 
0 
9 (26%)# 
1 (20%) 
4 (24%) 
1 (3%) 
2 (8%) 
5 (22%) 
2 (29%) 
1 (14%) 
3 (13%) 
6 (35%)# 
1 (9%) 
+ PDCs 
FP 
4 ( 8 % ) 
5 ( 1 1 % ) 
2 (22%) 
4 ( 2 1 % ) 
0 
1 0 ( 2 0 % ) 
4 ( 1 3 % ) 
3 ( 9 % ) 
2 ( 1 3 % ) 
1 (6%l 
5 (14%) 
1 (20%) 
6 (35%) 
2 ( 5 % ) 
0 
1 (4%) 
0 
0 
1 (4%) 
1 (6%) 
0 
patients 
helpful 
6 ( 5 % ) # 
6 (5%) 
0 
0 
1 (2%) 
2 (6%)# 
3 (20%) 
0 * 
0 
0 
0# 
1 (5%) 
0 
0 
1 (11%) 
4 ( 1 5 % ) 
2 (11%) 
0 
0 
0# 
0 
-PDCs 
FP 
2 (2%) 
7 (6%) 
2 (11%) 
4 (6%) 
0 
4 ( 1 8 % ) 
1 (7%) 
2 (6%) 
3 (23%) 
0 
3 (13%) 
9 (41 %) 
6 (55%) 
0 
0 
2 (8%) 
0 
0 
0 
0 
0 
Overall 
sens 
9 5 % 
8 1 % 
1 0 0 % 
NC 
NC 
1 0 0 % 
9 4 % 
8 6 % 
1 0 0 % 
NC 
6 0 % 
1 0 0 % 
8 0 % 
1 4 % 
7 5 % 
NC 
NC 
NC 
NC 
NC 
NC 
spec 
9 6 % 
9 2 % 
8 5 % 
NC 
NC 
6 7 % 
7 8 % 
8 6 % 
7 5 % 
NC 
8 3 % 
6 0 % 
5 2 % 
9 6 % 
1 0 0 % 
NC 
NC 
NC 
NC 
NC 
NC 
Abbreviations: * = see results for detailed information; It - statistical significant in Fisher's test; В = 
Biopsy; BAL = bronchoalveolar lavage; BM = bone marrow; CT = computer tomography; Ga-67 = 
Galhum-67; ln'"lgG = lndium-111 -labeled Immunoglobulin G; NC = not calculated; PDCs = potentially 
diagnostic clues, sens = sensitivity; spec = specificity; US = ultrasonography; X-ray = radiography ; 
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Upper abdominal ultrasonography was performed in 158 of 167 patients 
because in 9 patients an abdominal computer tomography had already been 
performed before inclusion or referral to the university hospital. Upper 
abdominal ultrasonography contributed to the following diagnoses malignant 
lymphoma, liver abscess and pelvic abscess (in two patients each), 
angioimmunoblastic lymphoma, gamma-heavy chain disease, sarcoidosis, 
right-sided heart failure, systemic lupus erythematosus in a patient wi th 
enlarged kidneys and abnormal ultrasound reflections, liver metastasis (seen 
on second ultrasonography), chronic pyelonephritis in ureter obstruction and 
tuberculous pericarditis. In 68 patients abnormal findings were seen on 
ultrasonography, only in 12 patients (8%) these findings were such that they 
led to unnecessary investigations and thus considered false positive. In three 
patients ultrasonography was classified as false negative because abdominal 
CT revealed the diagnosis. 
Abdominal computer tomography (CT) was helpful in finding a diagnosis in 
two patients without PDCs (i.e. pericarditis due to vasculitis in rheumatoid 
arthritis and malignant lymphoma). In 14 patients abdominal computer 
tomographies (CTs) were considered false positive because they led to 
unnecessary investigations like laparoscopy, puncture of suspected lesions or 
laparotomy. In none of the patients wi th a normal abdominal CTs, abdominal 
causes for the fever were found. When considering these CTs as true 
negative, overall sensitivity and specificity can be calculated (Table 6 5). 
In three patients without PDCs a chest CT enabled us to diagnose 
tuberculous pericarditis, malignant lymphoma and dermatomyositis wi th 
interstitial lung fibrosis. In one patient the CT of the chest was normal, but 
shortly afterwards an enlarged axillary lymph node became palpable which 
turned out to be a lymph node metastasis of a previously treated larynx 
carcinoma. 
Transthoracic echocardiography was useful in finding the fol lowing diagnoses 
in six patients wi th PDCs for cardiac disease: endocarditis (n = 2), 
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pericardium infiltration in acute leukemia, mitral and tricuspid valve disease in 
heart failure, pericarditis due to vasculitis in rheumatoid arthritis, and 
tuberculous pericarditis. In one patient wi th endocarditis proven at autopsy, 
echocardiography was negative on several occasions. 
X-ray of the colon helped to find the following diagnoses in three patients 
wi th PDCs: colonic polyp in Str. bovis endocarditis, diverticulitis and 
diverticulitis causing multiple hepatic abscesses. 
X-ray series of the small bowel (n = 24) never contributed to the diagnosis in 
this study. Abnormal pictures (nodular ileitis not consistent with Crohn's 
disease) were found in one patient with positive Yersinia enterocolitica 
serology. Prolonged courses of antibiotics did not cure this patient and he still 
suffers from periodic fever. 
Imaging techniques that were helpful in finding the diagnosis (only in patients 
wi th PDCs) were the fol lowing: two out of 19 brain CTs, showing infarction 
in two patients wi th endocarditis; CT of thoracic spine showing lesions of 
Hodgkin's disease; intravenous pyelography showing obstruction of the left 
ureter in pelvic abscess; one out of 10 mammograms showing a lesion that 
proved to be cancer; two out of 13 Doppler ultrasound studies showing 
venous thrombosis and a lesion which turned out to be T-cell lymphoma. 
Scintigraphic techniques (Table 6.5) 
Results of the lndium-111-labeled Polyclonal Immunoglobulin G (111ln-lgG) 
scintigraphy are described extensively elsewhere 29. 
Other scintigraphic methods like i n ln- leukocyte scintigraphy performed in 16 
patients and Technetium-99m-leukocyte scintigraphy performed in eight 
patients were all performed in patients without PDCs for local inflammation or 
infection and did not help establishing a diagnosis. In six patients, positive 
scans were found but after extensive further investigations no local 
inflammation could be confirmed. Only in 2 of 17 patients wi th negative 
scans an infection was found. Overall sensitivity could not be calculated 
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because no true positive results were found, overall specificity was 7 1 % . A 
bone scintigraphy aided in finding the following diagnoses in four patients 
with PDCs for local inflammation: Hodgkin's disease (n = 2), Still's disease 
(showing arthritis) and bone metastasis of breast cancer. In one patient with 
endocarditis and osteomyelitis caused by Staphylococcus aureus bone 
scintigraphy was false negative. 
His tological in ves tiga tions (Table 6.5) 
Bone marrow aspiration aided in finding the diagnosis in one patient with 
acute monocytic leukemia. This patient had an extreme left shift in the 
peripheral blood and two previous bone marrow aspirations were not 
conclusive. In two patients bone marrow cytology was false positive. In one 
patient myelodysplastic syndrome was suspected in the first aspiration, but 
after spontaneous recovery this could not be confirmed. He is now afebrile 
for more than three years, a diagnosis has never been established. In the 
other patient myelodysplastic syndrome was suspected but at autopsy he 
turned out to have culture-negative endocarditis. In six patients bone marrow 
aspiration did not yield specific abnormalities, whereas bone biopsy was 
helpful in establishing the diagnosis; when considering these tests as false 
negative, and the remaining tests as true negative, overall sensitivity and 
specificity can be calculated (Table 6.5). 
Liver biopsy was helpful in finding the diagnosis in three patients (9%). In one 
patient without PDCs for liver disease this procedure aided in establishing the 
diagnosis of granulomatous hepatitis. No underlying disease was found, and 
after therapy with corticosteroids his condition improved in several months 
without recurrence for four years now. In one patient with disturbed liver 
chemistry only, liver biopsy was helpful in finding the diagnosis of 
disseminated cryptococcal infection. In a third patient with abnormal liver 
chemistry, ultrasonography of the upper abdomen was normal in the first 
week of admission. A second ultrasonography showed a large lesion in the 
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liver, a biopsy of which revealed adenocarcinoma. In 22 patients liver biopsy 
showed non-specific abnormalities only. In one patient a blind liver biopsy 
was false negative showing non-specific abnormalities only, whereas 
histology of biopsies taken at laparoscopy, showed granulomatous hepatitis. 
Bone marrow biopsy aided in establishing the diagnosis in nine patients 
(18%). In four patients without PDCs for blood disorders or lymphadenopathy 
the diagnosis malignant lymphoma and Hodgkin's disease (each twice) were 
found with help of bone marrow biopsy. In three patients with peripheral 
blood smear abnormalities (leukopenia in two, extreme left shift in one) 
biopsy established the following diagnoses: Hodgkin's disease, acute 
myelofibrosis and acute monocytic leukemia. Bone marrow biopsy in one 
patient with hot spots at a bone scintigraphy established the diagnosis of 
metastasis of a adenocarcinoma of the breast. The fifth patient had 
generalized lymphadenopathy, bone marrow biopsy pointed to the diagnosis 
of angioimmunoblastic lymphoma, which was confirmed by a third lymph 
node biopsy. In three patients the results were false positive. In one patient 
bone biopsy suggested myelodysplastic syndrome, but repeated biopsies 
could not confirm this. Eventually, temporal arteritis proved to be the cause 
of fever. In one patient, a bone biopsy showed features of malignant 
lymphoma, but the patient recovered spontaneously and a second bone 
biopsy was completely normal. She has been afebrile since three years now. 
In a third patient Hodgkin's disease was suspected in bone biopsy but after 
revision the diagnosis proved to be sarcoidosis. Since in three out of 37 
patients with normal bone biopsy, disorders were found eventually by other 
means that could have involved the bone marrow (angioimmunoblastic 
lymphoma, Hodgkin's disease and gamma-heavy chain disease) the possibility 
exists that the results were false negative. Therefore, it seems hazardous to 
give figures for sensitivity and specificity. 
Bronchoalveolar lavage (BAD was performed in 21 patients for cytological 
and microbiological investigations, 19 of whom had abnormal chest X-rays. A 
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BAL established the diagnosis in one patient who had culture-negative pleural 
empyema. Histological examination showed Actinomyces colonies. After six-
week treatment with penicillin, fever and symptoms subsided. 
In 25 patients a skin biopsy was performed, of whom two had no skin 
lesions. In three patients with skin lesions the procedure was helpful in 
finding the following diagnoses: urticarial vasculitis, hypersensitivity 
vasculitis, and erythema nodosum in the context of tuberculous axillary 
lymphoma. In 15 patients non-specific abnormalities were found. In one 
patient skin biopsy suggested septic embolism. Treatment with penicillin had 
no effect. Because of complaints of arthritis and urethritis with conjunctivitis 
and moderate response to salicylate the presumed diagnosis was Reiter's 
disease. His complaints disappeared completely after eight months, and three 
years later no other cause for the fever has been found. 
Biopsy of skin and muscle was performed in 17 patients with PDCs (skin 
diseases or abnormal electromyography) (Table 6.5). In one patient with 
abnormal electromyography histological examination of the biopsy material 
revealed lymphocytic arteritis; the patient recovered spontaneously after one 
month without a diagnosis being made. He has been free of disease for more 
than 4.5 years now. 
In 24 patients enlarged lymph nodes were removed for histological and 
microbiological investigations; this procedure helped to establish the diagnosis 
in 12 of them (50%). At admission no pathological lymph nodes were present 
at physical examination in five of these 12 patients, but in 11 of these 12 
patients, generalized lymphadenopathy was demonstrated after extensive 
ultrasonographic and radiographic investigations. Lymph node biopsies were 
not helpful in establishing the diagnosis if lymphadenopathy was confined to 
the cervical or inguinal region (n = 8). In patients with generalized 
lymphadenopathy, biopsy was helpful in 11 out of 14 (79%) (P = .001). 
In 3 out of 4 patients with urine abnormalities renal biopsy was helpful 
(Wegener's disease, systemic lupus erythematosus, mixed cryoglobulinemia). 
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Table 6.6. Comparison between "no diagnosis" and "diagnosis" group using 
univariate analysis. 
Parameter (no. of patients) 
elevated ESR (164) 
abnormal Hb (167) 
abnormal sodium (164) 
lowered serum protein (151) 
abnormal protein spectrum (145) 
abnormal ASAT (167) 
proteinuria (151) 
night sweats (140) 
periodic fever (167) 
duration hospitalization < 21 days 
No diagnosis 
n = 50 
38 (76%) 
29 (58%) 
5 (10%) 
9 (19%) 
29 (63%) 
10(20%) 
6 (14%) 
40 (91%) 
28 (56%) 
26 (52%) 
Diagnosis 
n = 117 
104 (90%) 
98 (84%) 
32 (28%) 
41 (39%) 
92 (93%) 
45 (39%) 
36 (33%) 
70 (75%) 
28 (24%) 
34 (20%) 
p-value 
< .05 
< .001 
< .02 
< .02 
< .0001 
< .02 
< .03 
< .04 
< .0001 
< .01 
duration hospitalization 
(days) median (range) 
19 (7-83) 34 (7-295) < .001 
In 11 patients a lumbar puncture was performed; in two as a screening 
procedure without any PDCs. In two patients (18%) this technique was 
helpful in finding the diagnosis; both patients had severe headache but no 
signs of meningitis. In these patients a sterile mononuclear infiltrate of the 
cerebrospinal fluid was found, and in one patient biopsy of the meninges was 
negative. The presumable diagnosis of Mollaret's meningitis was established 
in both by exclusion of other diseases. 
In five patients splenectomy was part of the diagnostic workup before referral 
because splenomegaly was found. In two patients this procedure led to the 
diagnosis. In one patient there was a discrepancy between the histology of 
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the bone biopsy and that of the spleen. The diagnosis remained uncertain 
until generalized lymphadenopathy developed and lymph node histology could 
be performed, proving AILD. In the other patient bone biopsy was suspect for 
Hodgkin's disease but proof could only be produced by spleen histology. 
Other successful histological investigations, performed because PDCs were 
present were articular puncture (n = 3) proving pseudogout in one patient, 
gastroscopy (n = 11) with gastric biopsy proving one case of stomach 
cancer, pleural puncture (n = 13) pointing to systemic lupus erythematosus 
in one patient and pericardial puncture (n = 1) in one patient proving 
tuberculous pericarditis. 
3. PREDICTORS OF LIKELIHOOD OF REACHING A DIAGNOSIS. 
Univariate analysis. 
Of all parameters and PDCs, the value of predicting the likelihood of reaching 
a diagnosis was established with help of univariate analysis. For most tested 
parameters no differences were found between patients with a final diagnosis 
and patients without a diagnosis. This was the case for all investigations that 
were obligatory in the diagnostic protocol except for the variables mentioned 
in table 6.6. Of all specific and non-specific PDCs in history and physical 
examination only night sweats reached statistical significance. There was also 
no significant difference between the two groups concerning sex, presence of 
PDCs, use of the screening diagnostic protocol, age, duration of fever, 
referral pattern, and fever pattern (continuous versus non-continuous). 
Logistic regression of prediction of possible diagnosis 
All values of the variables admitted in logistic regression were known in 92 
patients. After selection of protein spectrum (1 = normal, 2 = abnormal), 
periodic fever (1 = one period, 2 = more than one period) and Hb (1 = 
normal, 2 = abnormal) no other variables were entered into the model. 
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Table 6.7. Classification of patients with known values of variables and 
those with some missing values. 
KNOWN VALUES MISSING VALUES 
DIAGNOSIS Protein 
spectrum 
normal 
abnormal 
Periodic fever 
(periods) 
one 
more 
one 
more 
Hemoglobin 
normal 
abnormal 
normal 
abnormal 
normal 
abnormal 
normal 
abnormal 
YES 
1 
3 
0 
0 
5 
38 
2 
13 
NO 
1 
2 
6 
2 
3 
6 
3 
7 
YES 
0 
2 
1 
0 
4 
21 
4 
5 
NO 
1 
2 
2 
1 
2 
2 
2 
4 
EPD ' 
.25 
.53 
.07 
.21 
.68 
.88 
.33 
.63 
Estimated probability of diagnosis from logistic regression in patients with known values 
In an additional 53 patients the values of protein spectrum, periodic fever and 
Hb were known, while some of the other admitted variables had missing 
values. With the regression coefficients (1.83, -1 .43, 1.21, respectively) and 
an intercept of -2.70 the probability of finding a diagnosis was estimated. 
Discussion 
In this study, we prospectively evaluated the utility of diagnostic techniques 
used in patients wi th FUO. In a retrospective study on FUO 10, we found that 
the use of diagnostic techniques was abundant, whereas in many cases the 
exact indication for the investigation could not be retrieved. The present 
study allows us to draw conclusions on the overall diagnostic value of many 
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of these techniques, and by prospective registration of PDCs to estimate the 
screening diagnostic value of many of these techniques. 
The merit of chemical investigations is mainly to direct the physician to the 
possible location of disease, making a more selective search possible; only 
rarely these investigations directly lead to the diagnosis. In 5 0 % of the 
patients in this study non-specific liver disturbances were found and only in 6 
patients (4%) specific liver diseases were the cause of FUO. Thus, finding 
such disturbances is relatively meaningless. This is in agreement wi th data 
from earlier studies showing that abnormal liver tests in FUO are not 
predictive of a diagnostic liver biopsy 30,31. 
The diagnostic yield of immunological serology is also relatively low. Although 
ACE, ANCA, antidsDNA and ENA sometimes contributed to the diagnosis, 
these tests are more often false positive and are of little use in patients wi th 
negative antinuclear antibodies or without specific PDCs pointing to specific 
immunological disorders. Mixed cryoglobulinemia turned out to be a rather 
common cause of FUO even without specific PDCs and underlying disorders. 
Thus, also in patients without PDCs this investigation seems worthwhi le. 
In the literature, atypical subacute thyroiditis 32 and other masked thyroid 
diseases 3 3 3 4 appear as a cause of FUO. Most of the patients reported did not 
have overt thyrotoxicosis but had some features of thyroid disease such as 
weight loss despite a good appetite and frequent bowel movements. This 
finding was confirmed in our series. It can be concluded that the diagnostic 
yield of thyroid testing without the presence of any PDCs for thyroid disease 
is very low. 
In all published series on FUO, infections remain a common cause of FUO. 
However, in our series of patients without PDCs for infection, the diagnostic 
yield of microbiological serology appears to be very low. Such investigations 
should probably not be used as screening procedures in the diagnostic 
process of patients without PDCs for specific infections, e.g., serology for 
CMV infection appears to be helpful only in patients wi th PDCs for CMV 
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infection (i.e. atypical lymphocytosis), as has been described by others э'13. A 
relatively new technique that has been used in our series is Western blot 
serology for Yersinia enterocolitica. Although occasionally helpful, the low 
specificity appears to limit the use in this group of patients. 
The diagnostic yield of imaging procedures is often difficult to establish, 
because the yield of these techniques depends on previously performed 
investigations. In our study this problem is minimized by including a chest 
radiography and abdominal ultrasonography in the first obligatory part of the 
diagnostic protocol and by dividing the protocol in two stages. Whenever 
there were pulmonary complaints or abnormalities at physical examination, 
the chest radiography was very useful, but even in patients without 
pulmonary complaints this simple technique was of use sometimes. 
In a substantial proportion of patients upper abdominal ultrasonography was 
useful and being a technique with little discomfort it should remain an 
obligatory test in the diagnostic workup of all patients with FUO. However, 
we have to keep in mind that in a considerable proportion of patients upper 
abdominal ultrasonography was false positive leading to unnecessary 
investigations. Ultrasonography of the pelvis was not useful in patients 
without PDCs and led to unnecessary investigations in some patients. When 
negative in a patient with prolonged fever, the abdominal ultrasonography has 
to be supplemented by abdominal CT which has a very high sensitivity. One 
has to be careful, however, not to over-interpret CT data because of the 
relatively low specificity. Unnecessary and invasive diagnostic procedures 
may be initiated. Sensitivity and specificity of abdominal and chest CT appear 
to be similar. 
The value of echocardiography in patients with FUO has not been studied 
before. Our results show that in patients with FUO the technique was useful 
only in patients with PDCs for cardiac abnormalities (i.e. heart murmur, 
friction rub or chest pain), and that it is not an appropriate technique to use in 
the diagnostic process when such PDCs are absent. 
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Scintigraphic techniques were useful only in patients wi th PDCs for local 
inflammation or infection and useless as screening procedures in our 
population of patients which we discussed extensively elsewhere 29. 
Radiologic evaluation of the gastrointestinal tract can be valuable if performed 
in the proper setting. In our study it never was useful as a screening 
procedure, and we believe it should not be used as a screening procedure in 
patients without abdominal PDCs. Even in the presence of microcytic anemia, 
abnormalities of the gastrointestinal tract were not responsible for the fever in 
our series. 
When used as a screening procedure as advised by others 22 ·24 ·35-36 X-rays of 
the sinuses has a very low diagnostic yield and in many patients false positive 
findings led to unnecessary investigations. 
Bone marrow aspiration was of little use in the absence of PDCs for a bone 
marrow disorder. Thus, as a screening procedure this technique is of little use 
and anemia alone is certainly not reason enough to perform this investigation 
in patients wi th FUO. 
The diagnostic yield of liver biopsy in patients wi th FUO has been studied 
extensively in the past. It is likely that selected groups of patients wi th PDCs 
for liver abnormalities were studied. In our study, liver biopsy as part of the 
second stage of the diagnostic protocol, was performed in 9 patients without 
PDCs for liver abnormalities yielding one case of unexplained granulomatous 
hepatitis. We are aware of the discussion whether the descriptive diagnosis 
"granulomatous hepatitis" is a real diagnosis or should be put in the "no 
diagnosis" group 15. In order not to conceal this interesting group of patients -
even though the causal relationship between granulomatous hepatitis and 
FUO is not clear and in most cases the entity is secondary to a vast variety of 
diseases 37,38 - we did not classify this condition in the "no diagnosis" group. 
We feel that liver biopsy even in the absence of PDCs may be of some use in 
a later stage of the diagnostic workup. 
In our population of patients with FUO, bone marrow biopsy had a relatively 
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high diagnostic yield when performed in a later stage of the diagnostic 
process even in the absence of PDCs. We are not aware of other studies that 
investigated the screening value of this technique. 
Because temporal arteritis is an important cause of FUO in patients older than 
50 years 15 we included temporal biopsy as a screening procedure in a later 
stage of the diagnostic protocol in patients older than 55 years. Despite this 
rigorous search, temporal arteritis was found in only 2 patients without PDCs 
and in 2 patients wi th typical complaints. Thus, in our study the diagnostic 
yield was not as high as in that of Knockaert et al. who found temporal 
arteritis in 15% of the cases. In a late stage of workup and before starting 
empirical corticosteroids, it is justified to perform such a biopsy. 
The role of the BAL in patients wi th FUO has not been elucidated. Although 
in most patients undergoing BAL chest radiography was abnormal, the 
diagnostic yield was very low. Probably, selection of patients was the most 
important reason for this low utility. The technique is used early in the 
diagnostic process of lung abnormalities and patients in whom the procedure 
is useful will probably not classify as FUO. 
In this study the screening value of enteric biopsy was nihil. Also in patients 
wi th abdominal complaints it was of low value probably because Crohn's and 
Whipple's disease and coeliac disease were not found in our series. We feel it 
should not be used as a screening procedure early in the diagnostic process. 
Skin and skin-muscle biopsy had a diagnostic yield of 3 5 % in our series, only 
when performed in patients wi th skin abnormalities and/or abnormal 
electromyography. Other studies on PAN, systemic necrotizing vasculitis and 
FUO 39'41 also showed that skin-muscle biopsy is useful only in suspect skin 
or muscle areas. 
In our population, if lymphadenopathy was confined to the cervical or inguinal 
region (with negative chest X-ray and abdominal ultrasound) lymph node 
biopsy was not helpful in establishing the diagnosis, in contrast to patients 
wi th generalized lymphadenopathy in whom it had a very high yield. 
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Unlike in the study of Knockaert 15, blood cultures were still helpful in 
establishing the diagnosis of endocarditis in two patients. In both our patients 
blood cultures became positive after stopping of empirically started 
antibiotics, an aspect already emphasized by others 9·12·42. 
It can be concluded from our series that cultures of urine, sputum and from 
other specific sites were useful only in patients with PDCs pointing to those 
sites. By performing screening cultures the risk of confusion by false positive 
cultures exceeds the diagnostic yield. 
Tuberculin skin testing was positive in 2 patients who turned out to have 
active tuberculosis, in a third patient with tuberculosis a skin test was not 
performed. In none of the other patients a positive PPD was found, reflecting 
the very low prevalence of tuberculosis in our country. In other series 
tuberculin testing did not perform so well because of the high rates of false 
negative tests in patients with active tuberculosis (up to 25%)43 and high 
rates of positive tests without active disease in certain subgroups like elderly 
44
 and immigrants from developing countries 45. 
In many reviews on FUO, the importance of PDCs is emphasized. The 
attending physician is advised to observe Sutton's Law: "to go were the 
money is" 18'19'46-48. The value of PDCs has not been evaluated systematically 
before. Two retrospective studies showed significant lower chances in 
reaching a diagnosis when no PDCs were present 4 ,1°. This was not confirmed 
in the present study, in which we prospectively registered and used PDCs 
and found that its the presence of PDCs does not increase the chance of 
reaching a diagnosis. The major reason was probably the high percentage of 
patients with misleading PDCs. Still, the search for PDCs remains the key-
stone of the diagnostic approach of patients with FUO; most investigations 
performed in our prospective study were helpful only when performed in 
patients with specific PDCs for the diagnosis searched for. 
In univariate and logistic regression analysis of patients with and without a 
diagnosis we found significant differences for periodic or intermittent fever. 
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ESR and hemoglobin in accordance with Knockaert 49. The chances of finding 
a diagnosis is significantly higher in patients wi th continuous fever, high ESR 
and low hemoglobin. It is interesting to see that many parameters do not 
seem to influence the chance of finding a diagnosis, like hepatosplenomegaly, 
age, duration of fever, the presence of PDCs and the use of the screening 
diagnostic protocol. 
It was surprising to find our diagnostic protocol of use in 2 3 % of the patients 
to whom it was applied. Indeed, this figure seems high, but when we look at 
the investigations that really are of diagnostic value when used as screening 
procedure, only few were valuable: temporal artery biopsy in patients older 
than 55 years, fundoscopy, sophisticated serology for Yersinia enterocolitica, 
serum for cryoglobulinemia in an early, and bone biopsy, abdominal CT and 
chest CT in a later stage of the diagnostic process. This means that our 
screening diagnostic protocol can be limited rigorously in the absence of 
PDCs. By ordering investigations as screening procedures in the hope (mostly 
vain) that something abnormal will come up, also has many disadvantages, 
like possible adverse reactions or complications, loss of faith of the patient, 
staggering costs of testing, and - perhaps most important - a soporific effect 
on the doctor 's diagnostic mental activities. 
Summary and conclusions 
During a two-year period from January 1992 until January 1994, we used a 
standardized diagnostic protocol for all 167 immunocompetent patients wi th 
FUO, admitted on all internal medicine wards in all university hospitals. This 
protocol consisted of a standardized coded history and standardized physical 
examination. A number of additional investigations had to be performed in the 
first week of admission and all PDCs thus retrieved, had to be registered. In 
the presence of PDCs, specific investigations had to be performed based on 
the differential diagnosis. In the absence of PDCs, patients underwent a 
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staged standardized diagnostic protocol. 
In 162 (97%) patients PDCs were present after one week of admission. In 61 
patients these PDCs were all misleading. The chances of reaching a diagnosis 
in patients with PDCs was not significantly higher than in patients without 
PDCs, probably because of the high proportion of misleading PDCs. The 
chances of establishing a diagnosis was significantly lower ( < 1 0 % ) only for 
patients wi th recurrent fever, normal ESR and normal hemoglobin. All other 
PDCs were not significantly different in patients wi th a diagnosis compared 
with patients without a diagnosis. 
In 10 (23%) of 43 patients in whom the diagnostic protocol was used, the 
protocol proved useful. Investigations that proved to be of some use as 
screening procedure were: temporal biopsy in patients older than 55 years, 
fundoscopy, serology (Western blot) for Yersinia enterocolitica, serum for 
cryoglobulin in an early stage, and bone biopsy, liver biopsy, abdominal CT 
and chest CT in a later stage of the diagnostic process. 
The screening value of immunological and microbiological serology and 
endocrinological investigations was nihil and these investigations should 
probably be performed only when PDCs for the disease searched for are 
present. Scintigraphic techniques, echocardiography and other imaging 
procedures were never helpful in our population in the absence of PDCs. 
Many patients wi th FUO had non-specific anemia and disturbed liver 
chemistry. In the presence of these findings alone, wi thout other more 
specific PDCs, the chance of reaching a diagnosis wi th help of bone marrow 
aspiration and liver biopsy, respectively was nihil. Enteric biopsy was never 
helpful. If lymphadenopathy was confined to the cervical or inguinal region 
(with negative chest X-ray and abdominal ultrasound) lymph node biopsy was 
not helpful, in contrast wi th patients having generalized lymphadenopathy, in 
whom the technique had a yield of 7 9 % . 
As shown in this study, the search for PDCs remains an important tool in 
establishing the diagnosis in patients wi th FUO, although in many cases these 
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PDCs will appeared to be misleading. Directional diagnostic workup - using 
the PDCs retrieved by repeated, meticulous history taking and physical 
examination - remains the most efficient and intellectually satisfactory way to 
solve the problem of FUO in the individual patient. 
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Circulating and ex-vivo production of pyrogenic cytokines and interleukin-1 
receptor antagonist in 123 patients with fever of unknown origin (FUO) 
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Cytokines in patients with FUO 
Abstract 
Circulating and ex-vivo production of IL-1/?, TNFCT, IL-6 and IL-1ra and the 
diagnostic utility of these cytokines were studied in 123 patients with fever 
of unknown origin (FUO). After diagnostic workup, 28 patients had 
infections, 14 patients neoplasms, 32 patients non-infectious inflammatory 
diseases (NIIDs) and 10 patients miscellaneous diseases. In 39 patients no 
diagnosis could be made. 
Concentrations of IL-1/? IL-6 and IL-1 ra of patients wi th infections, neoplasms 
and NIIDs were higher than in normal controls. Patients with infections had 
higher concentrations of TNFo than normals. 
The ex-vivo production of IL-1/? and IL-1 ra in all patients with FUO was not 
different from that in normals, production of TNFa was lower in patients with 
neoplasms and NIIDs, IL-6 production was lower in patients with neoplasms. 
In 35 febrile patients no elevated cytokines were found at all. Although some 
significant differences were found between the diagnostic subgroups, the 
scatter is wide; these measurements do not help in the diagnostic process of 
patients with FUO. 
Introduction 
Fever of unknown origin (fever of 38.3 °C or higher on at least three 
occasions for more than 3 weeks, and no diagnosis after 1 week of in­
hospital evaluation 1) is a challenging clinical problem. The bona fide 
endogenous pyrogens are the pro-inflammatory cytokines interleukin-1/? 
(IL1/7), tumor necrosis factor-σ (TNFo), interleukin-6 (IL-6) and interferon 
(IFN)o 2. They are involved in various immunological and inflammatory 
processes and have been shown to act directly on the temperature regulation 
center in the hypothalamus 2. If the elevated temperature in these patients 
with FUO represents genuine fever, the set point at the temperature center in 
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the preoptic area of the hypothalamus is elevated which, according to the 
prevailing concept, is mediated by endogenous pyrogens entering the 
hypothalamus via the bloodstream. Thus, one or more endogenous pyrogens 
should be present in the circulation in these patients. Measurements of these 
cytokines could lead to insight in the pathogenesis of fever in patients. In a 
prospective cohort of patients with FUO we examined this pathophysiological 
concept by measuring IL-1/?, TNFa, and IL-6 in the circulation. We also 
measured the concentrations of circulating anti-inflammatory cytokine IL-1 
receptor antagonist (IL-1 ra), considered to be under the same control as IL-1/? 
3
. In addition, we addressed the question whether determination of these 
circulating cytokines or cytokine production capacity of blood cells is useful in 
the diagnostic process of FUO. 
Material and Methods 
Patients. 
In a prospective study of FUO, performed from January 1 992 until January 
1994 in all eight Dutch University hospitals, 167 patients fulfilling the criteria 
for FUO were included. Blood samples for cytokine measurements were 
drawn in 123 patients, none of whom used cyclooxygenase inhibitors or 
corticosteroids. The study was approved by all ethical committees. 
Blood samples. 
Blood samples were drawn from the antecubital vein and collected into three 
4-ml endotoxin-free EDTA tubes. Body temperature and time of venipuncture 
were noted. Most patients were punctured between 10 a.m. and 2.00 p.m. 
by the first author. Blood was processed as described elsewhere 4. 
Cytokine measurements. 
Cytokine measurements were performed using an immunoassay. IL-1/?, TNFa 
and IL-1 ra were measured by radio immunoassay (RIA) as described in detail 
115 
Cytokines in patients with FU О 
elsewhere 4 . Inter-assay variation of these RIA's is < 1 5 % , while intra-assay 
variation is < 1 0 % . The sensitivity of the assay wi th 1 0 0 μ Ι samples was 20 
pg/ml for IL-1ra, IL-1/? and TNFa. The TNFo assay measures both free and 
soluble receptor-bound TNFa. IL-6 was measured with an enzym-linked 
immunosorbent assay (ELISA) (CLB, Amsterdam, the Netherlands) according 
to the directions of the manufacturer 5. The lower limit of detection wi th this 
assay is 3 pg/ml. There is no interference of soluble IL-6 receptor. All samples 
from the same patient were analyzed in duplicate. Control values were 
obtained from 20 healthy sedentary volunteers for IL-1/?, IL-1 га and TNFo and 
from 50 healthy controls for IL-6. For circulating cytokines, median values 
were 40 pg/ml (range 20 - 65 pg/ml) for IL-10, 92.5 pg/ml (65 - 120 pg/ml) 
for TNFff, < 3 pg/ml for IL-6 and 212.5 pg/ml (110 - 490) for IL-Ira and for 
cytokine ex-vivo production 6.5 ng/ml (2.2 - 15.5) for IL-1/?, 6.8 ng/ml (1.8 -
9.7) for TNFa, 17.7 ng/ml (4.8 - 33.5) for IL-6 and 10.8 ng/ml (7.2 - 16.8) 
for IL-1 ra. 
Statistical analysis. 
Kruskal-Wallis nonparametric test, Dunn's multiple comparison test and Mann 
- Whitney - U test were used for statistical comparison of the median of 
values of groups of patients with different diagnosis after diagnostic 
evaluation and controls. Spearman r test was performed to assess 
correlations because of non-Gaussian distribution. Multivariate analysis 
(multiple regression) was used to evaluate the effect on cytokine values of 
the following variables: category of diagnosis, sex, age, time of venipuncture 
(before or after one p.m.), fever pattern (continuous or recurrent fever), 
number of days between start of fever and venipuncture, fever course after 
venipuncture (decreasing, increasing or stable), body temperature at the time 
of venipuncture and the hospital where blood was taken. In the multiple 
regression normals could not be included. 
116 
Chapter 7 
150 Interleukin-1В (pg/ml) 
100 
итт 
normals infection neoplasm NUD miscellaneous no diagnosis 
n=20 n=28 n=14 n=32 n=10 n=39 
different symbols indicate different subgroups: 
for infections: bacterial infection: о ; non-bacterial infection: · 
for neoplasms: hematological tumors: о ; solid tumors: · 
for NIIDs: vasculitis/mixed cryoglobulinemia: о ; granulomatous diseases: · ; 
connective tissue disease: + 
The bar indicates the median, the numbers the median concentration in pg/ml. 
An asterisk indicates significant difference {p < .05). 
Fig.7.1. Circulating IL-ß (pg/ml) in 123 patients with FUO according to 
diagnosis. 
Results 
Patient characteristics. 
The median age for the 123 patients was 52 years (range, 16 - 87); 61 were 
male, 62 female. Details on diagnoses are described elsewhere (de Kleijn et 
al, Medicine 1997;76, in press). Seven patients died due to their disease. 
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Fig.7.2. Circulating TNFa fpg/mlj in 123 patients with FUO according to 
diagnosis. 
Circulating cytokines (Figure 7.1., 7.2. and 7.3.). 
Median circulating IL-1/? concentrations for all patients was 55 pg/ml (range 
20 -150 pg/ml). The medians of the IL-1/3 concentrations for all five 
diagnostic groups and controls were different (P < .005). Patients with 
neoplasms, infections and NIIDs had significantly higher median circulating 
IL1/? than normals (P < .05). There were no significant differences between 
the diagnostic groups. 
Median circulating TNFa concentrations for all patients with FUO was 110 
pg/ml (range 2 0 - 5 1 0 pg/ml). 
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Fig.7.3. Circulating IL-6 and iL-ira (pg/ml) in 123 patients with FUO 
according to diagnosis. 
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Patients with infections had significantly higher median circulating TNFo than 
normals (P < .01). There was no difference between the diagnostic groups. 
Median circulating IL-6 concentration for all patients was not detectable 
(range not detectable - 2190 pg/ml). Patients with malignancies, infections 
and NIIDs had higher levels of IL-6 than normal controls (P < .001). Patients 
with malignancies had higher levels than those with no diagnosis or 
miscellaneous disorders (P < .05). 
Median circulating IL-1ra concentration in all patients with FUO was 320 
pg/ml (range not detectable - 2100 pg/ml). Patients with neoplasms, 
infections and NIIDs had significantly higher median circulating IL-1 ra than 
normals (P < .01). Patients with neoplasms had higher levels of IL-Ira than 
those with NIIDs (P < .01). 
In multiple regression analysis, some explanatory variability was found. IL-1 ra 
levels were found to be higher with increasing age, in patients with 
continuous fever and in patients with lower body temperature. In multiple 
regression analysis, patients with infections and malignancy had higher levels 
compared to patients with no diagnosis. 
Ex-vivo cytokine production (Figure 7.4. and 7.5.). 
The median ex-vivo production of IL-1/? for all patients with FUO was 8.4 
ng/ml (range 0 - 47.9 ng/l). There were no significant differences between the 
subgroups and normals. In multiple regression analysis some explanatory 
variability was found. Older patients tend to produce more IL-1/?, 
venipuncture in the afternoon is associated with lower production. 
The median ex-vivo production of TNFa in all patients with FUO was 4.2 
ng/ml (range, 0 - 9.8 ng/ml). Patients with neoplasms and NIIDs had 
significantly lower ex-vivo production of TNFo than normals (P < .05). In 
multiple regression analysis some explanatory variance was found. Males had 
lower ex-vivo production than females. 
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Fig.7.4. Ex-vivo production of IL-1ß and TNFafng/ml) in 123 patients with 
FUO according to diagnosis. 
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Fig.7.5. Ex-vivo production of IL-6 and IL-Ua (ng/ml) in 123 patients with 
FUO according to diagnosis. 
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Median production of IL-6 in all patients with FUO was 10.9 ng/ml (range 3 -
36.3 ng/ml). Patients with no diagnosis, malignancies, infections and NIIDs 
had significantly lower medians than normal controls (P < .05). Some 
explanatory variance was found in multiple regression analysis. Patients 
without fever at time of venipuncture had lower production than patients with 
fever (P = .02). 
The median ex-vivo production of IL-1 га of patients with FUO was 11.4 ng/ml 
(range 0 - 2 1 . 6 ng/ml). There were no significant differences between the six 
groups. In multivariate analysis some explanatory variability was found. When 
the period between the first day of fever and blood sampling was long, ex-
vivo production of IL-1ra was higher. In those patients whose body 
temperature rose after venipuncture, higher ex-vivo production was 
measured. 
Positive correlations were found between some circulating cytokines; for IL1/? 
and TNFo (r = . 3 1 , P< .001) and for IL-1ra and IL-6 (r = .33, P< .001). 
Stronger positive correlations were found for ex-vivo production of some 
cytokines; for IL-1£ and TNFo (r = .70, Ρ < .001 ), for IL-10 and IL-6 (r = .65, 
Ρ < .001) and for TNFo and IL-6 (r = .53, Ρ < .001). 
Negative correlation was found between all circulating cytokines and their ex-
vivo production, only being significant for IL-1 ra (r = - .53, Ρ < .001). 
If we compare circulating and ex-vivo production of measured cytokines of 
the seven deceased patients to patients still alive, only median circulating 
IL1 ra differed significantly between deceased patients (950 pg/ml; 525 -
1550) and surviving patients (310 pg/ml, 20 - 2100) (P < .001). 
In 35 patients of the 123 patients with longstanding fever no increased 
circulating cytokines could be measured. In 18 of 39 patients without a 
diagnosis this was the case as compared to 17 of 84 patients with a 
diagnosis (P < .005). 
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Discussion 
This is probably the first prospective investigation of the role of the putative 
pyrogenic cytokines in FUO. We measured concentrations and ex-vivo 
production of cytokines and evaluated their diagnostic value. Taken together, 
none of the pyrogenic cytokines could be held responsible for the fever in 
many patients wi th FUO and we could not link certain pyrogenic cytokines to 
certain disease categories. Despite the wide scatter, patients wi th infections 
were found to have high IL-Ira and TNFa plasma levels, patients wi th 
neoplasms had high IL-1/7 and IL-1ra plasma levels and low ex-vivo production 
of TNFo, patients wi th NIIDs had low production of TNFo. 
It has been suggested that cytokine patterns may be useful in the diagnostic 
workup of the patient wi th fever. Patients wi th viral meningitis had lower 
concentrations of TNFa in cerebrospinal fluid than patients wi th bacterial 
meningitis e. Similarly, patients wi th granulocytopenia and proven bacterial 
infections had higher IL-6 concentrations than those wi th unexplained fever 7 . 
Appreciable concentrations of IL-1/? and TNFo were noticed in patients with 
meningococcal disease e, whereas no elevated levels were seen in patients 
with typhoid fever 9. High variability of cytokine levels was observed in other 
diseases, i.e. chronic inflammatory bowel disease 10, rheumatoid arthritis 11 
and Hodgkin's disease 12. In our series of patients wi th FUO, despite 
significant differences in concentrations and ex-vivo production capacity of 
cytokines and inhibitors between subgroups, these measurements cannot be 
used in the diagnostic process. Pathophysiological interpretation of these 
cytokine patterns found is difficult because of the degree of variation 
between patients wi th the same disease. Perhaps factors such as genetic 
background and nutritional status are predominant determinants in the 
individual cytokine response. 
IL-1/?, TNFtf and IL-6 are considered to be the major known endogenous 
pyrogens. Despite long-standing fever in all patients and an actual febrile 
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state in most, we were unable to detect elevated concentrations of pyrogenic 
cytokines in all patients. There are a number of possible explanations for this 
phenomenon. Since these pyrogenic cytokines have a short half life, it is 
possible that while the set point in the hypothalamus has already become 
elevated these molecules have disappeared at time of sampling. Alternatively, 
the setpoint is being raised by cytokines that are produced at the level of the 
Organum vasculosum of the lamina terminalis 2. These cytokines would then 
be induced by a circulating exogenous pyrogen or some endogenous 
molecule. Finally, the possibility exist that there is a major pyrogenic cytokine 
which has not been identified. 
Despite reports of increased concentrations of TNFo in patients with fatal 
infection 1 3, TNFa, IL-1/? and IL-6 concentrations were similar in patients who 
died from their febrile illness and those who survived. However, the median 
concentration of the anti-inflammatory cytokine IL-1 га in deceased patients 
was higher than in surviving patients, pointing to greater cytokine activation 
in the former group. 
In conclusion, this prospective study on cytokines in FUO teaches us that 
subtle changes in circulating concentrations and ex-vivo production of 
cytokines are found. Such measurements do not help in the diagnostic 
process of the intriguing clinical problem of FUO. 
Acknowledgment 
We thank Mariëlle Spruytenberg for the analysis of IL-1/?, TNFo and IL-1 ra, 
Ineke Verschuren for the analysis of IL-6 and Johanna van de Ven Jongkrijg 
for preparation of the tracers. This study was supported by the Netherlands 
Institute for Internal Medicine through a grant from Glaxo Ine, Zeist, the 
Netherlands. 
125 
Cytokines in patients with FUO 
References 
1 Petersdorf RG, Beeson PB. Fever of unexplained origin: report on 100 cases. Medicine 
(Baltimore) 1961,40:1-30. 
2 Dinarello CA, Cannon JG, Wolff SM. New concepts on the pathogenesis of fever. Rev 
Infect Dis 1988,10 168-189. 
3 Dinarello CA. lnterleukin-1 and interleukin-1 antagonism. Blood 1991;77 1627-1652. 
4 Drenth JPH, van Uum SHM, van Deuren M, Pesman GJ, van der Ven Jongekrijg J, van 
der Meer JWM. Endurance run increases circulating IL-6 and IL-1 га but downregulates 
ex-vivo TNFo and IL-1/ff production. J Appi Physiol 1995;79:1497-1503. 
5 Helle M, Boeije L, de Groot E, de Vos A, Aarden L Sensitive ELISA for mterleukin 6. 
Detection of IL-6 in biological fluids: synovial fluids and sera. J Immunol Methods 
1991;138:47-56. 
6 Lopez Cortes LF, Cruz Ruiz M, Gomez Matos J, Jiménez Hernandez D, Palomino J, 
Jiménez E. Measurement of levels of tumor necrosis factor-σ and interleukin-1/ff in the 
CSF of patients with meningitis of different etiologies: Utility in the differential diagnosis. 
Clin Infect Dis 1993;166:534-539. 
7 Tilman Steinmetz H, Herbertz A, Bertram M, Diehl V. Increase in lnterleukm-6 serum level 
preceding fever in granulocytopenia and correlation with death from sepsis. J Infect Dis 
1995;171:225-228. 
8 van Deuren M, van der Ven Jongekrijg J, Demacker PNM, Bartelink AKM, van Dalen R, 
Sauerwein RW, Gallati H, Vannice JL, van der Meer JWM. Differential expression of pro­
inflammatory cytokines and their inhibitors during the course of meningococcal 
infections. J Infect Dis 1994;169:157-161. 
9 Keuter M, Dharmana E, Gasem MH, van der Ven Jongekrijg J , Djokomoeljanto R, 
Dolmans WMV, Demacker P, Sauerwem R, Gallati H, van der Meer JWM. Patterns of 
proinflammatory cytokines and inhibitors during thypoid fever. J Infect Dis 1994; 169: 
1306-1311. 
10 Haagen Nielsen 0 , Brynskov J, Bendtzen K. Circulating and mucosal concentrations of 
tumor necrosis factor and inhibitor(s) in chronic inflammatory bowel disease Dan Med 
Bull 1993;40:247-249. 
11 Al Janadi M, Al Balla S, Al Dalaan A, Raziuddin S. Cytokine profile in systemic lupus 
erythematosus, rheumatoid arthritis, and other rheumatic diseases. J Clin Immunol 
1993;13-58-67 
12 Gause A, Keymis S, Scholz R, Schobert I, Jung W, Diehl V, Pohl С, Pfreundschuh M. 
Increased levels of circulating cytokines in patients with untreated Hodgkin's disease. 
Lymphokme Res 1991;11:109-113. 
13 Friedland JS, Suputtamongkol Y, Remick DG, Chaowagul W, Stneter RM, Kunkel SL, 
White NJ, Griffin GE. prolonged elevation of lnterleukin-8 and lnterleukin-6 
concentrations in plasma and of leukocyte lnterleukin-8 mRNA levels during septicemic 
and localized Pseudomonas psei/oO/паУ/е/infection. Infect Immun 1992;60:2402-2408. 
126 
Chapter 8 
Utility of lndium-111-Labeled Polyclonal 
Immunoglobulin G Scintigraphy in fever of unknown origin (FUO) 
Elisabeth M.H.A. de Kleijn, Wim J.G. Oyen, Frans H.M. Corstens, 
Jos W.M. van der Meer, and The Netherlands FUO Imaging Group. 
Department of Medicine and Nuclear Medicine, 
University Hospital Nijmegen, The Netherlands. 
The Journal of Nuclear Medicine 1997;38: 484-489. 
Members of the Netherlands FUO Imaging Group are: 
E.M.H.A. de Kleijn, J.W.M. van der Meer, W.J.G. Oyen, F.H.M. Corstens, University 
Hospital, St. Radboud, Nijmegen; 
H.G. Kreeftenberg and D.R. Piers, University Hospital, Groningen; 
P. Speelman and E.A. van Royen, University Hospital of the University of Amsterdam; 
S. de Marie and E.P. Krenning, University Hospital Rotterdam; 
111
 In IgG scintigarphy in patients with FUO 
Abstract 
Background: We studied the role of n i ln-lgG scintigraphy in different 
subgroups of patients with fever of unknown origin (FUO). 
Methods: During a two-year period (January 1992 until January 1994), the 
internal medicine wards of all eight university hospitals in The Netherlands 
participated in this study. A total of 167 patients with FUO were 
prospectively included to prevent unintended selection, of whom 58 
underwent n i ln-lgG scintigraphy. In 23 patients without potentially diagnostic 
clues (PDCs) or only misleading PDCs 111ln-lgG scintigraphy was used as a 
screening procedure. In 35 patients with PDCs pointing at local inflammation 
this technique was used when indicated. 
Results: After diagnostic workup, infections were found in 17 out of 58 
patients (29%), neoplasms in 6 (10%), non-infectious inflammatory diseases 
(NIIDs) in 14 (24%), miscellaneous disorders in 3 (5%) and no diagnosis in 
18 (31%). n i ln-lgG scintigraphy was helpful in the diagnostic process in 9 
patients, all patients with PDCs pointing at local inflammation. The diagnostic 
yield of this technique in this subgroup was 26%. Infection was found in only 
10 of 41 patients with negative scintigram. All infections were non-focal or 
located in the heart, liver region or urinary tract, where physiological uptake 
obscures possible pathologic uptake. The overall sensitivity and specificity 
was 60% and 83%, respectively. 
Conclusion: In patients without PDCs for local inflammation, the diagnostic 
yield of scintigraphic techniques is quite low since no focal inflammation was 
observed. Therefore, in ln-lgG scintigraphy should not be used as a second-
step procedure in the workup of these subgroup of patients with FUO. In 
patients with PDCs for local inflammation, 111ln-lgG is helpful in the diagnostic 
process in one-fourth of the patients. This diagnostic yield is comparable with 
that of the majority of other scintigraphic techniques used in the diagnostic 
process of patients with FUO. 
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Introduction 
Petersdorf and Beeson 1 defined fever of unknown origin (FUO) as a febrile 
illness evolving over at least 3 weeks, with documented temperature of at 
least 38.3°C (101 °F) on three or more occasions and uncertain diagnosis 
after 1 week of diagnostic workup in the hospital. 
Scintigraphic methods play an important role in the diagnostic process of 
these patients as instruments to demonstrate or exclude local inflammatory 
and infectious diseases. Scintigraphic imaging with gallium citrate Ga 67 
(67Ga) 2, indium-111(111ln) 3'4 or technetium-99m (99mTc) 5 white blood cells 
(WBCs), 111ln-labeled polyclonal immunoglobulin G ( i nln-lgG) 6 and 99mTc 
labeled BW250/183, an antigranulocyte monoclonal antibody of murine origin 
7
 has been applied in patients with FUO to detect inflammatory foci. Some 
investigators believe that scintigraphy should be a second-step as apposed to 
a last-resort procedure in the evaluation of FUO 2. However, the diagnostic 
yield of scintigraphic methods in the diagnostic process of FUO is unknown, 
mainly because these previous studies were retrospective in nature. 
We performed a prospective study on the utility of 111ln-lgG scintigraphy to 
ascertain the role and diagnostic yield of scintigraphy in patients with FUO 
without indices of inflammation. 111ln-lgG scintigraphy has proven to be a 
promising technique in FUO in that it has technical advantages over other 
scintigraphic techniques and high diagnostic accuracy68. 
Methods 
Patients 
From January 1992 until January 1994, a prospective study on FUO, 
approved by all local ethical committees, was performed in all eight Dutch 
university hospitals. All immunocompetent patients fulfilling the classic 
criteria of FUO formulated by Petersdorf and Beeson1 were entered into the 
study. All participants gave informed consent and 167 patients were included 
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Table 8.1. Diagnostic Protocol. 
A. Obligatory investigations performed in all patients. 
ESR; hemoglobin; mean cellular volume; platelet count; leukocyte count and differentiation 
creatinine; sodium; potassium; protein, protein fractions; alkaline phosphatase; aminotransferase, 
LDH; creatine Phosphokinase; ANA; rheumatoid factors; urinary analysis; feces for occult blood; 
blood cultures aerobic and anaerobic (n = 3); tuberculin skin test; urine-, feces-, and sputum 
culture when indicated; chest X-ray; ultrasonography of upper abdomen, 
B. Phase 1 of standardized diagnostic protocol in patients without PDCs. 
Pulse/rectal temperature measurement by observer, fundoscopy by an ophthalmologist Calcium, 
phosphate, urate, amylase and TSH/T4, Immunoelectrophoresis serum and urine, CRP, ACE, 
ANCA, anti-dsDNA, ASO, cryoglobulin, C3, C4, CH50, serology for Cytomegalovirus, Epstem-
Barr virus. Mycoplasma, Brucella, Toxoplasma, Borrelia, Coxiella, Treponema, Yersinia, blood 
cultures incubating for more than 1 week, stools for worms, eggs, cysts, blood cultures, gastric 
fluid, urine cultures for tuberculosis, bone marrow aspiration for cytology and culture for 
Mycobacteria, Brucella, Yersinia, ln-111-lgG scintigraphy, X-Ray of sinus and teeth, 
ultrasonography of pelvis 
С Phase 2 of standardized diagnostic protocol in patients without PDCs. 
(performed when phase 1 does not reveal PDCs or diagnosis) 
hepatitis В serology, anergy tests, liver biopsy for histology and culture for Mycobacteria, 
bacteria and fungi, repeated chest X-ray, IgD in serum, bone biopsy for histology and culture for 
Mycobacteria, Brucella and bacteria, echocardiography, CT of abdomen, CT of chest, X-Ray of 
colon and temporal artery biopsy in patients over 55 years 
Abbreviations: ACE = Angiotensin-Converting enzyme; ANA = antinuclear factor; ANCA = Antineutrophil 
cytoplasmic autoantibodies; ASO = antistreptolysin 0 test; С = complement; CH50 = total hemolytic 
complement; CRP = C-reactive peptide; CT = computer tomography, dsDNA = double-stranded 
deoxyribonucleic acid; ESR = erythrocyte sedimentation rate; IF = immunofluorescence; Ιπ-111-lgG = 
lndium-111 -labeled polyclonal human Immunoglobulin G, LDH = lactate dehydrogenase; PDCs = 
potentially diagnostic clues; PPD = purified protein derivative; T4 = Thyroxine; TSH = Thyroid-stimulating 
hormone. 
in our FUO protocol, which consisted of a standardized multiple-choice 
history, physical examination and certain obligatory investigations (Table 8.1). 
In 58 of these 167 patients (33 women, 25 men, median age 55 yrs; range 
21-87 yrs) 111ln-lgG scintigraphy was performed. 
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Much consideration was given to the presence or absence of potentially 
diagnostic clues (PDCs), defined as all localizing abnormalities potentially 
pointing towards a diagnosis, and the use of these PDCs in the diagnostic 
process. Misleading PDCs were defined as PDCs not leading to the definite 
diagnose. All data, including those on PDCs, were prospectively registered in 
a structured data collection form. In the presence of PDCs, appropriate 
investigations were performed. In the absence of PDCs or in the presence of 
only misleading PDCs, patients underwent a two-staged standardized 
diagnostic protocol (Table 8.1) which included 111ln-lgG scintigraphy in the 
first stage. This diagnostic protocol was discontinued when a definite 
diagnosis was made, new PDCs appeared or fever subsided. 
The first stage of the diagnostic screening protocol was completed in 43 
patients without PDCs or only misleading PDCs at the initiation of the 
standardized protocol. Because this scintigraphic part of the study was not 
initiated until January 1993, only 23 of these 43 patients underwent i n l n - l gG 
scintigraphy. In the remaining 124 patients with PDCs 111ln-lgG scintigraphy 
was performed in 35 patients because of suspected localized inflammation 
based on PDCs. Both groups are evaluated separately in this study. 
Exclusion criteria for 111ln-lgG scintigraphy were agammaglobulinemia, 
selective IgA deficiency and a history of severe adverse reactions after 
intravenous or intramuscular administration of human IgG. Pregnant or lacta-
ting women were also excluded from this study. 
When possible, the scintigraphic findings were verified microbiologically but 
in some cases verification was made by clinical, radiographic and 
ultrasonographic methods. The final diagnosis and prospective analysis of 
diagnostic clues was made by the first author and the attending physicians. 
Radiopharmaceutical 
Human nonspecific polyclonal IgG conjugated to diethylene-triamine-penta-
acetic bicyclic anhydride (DTPA) was prepared as a lyophilized kit (R.W. 
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Johnson Pharmaceutical Research Institute, Spring House, PA, USA) for one-
step labeling with 1 1 1 ln (Mallinckrodt Medical, Petten, The Netherlands) 
according to the manufacturer's instructions. A dose of 2 mg IgG labeled 
wi th 75 MBq of 1 1 1 ln was injected intravenously. 
imaging Procedures 
Scintigraphic images were obtained with a gamma camera (Orbiter, Siemens 
Inc. Hoffman Estates, III.) connected to an image processor (Scintiview, 
Siemens Inc.). All images were collected in digital format in a 256 χ 256 
matrix. A medium-energy parallel-hole collimator was attached to the camera. 
Both 1 1 1 ln peaks of 173 and 247 keV were used with 15% symmetric 
windows. The 1 l 1 ln-lgG images were acquired 4, 24 and 48 hrs after injection 
for a preset time of 5, 7.5 and 10 min, respectively. At least once, 24 hrs 
after injection, spot views of the total body were obtained. 
All images were interpreted by t w o observers who were blinded to the results 
of the verification procedures. Disagreements were resolved by consensus. 
An 1 1 1 ln-lgG scan was interpreted as positive only if consistent, focally 
increasing accumulation could be observed over time. An 1 1 1ln-lgG scan was 
considered true positive only, when this imaging procedure was considered 
helpful in the diagnosis. 
Statistical Analysis 
Differences between groups were analyzed using Fischer's exact test and 
Mann-Whitney U-test or Student's t-test. 
Results 
Of the 58 patients who underwent 1 1 1ln-lgG scintigraphy, no diagnosis was 
established in 18 patients (31%), infection was found in 17 patients (29%), a 
neoplasm in 6 patients (10%), noninfectious inflammatory disease (NIIDs) in 
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Table 8.2. Patients Characteristics of "Ίη-lgG Scans Performed on Indication 
(n = 35). 
Ptn/ Clinical data 
age.Y 
localization 
uptake 
Final diagnosis 
(follow-up,days) 
Additional studies 
TRUE POSITIVE SCANS (n = 9) 
1/65 Abdominal pain, diarrhea 
2/24 Rattling with normal X-ray 
3/26 Diffuse abdominal pain 
4/72 Diffuse abdominal pain 
5/72 Cervix cancer, tumor US 
6/37 Pain wrist, sicca syndrome 
7/33 Gartner's syndrome, 
abdominal pain 
8/62 Anemia, vascular graft 
9/53 Heart murmur/S. aureus 
Colon area Diverticulitis Coloscopy, CT 
Right lung (fig.8 1) Pleural empyema CT, С, course 
Right low abdomen Right adnexitis S, C, course 
Ascending colon Diverticulitis, X, US, 
Abdomen (fig.8.2) Pelvic abscess S, С 
Left arm Granulomatous myositis Muscle В 
Desmoid tumor Necrosis desmoid tumor CT, negative С 
Colon Ischemic colitis S 
hip (fig 8 3) Endocarditis, abscesses Echocardiography 
POSITIVE, NOT HELPFUL SCANS (n = 5) 
10/48 Vasculitis, breast cancer. Many joints Small metastasis 
arthritis 
11/27 Abn. liver biopsy, arthritis Knee Hepatitis С 
1 2/52 IBD in past, abscess chest Right iliosacral joint Relapse IBD 
1 3/69 Abdominal pain, diarrhea Ascending colon No diagnosis (362) 
14/46 Lymphomaneck, Terminal ileum No diagnosis (1067) 
abscesses liver biopsy 
NEGATIVE SCANS (n = 21) 
Protocol 1 + 2 ' , 
lymph node В 
Serology, fluid С 
MRI pelvis / coloscopy 
Coloscopy, colon X, С 
Protocol 1 + 2 . 
15/78 Cystitis, cryoglobulinemia No activity 
1 6/65 Erythrocyturia, No activity 
heart murmur 
17/77 Abnormal urinary analysis No activity 
18/87 Heart murmur, anemia. No activity 
splenomegaly 
19/67 Raynaud, valve disease No activity 
Mixed cryoglobulinemia 
Mixed cryoglobulinemia, 
glomerulonephritis 
Urinary tract infections 
Culture - endocarditis 
Drugfever 
C-, cryoglobulines 
kidney B, cryoglobulines 
3rd С during antibiotics 
Echocardiography + 
Clinical course 
Abbreviations: * See Table 8 . 1 . ; IBD = inflammatory bowel disease; ANA = antinuclear antibody; RA = 
rheumatoid arthritis; T4 = thyroxine, TSH = thyroid-stimulating hormone, у = years; d = days, С = 
culture, В = biopsy; S = surgery, 
(continued) 
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Table 8.2. Patient Characteristics of lndium-111 Scans Performed on 
Indication (n = 35) (continued). 
Ptn/ Clinical data 
ege.y 
localization Final diagnosis 
uptake (follow-up,days) 
Additional studies 
NEGATIVE SCANS (continued) 
20/30 Tropical trip. 
gonorrhea past 
21/42 Hematospermia, 
gonorrhea past 
22/68 Mexican travel, diarrhea, 
dysuria 
23/70 Erythema nodosum. 
abdominal pain 
24/64 Heart murmur. 
lung atelectasis 
25/65 Pain back, caries 
breast cancer past 
26/55 Tropical travel, pain. 
smelly urine 
27/31 Epididymitis, rash 
lesion spine on M RI 
28/21 Wound contact mud. 
heart murmur 
29/21 Yersinia abscess spleen. 
aneurysms 
30/39 Arthritis, heart murmur, 
urticaria 
31/31 Spitz-Holter drain. 
bloody stools 
32/65 Heart murmur, hip prothesis 
33/57 Lung infiltrate, osteolysis 
paraprotein 
34/32 Abdominal pain. 
polycystic ovaries 
35/18 Abdominal pain, cough 
No activity 
No activity 
No activity 
No activity 
No activity 
No activity 
No activity 
No activity 
No activity 
No activity 
No activity 
No activity 
No activity 
No activity 
No activity 
No activity 
Secondary syphilis 
Recurrent prostatitis 
Urinary tract infection 
Polymyalgia rheumatica 
Endocarditis S.bovis 
Temporal arteritis 
Chronic yersiniosis 
Non-class ifiable 
vasculitis 
Reiter's syndrome 
Polyangntis syndrome 
No diagnosis (1365) 
No diagnosis (1113) 
No diagnosis (1107) 
No diagnosis (1142) 
No diagnosis (854) 
No diagnosis (627) 
Serology, US/CT 
Clinical course, response 
therapy 
2nd urine С / therapy 
typhus. 
US/CT, course 
Echocardiography/ С 
Protocol 1 plus 2. 
(temporal biopsy) 
Protocol 1 ', course 
Protocol 1 + 2 ' , spine В 
echocardiography, course 
Skin B, thoracal DSA 
Protocol 1 ', joint X-ray, 
US heart 
Colon X-ray, negative С 
echocardiography, course 
Protocol 1 plus 2', 
bronchoscopy 
US, coloscopy, S 
Protocol 1 ', CT abdomen 
Abbreviations: * See Table 8 1.; IBD = inflammatory bowel disease; ANA = antinuclear antibody; RA 
rheumatoid arthritis; T4 = thyroxine; TSH = thyroid-stimulating hormone; y = years, d = days, С 
culture, В = biopsy; S = surgery; L = lymphadenopathy 
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Fig.8.1. A 24-yr-old mentally disabled man presenting with fever and rattling 
respiration had a normal chest radiography, the "Ίη-lgG scan shows 
abnormal activity in the right lung (posterior view). CT and pleural puncture 
proved pleural empyema caused by Streptococcus pneumoniae. After 
antibiotic therapy, fever and symptoms resolved (Patient 2). 
14 patients (24%) and miscellaneous diseases in 3 patients (5%). For the 
following variables there were no significant differences between the group of 
patients with FUO who underwent 1 l 1 ln-lgG scintigraphy (n = 58) and those 
who did not (n = 109): percentage of patients with no diagnosis and periodic 
fever, duration of diagnostic process, period of follow-up, age, and duration 
of hospitalization. Fourteen of 35 (40%) patients (Table 8.2) with PDCs had 
positive scans as compared to 3 of 23 (13%) patients (Table 8.3) who had 
1 1 1ln-lgG scintigraphy as a screening procedure (P = 0.04). In patients with 
PDCs, 1 1 1ln-lgG scintigraphy helped establish the final diagnosis in 9 of 35 
(26%) patients (Table 8.2, figures 8.1 - 8.3)), in contrast to none out of 23 
patients (Table 8.3) who had the test as a screening procedure (P = 0.03). 
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Table 8.3. Patients Characteristics of Indium-111-IgG Scans Performed as 
Screening IN =23). 
Ptn/ Clinical data 
age,y 
localization 
uptake 
Final diagnosis 
(follow-up.days) 
Additional studies * 
POSITIVE, NOT HELPFUL SCANS (n = 3) 
36/70 None Malleolus lateralis 
37/57 Heart murmur, RA Both lungs 
dyspnea with negative chest X-ray 
38/52 Abdominal L Paranasal sinuses 
No diagnosis (11691 
No diagnosis (1263) 
Ankle X-ray, negative В 
Ventilation/perfusion scan 
Malignant lymphoma sinus X-ray/mucosal swelling 
NEGATIVE SCANS In = 20) 
39/37 L, erythema nodosum 
40/38 Changed defecation, 
normal coloscopy 
41/36 L, splenomegaly 
42/46 Arthralgia, red joint 
43/67 Emphysema, 
44/62 Prosthetic valves,-US 
right heart failure 
45/71 Lung lesion for 1 yr, 
46/21 L, splenomegaly 
47/66 None 
48/64 L 
49/25 L, abdominal pain 
50/33 Unexplained diarrhea 
51/43 Urticaria, L 
52/58 Liver function disorder, 
skin lesions 
53/29 Low back pain, 
diarrhea, iridocyclitis 
54/55 Sarcoidosis past, rash, 
55/71 Urticarial vasculitis, Ig M No 
56/42 Cardiac valve disease/ 
- US, abdominal L 
57/44 Hepatosplenomegaly, 
58/65 Weight loss, heart failure 
No activity 
No activity 
No activity 
No activity 
No activity 
No activity 
No activity 
No activity 
No activity 
No activity 
No activity 
No activity 
No activity 
No activity 
No activity 
No activity 
 activity 
No activity 
No activity 
No diagnosis (1400) 
No diagnosis (1269) 
No diagnosis (1039) 
No diagnosis (999) 
No diagnosis (976) 
No diagnosis (948) 
No diagnosis (868) 
No diagnosis (904) 
Mixed cryoglobulinemia 
AILD 
Takayasu's disease 
Factitious fever 
Urticarial vasculitis 
Cholangitis/sludge 
Still's disease 
CMV infection 
Schnitzler's disease 
Hodgkm's disease 
CMV infection 
No activity 
Protocol 1 ' 
Protocol 1 ' 
Protocol 1 ' 
Enteric X-ray, coloscopy 
Culture, US, liver В 
Protocol 1 + 2 ' 
Chest X-ray, bone marrow В 
Protocol 1 + 2 ' , 
Protocol 1 ' 
Fourth lymph-node biopsy 
Protocol 1 + 2 ' , laparoscopy 
Proven laxative disuse 
Protocol 1 + 2 ' , skin biopsy 
Abdominal CT and US 
Protocol 1. , clinical course 
Serology, ACE / chest X-ray 
Protocol 1 *, skin B, course 
Bone B, histology spleen 
Serology 
HyperthyroidismT4 and TSH 
Abbreviations' see Table 8 2. 
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Fig. 8.2. Cervical carcinoma was diagnosed in this 72-yr-old woman. Surgery 
was unsuccessful and radiotherapy was administered. After 3 mo, fever and 
abdominal pain developed. Abdominal US revealed a tumor consistent with 
abnormal uptake in the lower abdomen on "Ίη-lgG scintigraphy. Laparotomy 
and culture revealed a pelvic abscess caused by Peptococcus spp. After 
surgery and antibiotic therapy, she recovered and fever resolved /Patient 5). 
In nine patients (16%), all patients with PDCs at local inflammation, 1 1 1 In-IgG 
scintigraphy was helpful in establishing a diagnosis. In eight patients (14%), a 
positive 1 1 1ln-lgG scintigram did not lead to the final diagnosis. In t w o of 
these patients, clinically suspected arthritis was confirmed by the n i l n - l g G 
scintigraphy, and in one patient, activity in the maxillary sinus was confirmed 
radiographically. However, a malignant lymphoma proved to be the cause of 
the fever. In the five remaining patients, 1 1 1 In-IgG scintigraphy was false 
positive and resulted in several unnecessary tests. In one of the latter 
patients, focal activity was observed in the right iliosacral joint. Pathological 
abdominal activity was observed in t w o patients, in the right ankle in one 
patient and abnormal activity was observed in both lungs in the f ifth patient. 
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Table 8.4. Diagnostic utility of scintigraphic techniques in FUO in 
literature 
INVESTIGATORS NO. OF SCANS % HELPFUL 
PATIENTS SCANS 
Habibian et al 1 5, 
Hilson, Maisey ' 6 , 
Schmidt et al \ 
Syrjala et al э, 
Roddie et al s. 
Macsweeney et al " , 
Davies et al 1 8, 
Kelly et al 19, 
Suga et al 2°, 
Becker et al 7, 
Knockaert et al 2, 
Present study 
1975 
1979 
1987 
1987 
1988 
1990 
1990 
1990 
1991 
1993 
1994 
22 
67 
32 
68 
17 
25 
28 
28 
36 
34 
145 
58 
67Ga 
67Ga 
"Ίη-οχιηβ WBCs 
1 1 l l n oxine WBCs 
39mTc-HMPAO WBCs 
1 1 1 ln tropolonate WBCs 
n l l n tropolonate WBCs 
1 l l ln-oxine WBCs 
67Ga 
" T c - a n t i NCA 
67Ga 
l n l n IgG 
55 * 
75 * 
22 
28 
24 
24 
18 
21 
47 ti 
24 
29 
16 
Abbreviations NCA = nonspecific cross reacting antigen, 
* = also postoperative patients included 
# = other FUO criteria 
In four of these five patients, no definite diagnosis could be established. Data 
on the 41 patients with negative 111ln-lgG scans are shown in Tables 8.2 and 
8.3 In 14 of these patients, no diagnosis was established after extensive 
workup. The follow-up after inclusion in the study varied from 33 - 1,421 
days (median 834 days). In patients without diagnosis, follow-up after study 
inclusion ranged from 362 - 1,400 days (median 1,053 days). 
In 10 patients an infection was diagnosed, urinary tract infections (n = 3), 
viral infections (n = 3), endocarditis, secondary syphilis, cholangitis due to 
sludge and chronic yersiniosis. Calculated overall sensitivity of i n ln-lgG 
scintigraphy in this study was 60%, with a specificity of 83%. 
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Fig.8.3. A 53-yr old woman was referred from another hospital because of 
fever of more than 3 wk duration. She also had a painful hip. Blood cultures 
grew S. aureus and echocardiography revealed vegetations on the mitral 
valve. The "Ίη-lgG scintigraphy revealed metastatic abscesses in hip (figure) 
femur, skull, and chest. A culture of material obtained by puncture of the hip 
grew S. aureus. After antibiotic therapy, the patient underwent cardiosurgery 
for valve replacement. Thereafter, her fever disappeared (Patient 9). 
Discussion 
In this study, we prospectively studied the utility of i n l n - l g G scintigraphy in 
patients with FUO. Sixteen percent of the l 1 l ln- lgG scans were helpful in the 
diagnostic process. The percentage of scans helpful in the diagnostic 
process, as reported in literature, varied from 1 8 % to 7 5 % (Table 8.4), but in 
most studies the scintigraphic method was helpful in the diagnostic work-up 
in about one-quarter of the patients. This was also observed in our study, 
since 1 1 1 Ιη-lgG scintigraphy had a diagnostic yield of 2 6 % in a subgroup of 35 
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patients with PDCs for local inflammation. The variation of diagnostic yield 
inliterature probably depends on the degree of selection in the group of 
patientswith FUO. All but one study 2 was conducted retrospectively. 
Moreover, in some studies, a large percentage of postoperative patients were 
included or no or other criteria for FUO were used. 
No diagnosis could be made in 18 out of 58 (31%) patients in our study. Our 
findings are similar to data presented in other recent studies 9,1°. In earlier 
studies, this percentage is even lower 1 , n . 
There are definitely some problems with the calculation of sensitivity and 
specificity of scintigraphic techniques in patients with FUO. First, since a final 
diagnosis is not established in all patients undergoing scintigraphy, the 
interpretation of the results of this procedure is hampered due to a lack of a 
golden standard. When additional investigations are negative and long term 
follow-up does not reveal an infection in these patients, it is probably 
legitimate to presume that local inflammation is not the cause of fever in 
these patients. In 30% of patients in our study, no diagnosis could be made 
after a median follow up of 2.5 years. Second, in the subgroup of patients 
without PDC, no local inflammatory processes were found causing FUO. 
Thus, neither true positive scans nor false negative were found, making 
calculation of sensitivity and specificity impossible in this subgroup. Third, in 
patients with a negative scintigram, a variety of diseases were found that 
could not be diagnosed with l1 ,ln-lgG scintigraphy because lesions were 
present in organs with relatively high physiologic uptake, such as the liver, 
heart and urinary tract. Non-focal infections such as viral infections could not 
be excluded by 111ln-lgG scintigraphy. Despite these technical limitations a 
negative scan did rule out focal infection or inflammation with a high degree 
of certainty. 
Similar to 67Ga 12, i n ln-white blood cells (WBCs) 13 and "Technetium-
HMPAO-labeled WBCs 5, 111ln-lgG can be excreted in the bowel under 
physiological conditions. However, such excretion was not significant and 
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hardly interfered with adequate evaluation of possible abdominal infections or 
inflammation 14. We observed in two patients only, false abnormal bowel 
activity. In six other patients, however, pathological activity in the abdomen 
led to the final diagnosis. 
In contrast to Knockaert et al. 2, in our study the duration of hospitalization 
and diagnostic process of patients with scintigraphy was not significantly 
longer than in patients who did not undergo scintigraphy. We performed 1 n l n -
IgG scintigraphy as a secondary step in the diagnostic protocol for patients 
without PDCs, whereas Knockaert scheduled 67Ga scintigraphy as a third-step 
or last-resort procedure when the source of fever remained unknown. 
Naturally, in this latter category, the chance of reaching a diagnosis is lower. 
By prospectively separating patients without PDCs from those with PDCs for 
local inflammation, we found a strikingly low diagnostic yield of this 
technique when using it as a screening procedure in patients with FUO. 
Therefore, scintigraphic imaging should not be a second-step procedure in the 
diagnostic work-up of this subcategory of patients with FUO. 
Conclusions 
During a 2-yr period we prospectively investigated 167 patients with FUO. Of 
these patients, 58 underwent n i ln-lgG scintigraphy. These patients were 
prospectively separated in patients with or without potentially diagnostic 
clues (PDCs). Overall sensitivity and specificity was 60% and 83%, 
respectively. In patients without PDCs for local inflammation, the diagnostic 
yield of scintigraphic techniques was very low since no focal inflammation 
was observed. Therefore, 111ln-lgG scintigraphy should not be used as a 
second-step procedure in the work-up of these subgroup of patients with 
FUO. In patients with PDCs at local inflammation, 111ln-lgG is helpful in the 
diagnostic process in one-fourth of the patients. This diagnostic yield is 
comparable with that of the majority of other scintigraphic techniques used in 
the diagnostic process of patients with FUO. 
141 
'"In IgG scintigarphy in patients with FUO 
Acknowledgments 
This study was supported in part by The Netherlands Institute for Internal 
Medicine through a grant from Glaxo Ine, Zeist, The Netherlands and a grant 
from R.W. Johnson Pharmaceutical Research Institute, Spring House, PA. We 
thank The Netherlands FUO Study Group for their contribution. 
References 
1 Petersdorf RG, Beeson PB. Fever of unexplained origin: report on 100 cases. Medicine 
(Baltimore) 1961;40:1-30. 
2 Knockaert DC, Mortelmans LA, de Roo MC, Bobbaers HJ. Clinical value of Galhum-67 
scintigraphy in evaluation of fever of unknown origin. Clin Infect Dis 1994;18:601-605. 
3 Syrjala MT, Valtonen V, Liewendahl K, Myllyla G. Diagnostic significance of lndium-111 
granulocyte scintigraphy in febrile patients. J Nucl Med 1987;28:155-160. 
4 Schmidt KG, Rasmussen JW, Sorrensen PG, Wedebye IM. lndium-111 -granulocyte 
scintigraphy in the evaluation of patients with fever of undetermined origin. Scand J 
Infect Dis 1987;19:339-345. 
5 Roddie ME, Peters AM, Danpure HJ, Osman S, Henderson BL, Lavender JP, Carroll MJ, 
Neinnckx RD, Kelly JD. Inflammation: imaging with Tc-99m HMPAO-labeled leukocytes. 
Radiology 1988;166:767-772. 
6 De Kleijn EMHA, Oyen WJG, Claessen RAMJ, Corstens FHM, van der Meer JWM Utility 
of Scintigraphic methods in Patients with Fever of Unknown Origin Arch Intern Med 
1995,155:1989-1994. 
7 Becker W, Dolkemeyer U, Gramatzki M, Schneider MU, Scheele J , Wolf F. Use of 
immunoscmtigraphy in the diagnosis of fever of unknown origin. Eur J Nucl Med 
1993;20 1078 1083. 
8 Gardner P, Oster ZH. Rubor, calor, tumor, and radionuclide scans. N Engl J Med 
1989;321:970-972. 
9 Knockaert DC, Vanneste LJ, Vanneste SB, Bobbaers HJ. Fever of unknown origin m the 
1980s. An update of the diagnostic spectrum. Arch Intern Med 1992;152 51-55. 
10 De Kleijn EMHA, van der Meer JWM Fever of unknown origin (FUO): report on 53 
patients in a Dutch university hospital. Neth J Med 1995;47'54-60. 
11 Larson EB, Featherstone HJ, Petersdorf RG. Fever of undetermined origin: diagnosis and 
follow-up of 105 cases, 1970-1980. Medicine (Baltimore) 1982:61.269-292. 
12 Palestro CJ. The current role of gallium imaging in infection. Semin Nucl Med 1994;24: 
128-141. 
13 Davis LP, Fink Bennett D. Nuclear medicine in the acutely ill patient~ll. Crit Care Clin 
1994;10:383-400. 
142 
Chapter 8 
14 Serafini AN, Garty I, Vargas Cuba R, Friedman A, Rauh DA, Neptune M, Landress L, 
Sfakianakis GN. Clinical evaluation of a scintigraphic method for diagnosing 
inflammations/infections using lndium-111 -labeled nonspecific human IgG. J Nucí Med 
1991;32:2227-2232. 
15 Habitúan MR, Staab EV, Mathews HA. Gallium-67 citrate scans in febrile patients. JAMA 
1975;233:1073-1076. 
16 Hilson AJW, Maisey MN. Ga-67 scanning in pyrexia of unknown origin. Br Med J 
1979;279:1330-1331. 
17 MacSweeney JE, Peters AM, Lavender JP. Indium labelled leucocyte scanning in pyrexia 
of unknown origin. Clin Radiol 1990,42.414-417. 
18 Davies SG, Garvie NW. The role of indium-labeled leukocyte imaging in pyrexia of 
unknown origin. Br J Radiol 1990,63·850-854 
19 Kelly MJ, Kalff V, Hicks RJ, Spicer WJ, Spelman DW. 111ln-oxme labelled leukocyte 
scintigraphy in the detection and localization of active inflammation and sepsis. Med J 
Aust 1990;152:352-357. 
20 Suga К, Nakagi К, Kuramitsu Τ, Itou К, Tanaka Ν, Uchisato Η, Nakanishi Τ, Utsumi Η, 
Yamada Ν. The role of Gallium-67 imaging in the detection of foci in recent cases of 
fever of unknown origin. Ann Nucl Med 1991;5 35-40. 
143 

Chapter 9 
Diagnostic Workup of Patients with FUO 
Elisabeth M.H.A. de Kleijn, M.D. and Jos W.M. van der Meer, M.D. 
Diagnostic workup of patients with FUO 
Abstract 
With help of data retrieved in a prospective multi center study on patients 
wi th FUO, conducted in the Netherlands from January 1992 until January 
1994, we formulated a diagnostic workup of patients wi th FUO. 
The most important step in this diagnostic workup is a (preferably 
standardized) thorough history-taking, physical examination combined with 
certain obligatory investigations in a meticulous search for potentially 
diagnostic clues (PDCs). Although often misleading, only wi th help of these 
PDCs the formation of a limited list of most probable diagnoses can be made 
and further diagnostic procedures should be limited to specific investigations 
used to confirm or exclude these diseases. 
In every patient drugfever and factitious fever should be ruled out in an early 
stage of the diagnostic protocol. 
In patients wi th recurrent fever, infectious or malignant disorders are rarely 
seen. The diagnostic workup can be even more limited than in patients wi th 
continuous fever and should probably consist only of a thorough first stage 
combined with the obligatory investigations and the search for periodic 
syndromes matching the PDCs retrieved. Only when PDCs for infections, 
vasculitis or malignancies are present or clinical condition deteriorates, further 
diagnostic workup is indicated. 
In patients wi th continuous fever without PDCs or only misleading PDCs only 
few diagnostic techniques proved useful as a screening procedure and helped 
to establish the diagnosis in our prospective study. Fundoscopy, serology 
(Western blot) for Yersinia enterocolitica, serum for cryoglobulin and temporal 
artery biopsy in patients older than 55 years were useful in an early stage. In 
a later phase of the diagnostic process, bone biopsy, liver biopsy (including 
culture) and abdominal CT and chest CT were useful in these patients. 
Repeating a thorough history-taking, physical investigation and obligatory 
investigations and waiting for PDCs to appear is a strategy superior to 
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ordering many screening investigations in the hope that something abnormal 
will come up. Supportive treatment with NSAIDs under careful observation 
for the development of new PDCs, can be helpful in this stage. Rarely, 
patients deteriorate while using NSAIDs, without presenting new PDCs. Only 
in these rare patients, further diagnostic workup should be performed and/or 
a therapeutic trial with e.g., antibiotics, steroids, or antituberculous agents 
started. 
Introduction 
Despite many reports on FUO published since the early twenties, the problem 
of FUO is still being regarded as a formidable diagnostic challenge. By 
defining FUO as an illness characterized by rectal temperature of 38.3°C or 
higher on at least three occasions, evolving during at least 3 weeks, with no 
diagnosis reached after 1 week of "intelligent" inpatient investigation, 
Petersdorf and Beeson made it possible to perform epidemiological studies \ 
Recently this definition has been adapted to modern times by excluding 
immunocompromised patients 2'3. During 1992 and 1993, we performed a 
prospective study on FUO using this new criterium 4. Furthermore, we 
propose to replace the time-criterium of one week of "intelligent" inpatient 
investigation, which can lead to unwanted selection bias (influenced by the 
experience of the doctor, the facilities and differences in management 
between countries or even hospitals), by a quality-criterium that requires a 
number of investigations to be performed during the first couple of days in 
hospital (Table 9.1). 
There is an increasing tendency to assess FUO on a out-patient basis and 
this group should be included in future studies 2 · 3 , 5 . We would like to include 
outpatients in future studies provided they fulfill the other criteria of FUO. 
We propose a revised definition of classical FUO to be used in future 
investigation (Table 9.2). 
147 
Diagnostic workup of patients with FUO 
Table 9.1. Obligatory investigations performed in all patients with FUO. 
Sedimentation rate; hemoglobin; mean cellular volume; platelet count; leukocyte count and 
differential count; creatinine; protein; protein fractions; alkaline phosphatase; aminotransferase; 
lactate dehydrogenase; creatine Phosphokinase; antinuclear antibodies; rheumatoid factors; 
urinary analysis; feces for occult blood; blood cultures aerobic and anaerobic (n = 3); tuberculin 
skin test; urine-, feces-, and sputum culture when indicated; chest X-ray; ultrasonography of 
upper abdomen; 
Diagnostic workup of FUO 
The workup of the immunocompetent patient with FUO starts with a 
complete and repeated history and physical examination, carried out 
meticulously, supplying the clinician with potentially diagnostic clues 
(PDCs)to the most likely causes of FUO, thereby permitting that an adequate 
workup can be initiated. For clinicians with limited experience in this field, the 
use of a pre-coded history and physical examination form is advisable in this 
phase of the diagnostic process. 
Rarely, a patient with an acute life-threatening infection (e.g., sepsis or acute 
bacterial endocarditis) will seek medical care after a prolonged period of 
fever. By that time, localizing signs or even shock will usually have 
developed. In such patients, it is obvious that leukocyte differential count, 
erythrocyte sedimentation rate, urinalysis with Gram stain of the sediment 
and cultures of blood and urine must be performed immediately. Often 
empirical antibiotic therapy has to be started in such patients. 
In all other patients, a certain number of obligatory investigations should be 
performed (Table 9.1). These investigations will possibly reveal new PDCs 
that can be used in the diagnostic process. After identification, sorting and 
registration of all PDCs thus retrieved, it is possible to make a limited list of 
most probable diagnoses, enabling to draw up a list of further investigations. 
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Table 9.2. Revised definition for classical fever of unknown origin. 
1. Fever of 38.3 °C (101 °F) or higher on 3 or more occasions. 
2. Illness of more than 3 weeks duration 
3. Exclusion of immunocompromised patients 
(neutropenia for at least 1 week, within 3 months before the onset of fever (WBC < 1.0 χ 
109/L and/or granulocyte count < 0.5 χ 109/L), HIV-positive, known hypogammaglobulinemia 
(IgG < 50%) and the use of the equivalent of more than 10 mg prednisone for at least 2 
weeks). 
4. Diagnosis uncertain after the use of a (standardized) thorough history and physical 
examination and the following obligatory investigations: 
Sedimentation rate; hemoglobin; mean cellular volume; platelet count; leukocyte count and 
differential count; serum creatinine; protein; electrophoresis; alkaline phosphatase; 
aminotransferase; lactate dehydrogenase; creatine Phosphokinase; antinuclear antibodies; 
rheumatoid factors; urinary analysis; stools for occult blood; blood cultures aerobic and 
anaerobic (n = 3); tuberculin test; culture of urine, stool, and sputum when indicated; chest 
X-ray; ultrasonography of upper abdomen. 
Moreover, in patients with FUO all medication should be discontinued in order 
to exclude drugfever. Fraudulent fever should be ruled out early in the 
diagnostic process by measurement of the temperature by an observer. 
Modern fast electronic equipment, such as tympanic infra-red thermography 
could be useful to exclude fraudulent fever. To rule out factitious fever in 
outpatients a short admission may be necessary. 
In conclusion, the initial diagnostic approach of patients with FUO consists of 
a thorough search for PDCs. The importance of PDCs has been emphasized 
inmany reviews on FUO and many times one is advised to adhere to Sutton's 
Law: " to go were the money is" 6"1 0. However, one has to keep in mind that 
often PDCs are misleading. In our prospective study on diagnostic procedures 
in patients with FUO, we did not find a significant difference in finding the 
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diagnosis, between patients with and without PDCs. The major reason was 
probably the high percentage of patients with misleading PDCs (65%) 11. 
When comparing all PDCs in the group of patients with a diagnosis and the 
group of patients without a diagnosis, only three PDCs were independent 
predictors for finding a diagnosis (fever pattern, hemoglobin and erythrocyte 
sedimentation rate). For all other PDCs there was no significant difference 
between the two groups. Still, the search for PDCs remains highly important 
in the diagnostic approach of patients with FUO; most investigations 
performed in our prospective study were helpful only when performed in 
patients with specific PDCs for the diagnosis searched for. 
In patients without PDCs or only misleading PDCs, second stage 
investigations should be considered when the first phase remained 
inconclusive (Figure 9.1). Which investigations should be performed in these 
patients and in which subgroups is the longstanding fever more likely to be 
benign? 
7. Recurrent or episodic fever. 
In our prospective study 11 we found that the chance of reaching a diagnosis 
in patients with periodic fever and normal ESR and hemoglobin at the time of 
fever was less than 10%. Patients with recurrent or episodic fever rarely have 
infectious or malignant disorders. In these patients, the most common 
encountered conditions are adult-onset Still's disease or familial 
Mediterranean fever, hypersensitivity pneumonitis and some rare diseases: 
e.g., Schnitzler's disease, Hyper IgD Syndrome (HIDS), FAPA syndrome 
(syndrome of periodic fever, aphtous stomatitis, pharyngitis and cervical 
adenitis), Loch Fyne fever, familian Hibernian fever or cyclic neutropenia. 
In patients with familial fever or recurrent fever for more than two years, it is 
very unlikly that the fever is being caused by infection or malignancy. 
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Repeated (standardized) thorough history and physical examination 
Obligatory investigations (Table 9 1) 
stop or replace medication to exclude drugfever 
ι — 
measure temperature by observer or exclude fraudulent fever 
/ 
I. PDCs present 
categorize PDCs 
continuous fever 
I 
recurrent or familial fever 
order appropiate 
investigations 
X 
NO DIAGNOSIS -> II. 
search for specific 
syndromes 
DIAGNOSIS 
x: II. no PDCs or only 
misleading PDCs 
consider use NSAIDs 
or therapeutic trial 
= fundoscopy, serology (Western blot) for Yersinia enterocolmca. serum for cryoglobulin and 
temporal biopsy in patients over 55 years 
= bone biopsy, liver biopsy (including culture), abdominal CT and chest CT. 
Fig. 9.1. Diagnostic workup in patients with FUO. 
In these patients the diagnostic workup should consist only of the thorough 
history-taking, physical examination and obligatory investigations. The search 
for PDCs should be directed to the search for PDCs matching known 
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recurrent syndromes. Only when PDCs for infections, vasculitis syndromes or 
malignancies are present, and clinical condition is deteriorating, invasive 
diagnostic workup should be performed in these patients. 
2. Continuous fever. 
Attempts have been made in the past to outline diagnostic approaches 9·10·12-16 
in patients with continuous fever. Although of help, such algorithms have not 
been validated and extrapolation to individual patients with FUO without 
PDCs remained difficult. In order to assess the screening utility of the 
investigations most often mentioned in these algorithms, we prospectively 
used a staged standardized diagnostic workup in this subgroup of patients 11. 
Only few investigations were actually useful as screening procedure in our 
population of patients without PDCs. In the early stage of the diagnostic 
workup of these patients the following procedures can be useful: fundoscopy, 
serology (Western blot) for Yersinia enterocolitica 17, serum for cryoglobulin 
and temporal artery biopsy in patients older than 55 years. In a later phase of 
the diagnostic process, bone biopsy, liver biopsy, abdominal CT and chest CT 
can be useful in patients without PDCs. Repeating a thorough history-taking, 
physical examination and obligatory investigations and waiting for PDCs to 
appear, probably is better than ordering more screening investigations in the 
hope that something abnormal will come up. Supportive treatment with 
NSAIDs can be helpful in this stage. Only rarely, patients deteriorate while 
using NSAIDs without presenting new PDCs. Only in these rare patients, 
further diagnostic workup should be performed or a therapeutic trial with e.g., 
antibiotics, steroids, or antituberculous agents started. 
Conclusion 
A screening diagnostic protocol can be limited in the absence of PDCs. Of 
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course, a first requisite is a continuous rigorous search for PDCs by taking a 
thorough, preferably standardized history and physical examination and by 
ordering the obligatory investigations. The patients in our prospective study 
had undergone such a meticulous diagnostic workup and extrapolation to the 
individual patient with FUO can only be made by using such an initial workup. 
References 
1 Petersdorf RG, Beeson PB. Fever of unexplained origin: report on 100 cases. Medicine 
(Baltimore) 1961;40:1-30. 
2 Durack DT, Street AC. Fever of unknown origm-reexamined and redefined. In: Remington 
JS, Swartz MN, eds. Current Clinical Topics in Infectious Diseases, 11. Boston: Blackwell 
Scientific Publications Inc., 1991:35-51. 
3 Petersdorf RG. Fever of unknown origin. An old friend revisited. Arch Intern Med 
1992;152:21-22. 
4 De Kleijn EMHA, Vandenbroucke JP, van der Meer JWM, and the Netherlands FUO study 
group . Fever of unknown origin. I. A prospective multi center study of 167 patients with 
FUO, using fixed epidemiologic entry criteria. Medicine (Baltimore) 1997;76, in press. 
5 Knockaert DC, Vanneste LJ, Vanneste SB, Bobbaers HJ. Fever of unknown origin in the 
1980s. An update of the diagnostic spectrum. Arch Intern Med 1992;152:51-55. 
6 Musher DM, Fernstem V, Young EJ, Pruett TL. Fever patterns. Their lack of clinical 
significance. Arch Intern Med 1979;139:1225-1228. 
7 Jaco by GA, Swartz MN. Current concepts. Fever of undetermined origin. N Engl J Med 
1973;289:1407-1410. 
8 Brusch JL, Weinstein L. Fever of unknown origin. Med Clin North Am 1988,72·-
1247-1261. 
9 Vickery DM, Quinnell RK. Fever of unknown origin. An algorithmic approach. JAMA 
1977;238:2183-2188. 
10 Esposito AL, Gleckman RA. A diagnostic approach to the adult with fever of unknown 
origin. Arch Intern Med 1979;139:575-579. 
11 De Kleijn EMHA, van Lier HJJ, van der Meer JWM and the Netherlands FUO study group. 
Fever of unknown origin (FUO): II. Diagnostic procedures m a prospective multi center 
study of 167 patients. Submitted. 
12 Hurley DL. Fever in adults. What to do when the cause is not obvious. Postgrad Med 
1983;74:232-244. 
13 Gries E, Hoensch H, Ohnhaus ЕЕ. Differentialdiagnose bei bisher ungeklärtem Fieber: 
Bedeutung klinischer Begleitsymptome. Klin Wochenschr 1986;64:307-313. 
14 Nolan SM, Fitzgerald FT. Fever of unknown origin. The general internist's approach. 
Postgrad Med 1987;81:190-205. 
153 
Diagnostic workup of patients with FUO 
15 Koch H, Jenke V. Fieber unklarer Ursache - ein diagnostisches Basisprogramm. Ζ 
Gesamte Inn Med 1990;1890:560-562. 
16 Fischer JL, Henselmann L. Stufendiagnostik des Fiebers. Fieber unbekannter Ursache. 
Med Kim 1987;82:229-235. 
154 
Chapter 10 
Addendum 
Addendum 
Standaardanamnese en lichamelijk onderzoek. 
ANAMNESE: 
start bewezen (gedocumenteerde) koorts 
datum presentatie koortsanalyse o afdeling o poli 
aard van de koorts o continua o intermittens o remittens 
o pel-ebstein o wisselend o piekend 
o met grotere koortsvrije perioden (periodiek) 
febns continua = temperatuur steeds verhoogd, verschil niet groter dan 1 °C 
febns intermittens = temperatuur tussendoor ook normaal gedurende meer dan 24 uur 
febns remittens = temperatuur steeds verhoogd, verschillen ook groter dan 1 °C 
pel ebstein type = golvend koortsbeloop tussen vrijwel normale temperatuur en hoge koorts met 
periode van ongeveer 3 weken 
piekende temp = temperatuur wisselt in 24 uur tussen normaal en hoog 
wisselend beloop = geen enkele omschrijving steeds van toepassing 
Hoeveel dagen koorts achtereen 
hoeveel pieken per dag 
vaste tijden koorts (welke) o ja o nee 
hoelang houdt de koorts aan(uren) 
koude rillingen 
overmatig transpireren 
nachtzweten 
algehele malaise 
gewichtsverlies 
zo ja, hoeveel 
minder gaan eten 
slecht uitzien 
moeheid 
spierzwakte 
bloedingsneigmg 
recidiverende infecties 
lymfklierzwelhngen bemerkt 
jeuk 
o ja 
o ja 
o ja 
o ja 
o ja 
o ja 
o ja 
o ja 
o ja 
o ja 
o ja 
o ja 
o ja 
o nee 
o nee 
o nee 
o nee 
o nee 
kg/ti|dseenheid 
o nee 
o nee 
o nee 
o nee 
o nee 
o nee 
o nee 
o nee 
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seksueel risicogedrag o ja o nee 
huisdieren o ja o nee 
zo ja, welke 
contact met schapen,vee o ja o nee 
ongezuiverd voedsel o ja o nee 
insectenbeten o ja o nee 
tropenbezoek o ja o nee 
waar, wanneer 
ziek in tropen o ja o nee 
welke ziekten 
vacantie subtropen o ja 
waar, wanneer 
huiduitslag o ja 
zo ja, wat 
bekend met allergie o ja 
zo ja, welke 
mensen in omgeving ziek o ja 
welke ziekten 
in verleden contact met tbc o ja o nee 
zoet water/sloot/modder o ja o nee 
beroep 
contact toxische stoffen o ja o nee 
zo ja, welke 
andere woon/werkomgeving o ja o nee 
familiaire koorts bekend o ja o nee 
buitenlandse voorouders o ja o nee 
zo ja, welke 
koorts na stress of werken o ja o nee 
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medicijngebruik о ja о nee 
welke, sinds wanneer 
alkoholgebruik o ja o nee 
hoeveel (E/wk) 
roken o ja o nee 
hoeveel 
intraveneus druggebruik o ja o nee 
welke 
relevante ziekten VG 
relevante OKs 
relevante familieanamnese 
eerder opnamen ivm koorts o ja 
waar, wanneer 
elders diagnose gesteld o ja 
welke,wanneer 
elders behandeling gestart o ja 
welke,hoelang 
TRACTUS RESPIRATORIOS: 
bekend met CARA o ja 
keelpijn o ja 
oorpijn o ja 
heesheid o ja 
rhinitis o ja 
pijn in mond o ja 
gebitsafwijkingen o ja 
o nee 
o nee 
o nee 
o nee 
o nee 
o nee 
o nee 
o nee 
o nee 
o nee 
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recent tandartsbezoek o ja o nee 
blaasjes/aphten mond o ja o nee 
hoesten o ja o nee 
sputum o ja o nee 
aspect 
hemoptoe o ja o nee 
dyspnoe o ja o nee 
piepen o ja o nee 
pijn bij zuchten o ja o nee 
CARDIOVASCULAIRE TRACTUS: 
angina pectoris 
pijn thorax 
hartkloppingen 
orthopneu 
oedeem 
nycturie 
dyspnoe d'effort 
claudicalo intermittens 
raynaudfenomeen 
trombose verleden 
thrombophlebitis 
hypertensie 
TRACTUS UROGENITALS 
veranderde mictie 
pijnlijke mictie 
troebele urine 
schuimende urine 
Pneumaturie 
hématurie 
o ja 
o ja 
o ja 
o ja 
o ja 
o ja 
o ja 
o ja 
o ja 
o ja 
o ja 
o ja 
o ja 
o ja 
o ja 
o ja 
o ja 
o ja 
o nee 
o nee 
o nee 
o nee 
o nee 
o nee 
o nee 
o nee 
o nee 
o nee 
o nee 
o nee 
o nee 
o nee 
o nee 
o nee 
o nee 
o nee 
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nierstenen o ja 
prostatisme o ja 
retentiegevoel o ja 
recidiverende urineweginf o ja 
incontinentie o ja 
fluor o ja 
in verleden genitale infectie o ja 
о nee 
о nee 
о nee 
о nee 
о nee 
о nee 
o nee 
o nvt 
o nvt 
o nvt 
zo ja, welke 
behandeling 
irregulaire menses 
leeftijd menopauze 
postmenopauzaal bloed 
o ja 
o ja 
aantal zwangerschappen/miskramen 
TRACTUS DIGESTIVUS: 
verminderde eetlust 
misselijkheid 
opgezette buik 
passageklachten 
regurgitatie 
ructus 
zuurbranden 
buikpijn 
hikken 
braken 
voedselintolerantie 
veranderd defecatiepatroon 
bloedbijmenging 
slijmbijmenging 
melena 
o ja 
o ja 
o ja 
o ja 
o ja 
o ja 
o ja 
o ja 
o ja 
o ja 
o ja 
o ja 
o ja 
o ja 
o ja 
o nee 
o nee 
o nee 
o nee 
o nee 
o nee 
o nee 
o nee 
o nee 
o nee 
o nee 
o nee 
o nee 
o nee 
o nee 
o nee 
o nee 
o nvt 
(jaren) 
o nvt 
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o ja 
o ja 
o ja 
о ja 
о ja 
о ja 
о nee 
о nee 
о nee 
о nee 
о nee 
о nee 
diarree о ja o nee 
ooit icterus gehad o ja o nee 
steatorrhoe o ja o nee 
TRACTUS CENTRAAL ZENUWSTELSEL: 
duizeligheid 
hoofdpijn 
slechter zien 
slechter horen 
uitvalsverschijnselen 
tintelingen 
zo ja, waar 
andere sensibiliteitsafw. 
krachtsverlies o ja o nee 
concentratiestoornissen o ja o nee 
coordinatiestoornissen o ja o nee 
epileptische aanvallen o ja o nee 
collaps gehad o ja o nee 
stemmingsveranderingen o ja o nee 
psychiatrische VZ o ja o nee 
TRACTUS LOCOMOTORIUS: 
arthralgie o ja o nee 
zo ja, waar 
arthritis o ja o nee 
zo ja, waar 
myalgie o ja o nee 
zo ja, waar 
botpijn o ja o nee 
zo ja, waar 
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rugpijn o ja 
zo ja, waar 
ochtendstijfheid in rug 
beperkte beweeglijkheid rug 
spontane fracturen 
stijfheid gewrichten 
strakkere huid 
droge slijmvliezen 
ENDOCRIENE TRACTUS: 
polyune/dorst 
hypogevoel 
polyfagie 
nervositas/onrust 
warmte intolerantie 
koude intolerantie 
mensesproblemen 
haaruitval 
drogere dikkere huid 
stemveranderingen 
veranderd behanngspatroon 
traagheid 
pigmentatieverandenngen 
tétanie 
DIVERSEN: 
o ja 
o ja 
o ja 
o ja 
o ja 
o ja 
o ja 
o ja 
o ja 
o ja 
o ja 
o ja 
o ja 
o ja 
o ja 
o ja 
o ja 
o ja 
o ja 
o ja 
o nee 
o nee 
o nee 
o nee 
o nee 
o nee 
o nee 
o nee 
o nee 
o nee 
o nee 
o nee 
o nee 
o nee 
o nee 
o nee 
o nee 
o nee 
o nee 
o nee 
LICHAMELIJK ONDERZOEK: 
ALGEMEEN: 
bloeddruk (mmHg) Re-
centraal veneuze druk normaal o ja 
Li 
o nee 
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ademhalingsfreqentie (/ 
pols (/ min) 
templtegelijk met pols) 
anemische slijmvliezen 
dyspnoe 
cyanose 
icterus 
turgor normaal 
droge slijmvliezen 
oedeem 
toestand 
euthyreoot 
compos mentis 
voedingstoestand 
spieratrofie 
lymfomen palpabel 
waar,aspect 
mm) 
o ja 
o ja 
o ja 
o ja 
o ja 
o ja 
o ja 
o ziek 
o ja 
o ja 
o normaal 
o ja 
o ja 
o nee 
o nee 
o nee 
o nee 
o nee 
o nee 
o nee 
o niet ziek 
o nee 
o nee 
o adipeus 
o nee 
o nee 
o matig ziek 
o mager 
huidafwijkingen o ja o nee 
(pnkgaatjes,furunkels,splinterbloedinkjes,spider naevi etc) 
welke 
afwijkingen nagelriemen o ja o nee 
spoelvormige vingers o ja o nee 
HOOFD-HALS GEBIED: 
funduscopie afwijkend o ja o nee 
zo ja, hoe 
arteria temporalis afwijkend o ja 
zo ja, hoe 
kloppijn sinus o ja 
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rhinitis 
gebitsafwijkingen 
zo ja, welke 
o ja 
o ja 
o nee 
o nee 
aphten of wondjes mond o ja o nee 
candida mond/keelslijmvlies o ja o nee 
schildklier afwijkend o ja o nee 
zo ja, hoe 
afwijkingen a carotis o ja o nee 
andere afw hoofd/hals 
THORAXONDERZOEK: 
aspect thorax afwijkend o ja o nee 
zo ja, hoe 
afwijkingen mammae o ja 
zo ja, hoe 
afwijkend onderzoek longen o ja o nee 
zo ja, hoe 
drukpijn thorax o ja o nee 
zo ja, waar 
afwijkend onderzoek hart o ja 
zo ja, hoe 
ONDERZOEK ABDOMEN: 
afwijkende inspectie o ja 
(littekens,ascites,etc) 
afwijkende penstaltiek o ja o nee 
souffles in buik o ja o nee 
vergrote lever o ja o nee 
vergrote milt o ja o nee 
andere afwijkingen o ja o nee 
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pijn bij palpatie o ja o nee 
afwijkingen in testes o ja o nee 
zo ja, welke 
erosies of wondjes penis o ja o nee 
andere afw gen ext. o ja o nee 
zo ja, welke 
vaginaal toucher afwijkend o ja o nee 
zo ja, welke 
abnormale fluor o ja o nee 
zo ja, hoe 
anus/rectaal toucher afw. o ja o nee 
zo ja, hoe 
RUG EN EXTREMITEITSONDERZOEK 
kloppijn wervelkolom o ja o nee 
zo ja, waar 
normale beweeglijkheid rug o ja o nee 
slagpijn nierloges o ja o nee 
afwijkende stand rug o ja o nee 
afwijkende gewrichten o ja o nee 
zo ja, waar 
artenele pulsaties afwijkend o ja o nee 
zo ja, hoe 
afwijkende reflexen o ja o nee 
zo ja, hoe 
sensibiliteitsstoornis o ja o nee 
zo ja, waar,welke 
Addendum 
Mogelijke oorzaken van febris e causa ignota. 
INFECTIES 
Bacterieel 
Niet specifiek 
Endocarditis, abdominale abcessen (bekken, milt, lever, subfrenisch, 
subhepatisch, periapendiculair, pylephlebitis, diverticula^), adnexitis, 
placenta abces, endometritis, nierabces, xanthogranulomateuze 
pyelonephritis, prostatitis, cholangitis, bacteriële hepatitis, urineweg 
infecties, granuloma apicale, sinusitis, infectie van vaatprothese, 
osteomyelitis, infectieuze arthritis, centrale lijn infectie. 
Specifiek 
Actinomycosis, brucellosis, campylobacteriosis, Chlamydia pneumoniae 
(TWAR), febris recurrens {Borre/lia recurrentis), gonokokkemie, 
kattekrabziekte (Bartonella henselae), loopgravenkoorts (Bartonella 
quintana), leptospirosis, listeriosis, Lyme-ziekte, melioidosis, chronische 
meningokokkose, mycoplasma, psittacosis, rattebeetziekte (Spirillum minus, 
Streptobacillus moniliformis), rickettsiose [Q-koorts, ehrlichiosis, 
tsutsugamushi-koorts, endemic typhus (Rickettsia typhi)], salmonellosis, 
syfilis, tularemie, tuberculosis, m. Whipple (Tropheryma whippelii), 
yersiniosis. 
Viraal 
Cytomegalovirus, groep В Coxsackievirus, Epstein Barr virus, hantavirus, 
hepatitis (A,B,C), HIV, parvovirus. 
Fungal 
Aspergillosis, candidiasis, cryptococcosis, histoplasmosis, malassezia furfur. 
Parasitair 
Amoebiásis, babesiosis, bilharziosis (schistosomiasis), echinococcosis, 
fascioliasis, leishmaniasis, malaria, toxocariasis, toxoplasmosis, trypano-
somiasis, trichinosis. 
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MALIGNITEITEN 
Hematologische maligniteiten 
Angioimmunoblastisch lymfoom (AILD), m. Hodgkin, non-Hodgkin maligne 
lymfomen, m. Kahler, leukemie, maligne histiocytosis, mucocutaan 
lymfekl iersyndroom (m. Kawasaki), myelodysplast isch syndroom, 
myelofibrose, lymphomatoide granulomatosis, systemische mastocytosis, 
Solide tumoren 
Alle solide tumoren en hun metastasen kunnen koorts veroorzaken. 
Meest voorkomend als oorzaak van febris eci: atriaal myxoom, borst, colon, 
lever, long, pancreas. 
Verder beschreven als oorzaak van febris eci: bijnier, bot, cervix, dundarm, 
galblaas, larynx, leiomyosarcoom, maag, melanoom, mesothelioom, 
neuroblastoom, ovarium, rhabdomyosarcoom, sarcoom, schildklier, 
xanthofibrosarcoom. 
Benigne tumoren 
angiomyolipoom, craniopharyngioom, caverneus hemangioom van de lever, 
necrose in dermoid tumor in syndroom van Gardner. 
NIET-INFECTIEUZE INFLAMMATOIRE ZIEKTEN 
"Collageenziekten" 
acuut rheuma, Behcet's syndroom, dermatomyositis, Felty syndroom, lupus 
erythematosus, mixed connective tissue disease, polychondritis recidivans, 
polymyositis, Reiter's syndroom, reumatoïde arthritis, Sjogren's syndroom, 
m.Still, spondylitis ankylopoetica. 
"Vasculitis beelden" 
allergische vasculi t is, Polyarteriitis nodosa, urticariële vascul i t is, 
m.Takayashu, m.Wegener. 
"Granulomateuze ziekten" 
arteriitis temporalis (polymyalgia rheumatica), m.Crohn, erythema nodosum 
eci, granulomateuze hepatitis, granulomateuze myositis, sarcoidosis. 
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DIVERSEN 
M.Addison, allergische pneumonitis, amyloidosis, aneurysmata, anhidrotisch 
ectodermale dysplasie, anomalie d. thoracicus, aseptic meningitis (Mollaret's 
syndroom), autosomaal dominante FMF-achtig syndroom met amyloidosis, 
bevochtigingslong ("humidifier"), brouwer's gist blootstelling, m.Caroli, 
m.Castleman, cholesterol embolie, cirrose, cyclische neutropenie, doofheid-
urticaria-amyloidosis syndroom, duivenmelkersziekte, epilepsie, erythema 
multiforme, m.Fabry, FAPA-syndroom, familiale Ierse koorts ("Hibernian"), 
f a m i l i a l e m e d i t e r r a n e k o o r t s , f e o c h r o m o c y t o o m , f a c t i t i a , 
geneesmiddelkoorts, habituele hyperthermie, Hamman Rich syndroom 
( idiopathische longf ibrosis) , hematomen, hemolyt ische anemie, 
herseninfarct, hyper IgD syndrome, hyperparathyreoidie, hyperthyreoidie, 
hypertriglyceridemie, hypothalamische hypopituitarisme, inflammatorische 
pseudotumor, j icht, lineair IgA dermatose, longembolie, m.Kikuchi, koemelk 
allergie, metaalrook koorts, myxoma, primaire biliaire cirrose, pseudojicht, 
psychogene koorts, retroperitoneale fibrose, Schnitzler's syndroom, silicone-
geïnduceerde granulomatosis, Teflon embolie, thyreoiditis, Vogt-Koyanagi-
Harada syndroom, m.Weber-Christian. 
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Mogelijke oorzaken van periodieke koorts. 
I. syndromen die familiair kunnen voorkomen. 
Autosomaal dominante familiaire mediterrane-koorts gelijkend syndroom met 
amyloidosis 
Familiale mediterrane koorts 
Familiale Ierse koorts 
Hypertriglyceridemie 
M. Fabry 
Hyper IgD syndroom (HIDS) 
Doofheid, urticaria en progressieve amyloidosis 
II. overige periodieke koorts syndromen 
(naarmate de koorts langer duurt, wordt een infectie minder waarschijnlijk) 
INFECTIES 
Bacterieel 
Niet specifiek: 
Recidiverende bacteriëmie bij colonpoliep, prostatitis, granuloma apicale 
Specifiek: 
Brucellosis, chronische meningokokkose, febris recurrens [Borrel/ia 
recurrentis), melioidosis [Pseudomonas pseudomallei), Q-koorts (Coxiella 
burnetii), rattebeetziekte (Spirillum minor, Streptobacillus moniliformis), 
salmonellosis (Salmonella paratyphi), syfilis, tularemia (Francisella tu/arensis), 
yersiniosis (Yersinia enterocolitica), m. Whipple (Tropheryma whippe/ii). 
Parasitair 
Toxoplasmosis, trypanosomiasis, malaria, visceral leishmaniasis (Kala Azar). 
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MALIGNITEITEN 
Angioimmunoblastisch lymfoom (AILD), colon carcinoom, maligne non-
Hodgkin lymfoom, m. Hodgkin, lekkend craniofaryngioom, maligne 
histiocytose. 
NIET-INFECTIEUZEONTSTEKINGSZIEKTEN 
Adult-onset juveniele reumatoïde arthritis (m. Still), m. Crohn, granulomateuze 
hepatitis, lupus erythematosus, mixed cryoglobulinemie, recidiverende 
panniculitis, recidiverende polychondritis, Reiter syndroom, sarcoidosis, 
spondylitis ankylopoetica, m. Schnitzler (urticariële vasculitis, monoclonal 
IgM, hyperostosis). 
DIVERSEN 
Aorto-enterale fistel, allergische pneumonitis, atrium myxoma, brouwers gist 
blootstelling, m. Castleman (angiofolliculaire lymfeklier hyperplasie), 
cholesterol embolietjes, cyclische neutropenie, factit ia, m. Fabry, FAPA 
syndroom, m. Gaucher, geneesmiddelkoorts, habituele hyperthermic, 
bevocht ig ings long ( "humid i f ie r " ) , hypothalamisch hypopi tu i tar isme, 
inflammatorische pseudotumor, Loch Fyne koorts, long embolie, metaalrook 
koorts, koemelk allergie, polymeer rook koorts, psychogene koorts, syndroom 
van urticaria, doofheid en progressieve amyloidosis. 
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Summary and conclusions 
Summary 
Ever since the recognition of the syndrome of fever of unknown origin (FUO), 
the diagnostic workup of patients with FUO has constituted an enormous 
diagnostic challenge. After the introduction of a definition of FUO by 
Petersdorf and Beeson in 1961 , epidemiological^ comparable studies were 
possible and many series appeared since. There were several reasons to 
undertake this multicenter study in the Netherlands. The spectrum of diseases 
causing FUO seemed to be determined by geographical factors and no 
epidemiological study of FUO had been performed in this country. It had been 
shown by other studies that the spectrum of diseases causing FUO appeared 
to change wi th t ime, and updating of information on FUO in the 1990s 
seemed desirable. The definition of FUO had to be adapted to modern times 
by excluding immunocompromised patients, in whom an entirely different 
spectrum of causes of FUO is found, and a different diagnostic and 
therapeutic workup is needed in such patients. Uniform epidemiological entry 
criteria and a standardized diagnostic workup, necessary to avoid unintended 
bias, were not used in past studies, and this made comparison troublesome. 
Although the search for potentially diagnostic clues (PDCs) was emphasized 
by all experts on FUO, the value of individual PDCs had never been evaluated 
prospectively. Although some attempts were made to outline diagnostic 
approaches in algorithms, the diagnostic utility of many of the investigations 
mentioned, had never been established in patients wi th or without PDCs for 
the diagnosis searched for. 
Before we embarked on a prospective multicenter study in patients with FUO, 
we wanted to obtain a better insight into FUO and the diagnostic workup of 
patients wi th FUO in the Netherlands. 
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Chapter 2 
During a 3.5-year period between August 1988 and January 1992, we 
retrieved 53 patients in our hospital, fulfilling the classical criteria for FUO, by 
using combined searching techniques. In 11 (21%) patients infections were 
found, in 10 (19%) neoplasms, in 12 (23%) non-infectious inflammatory 
diseases and in 16 (30%) patients no diagnosis could be made. The 
proportion of patients without diagnosis was increased compared with other 
series on FUO. There were five patients without PDCs; in none of them a 
diagnosis could be made. The presence of PDCs seemed important for the 
diagnostic outcome and prospective evaluation of its importance could be of 
interest. We also studied diagnostic workup in these patients. It appeared 
that many diagnostic techniques were used as screening techniques wi thout 
PDCs for the diseases searched for. A prospective study of the diagnostic 
yield of those techniques seemed worthwhi le. 
Chapter 3 
We performed an in-depth inquiry among a total of 24 internists in each of 
the 8 university hospitals in the Netherlands, to obtain insight into the 
diagnostic approaches, used in patients wi th FUO. Nineteen internists filled 
out a questionnaire consisting of two parts. The first section was a 
description of a patients with FUO having few PDCs and questions on the 
workup of this patient. A median of six diagnoses (range 2 to 16) were 
suggested by the participants. Many investigations were ordered on the basis 
of this differential diagnosis. The second section consisted of a multiple 
choice form, specifying the clinical situation in which one would order, in 
general, each of the 182 investigations mentioned. Many investigations were 
ordered as a screening procedure although no information on the diagnostic 
utility of these techniques was available at the time of the study. Based on 
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retrospective analysis of diagnostic management of patients with FUO in 
Nijmegen and data from this study, a two-staged standardized diagnostic 
protocol was developed, which would be applied in a large prospective 
multicenter study. 
Chapter 4 
Before starting a prospective multicenter study on the diagnostic utility of 
indium-111 -labeled polyclonal human IgG (111ln-lgG) scintigraphy, we 
retrospectively studied all 24 patients seen at our university hospital in whom 
this relatively new technique was performed and who fulfilled the classical 
criteria for FUO. In nine of 13 patients with positive scans, the technique led 
to the final diagnosis. In nine of 11 patients wi th a negative scan, extensive 
diagnostic workup produced no infection as the final diagnosis. Overall 
sensitivity and specificity of 111ln-lgG were 8 1 % and 6 9 % , respectively. 
These data compared favorably wi th data in the literature on scintigraphic 
techniques in patients wi th FUO. Because of several advantages of this 
technique, a larger prospective evaluation of this technique in patients wi th 
FUO was started. 
Chapter 5 
All internal medicine wards in all 8 university hospitals participated in a 
prospective study on FUO during a two-year period from January 1992 until 
January 1994, using fixed epidemiological entry criteria and a standardized 
diagnostic protocol to achieve completeness of enrolment, avoid unintended 
selection bias and minimize diversity in diagnostic management. We adjusted 
criteria of FUO by excluding immunocompromised patients and replacing the 
time-criterium "1 week in hospital without a diagnosis" by a quality-criterium 
stating that certain investigations had to be performed and PDCs had to be 
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followed adequately for at least 1 week, without a diagnosis being reached. 
A total of 167 immunocompetent patients with FUO were thus retrieved, of 
whom 43 (27%) had infections, 21 (13%) neoplasms and 40 (24%) non-
infectious inflammatory diseases. In 50 patients (30%) no diagnosis was 
made, of whom 37 recovered spontaneously. In 11 of 13 patients with 
persistent fever, some form of recurrent fever was present with complete 
recovery between the periods of fever. 
This study confirmed the changing spectrum of diseases causing FUO. The 
proportion of patients in whom no diagnosis could be made was increased, 
mostly it concerned benign self-limiting or recurrent fevers. Probably, this 
could be attributed to the increased use of advanced diagnostic techniques 
early in the diagnostic process, which left us with a group of patients fulfilling 
classical criteria, in whom a diagnosis was much more difficult to make with 
currently available techniques. 
In patients with recurrent fever or fever lasting longer than 6 months, the 
chance of reaching a diagnosis was significantly lower and particularly in this 
group, one should avoid extensive diagnostic workup. 
Chapter 6 
During the two-year period from January 1992 until January 1994, we used 
a standardized diagnostic protocol for all 167 immunocompetent patients with 
FUO, admitted on all internal medicine wards in all Dutch university hospitals. 
This protocol consisted of a standardized coded history and standardized 
physical examination. A number of additional investigations had to be 
performed in the first week of admission and all PDCs thus retrieved, had to 
be registered. In the presence of PDCs, specific investigations had to be 
performed based on the differential diagnosis. In the absence of PDCs, 
patients underwent a staged standardized diagnostic protocol. 
In 162 (97%) patients PDCs were present after one week of admission, 
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which all proved misleading in 61 patients. The chances of reaching a 
diagnosis in patients wi th PDCs was not significantly higher than in patients 
without PDCs, probably because of the high proportion of misleading PDCs. 
The chances of establishing a diagnosis was significantly lower ( < 1 0 % ) only 
for patients wi th recurrent fever, normal ESR and normal hemoglobin. All 
other PDCs were not significantly different in patients wi th a diagnosis 
compared w i th patients without a diagnosis. 
In 10 (23%) of 43 patients in whom the diagnostic protocol was used, the 
protocol proved useful. Investigations that proved to be of some use as 
screening procedure were: temporal biopsy in patients older than 55 years, 
fundoscopy, serology (Western blot) for Yersinia enterocolitica, serum for 
cryoglobulinemia in an early stage, and bone biopsy, liver biopsy, and 
abdominal and chest CT in a later stage of the diagnostic process. 
The screening value of immunological and microbiological serology and 
endocrinological investigations was nihil and these investigations should 
probably be performed only when PDCs for the disease searched for are 
present. Scintigraphic techniques, echocardiography and other imaging 
procedures were never helpful in our population in the absence of PDCs. 
Many patients wi th FUO had non-specific anemia and disturbed liver 
chemistry. In the presence of these findings alone, without other more 
specific PDCs, the chance of reaching a diagnosis wi th help of bone marrow 
aspiration and liver biopsy, respectively, was nihil. Enteric biopsy was never 
helpfulin our series and skin-muscle biopsy was never helpful in the absence 
of PDCs. If lymphadenopathy was confined to the cervical or inguinal region 
(with negative chest X-ray and abdominal ultrasound) lymph node biopsy 
was not helpful, in contrast to patients with generalized lymphadenopathy, in 
whom it had a high yield of 7 9 % . 
As shown in this study, the search for PDCs remained an important tool in 
establishing the diagnosis in patients wi th FUO, although in many cases these 
PDCs will appeared to be false. Directional diagnostic workup - using the 
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PDCs retrieved by repeated, meticulous history taking and physical 
examination - still is the most efficient and intellectually satisfactory way to 
solve the problem in the individual patient with FUO. 
Chapter 7 
In the literature, it was suggested that determination of cytokine patterns 
could be useful in the diagnostic workup of patients with fever. The 
diagnostic utility of cytokine measurements was never investigated in 
patients with FUO. Cytokines are involved in various immunological and 
inflammatory processes and act directly on the temperature regulation center 
in the hypothalamus. Measurements of these cytokines could possibly lead to 
an insight in the pathogenesis of fever in patients with FUO. 
In 123 patients with FUO, circulating and ex-vivo production of IL-1/?, TNFo, 
IL-6 and IL-1 ra were studied. After diagnostic workup, 28 patients had 
infections, 14 patients neoplasms, 32 patients non-infectious inflammatory 
diseases (NIIDs), 10 patients miscellaneous diseases and in 39 patients no 
diagnosis was established. 
Concentrations of circulating IL-1/?, IL-6 and IL-1 ra of patients with infections, 
neoplasms and NIIDs were higher than in normal controls. Patients with 
infections had higher concentrations of TNFa than normals. 
The ex-vivo production of IL-1/? and IL-1 ra in all patients with FUO was not 
different from that in normals, production of TNFo was lower in patients with 
neoplasms and NIIDs, IL-6 production was lower in patients with neoplasms. 
In 35 febrile patients, no elevated cytokines were found at the time of 
venipuncture, while fever persisted. We discussed the possible explanations 
for this phenomenon. 
The differences, although significant, found between the diagnostic 
subgroups did not help in the diagnostic process of FUO, as enormous 
overlap existed between all subgroups. 
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Chapter 8 
During a two-year period (January 1992 until January 1994) we studied 
prospectively 167 patients wi th FUO, 58 patients of whom underwent 
indium-111-labeled polyclonal immunoglobulin G ( i n ln- lgG) scintigraphy. In 
23 patients the technique was used as a screening procedure, in the other 35 
patients PDCs pointing at local inflammation were present. 
In nine (26%) of 35 patients wi th PDCs 111ln-lgG scintigraphy was helpful in 
the diagnostic process, in contrast to none of the 23 patients without PDCs. 
Infection was found in 10 (24%) of 41 patients wi th negative scans. All 
infections were non-focal or located in the heart, liver region or urinary tract, 
where physiological uptake obscures possible pathologic uptake. 
In the diagnostic workup of patients without PDCs for local inflammation or 
infection 111ln-lgG scintigraphy should not be used routinely. In patients wi th 
PDCs for local inflammation, i n l n - l gG was helpful in one-fourth of the 
patients. This diagnostic yield was comparable wi th that of the majority of 
other scintigraphic techniques, used in the diagnostic process of patients wi th 
FUO so far. 
Chapter 9 
With help of the data retrieved in our prospective study, we formulated a 
diagnostic workup of patients wi th FUO. In this proposal, we emphasized the 
importance of a repeated thorough standardized history-taking, physical 
examination and a certain number of obligatory investigations, as used in our 
prospective study, in a meticulous search for PDCs. 
The first step in the diagnostic process consists of the sorting of PDCs and 
drawing up of a program of specific investigations based on a limited list of 
most probable diagnoses, matching the PDCs in this particular patient. All 
medication should be discontinued or displaced to rule out drugfever and 
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fraudulent fever should be excluded in this early stage by temperature 
measurement by an observer. 
In patients with recurrent fever, infectious or malignant disorders are rarely 
seen. In these patients, diagnostic workup should probably consist only of a 
thorough first stage combined with the obligatory investigations and the 
search for periodic syndromes matching the PDCs retrieved. Only when PDCs 
for infections, vasculitis or malignancies are present or clinical condition 
deteriorates, further diagnostic workup is indicated. 
In patients with continuous fever without PDCs or only false PDCs few 
diagnostic techniques proved useful as a screening procedure in establishing 
the diagnosis in our prospective study. Fundoscopy, serology (Western blot) 
for Yersinia enterocolitica, serum for cryoglobulin and temporal artery biopsy 
in patients older than 55 years were useful in an early stage. In a later phase 
of the diagnostic process, bone biopsy, liver biopsy (including culture), 
abdominal CT and chest CT were useful in these patients. Repeating a 
thorough history-taking, physical examination and obligatory investigations 
and search for PDCs to appear, is a strategy superior to ordering many 
screening investigations in the hope that something abnormal will come up. 
Supportive treatment with NSAIDs combined with this careful observation for 
the occurrence of new PDCs, can be helpful in this stage. Only seldom, 
patients deteriorate while using NSAIDs without presenting new PDCs. Only 
in these rare patients, further diagnostic workup should be performed and/or 
a therapeutic trial with e.g., antibiotics, steroids, or antituberculous agents 
started. 
Conclusions 
In conclusion, the spectrum of diseases causing FUO, has changed during the 
last 30 years. Most striking is the fact that in 30% of the patients no diagno-
sis could be made. Due to the early use of sophisticated diagnostic 
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techniques in patients with fever, diseases that used to cause FUO are now 
diagnosed within 1 week. This leaves us with a group of patients more 
difficult to diagnose. It is a reassuring thought that most have benign, self-
limiting or recurrent fever. 
We used a standardized diagnostic protocol and prospectively studied PDCs, 
with help of the data retrieved in this study it was possible to formulate a 
general proposal for diagnostic workup of patients with FUO. 
Future studies on FUO should be performed on a regular basis because of an 
ongoing development in the use of diagnostic techniques and the prospective 
influence on the spectrum of diseases causing FUO. Future studies should 
include outpatients and use fixed epidemiological entry criteria to avoid 
unwanted selection bias. Newer techniques (e.g., 16S ribosomal RNA 
amplification) may be needed as an approach in the relatively large proportion 
of patients in whom we now fail to make a diagnosis. 
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Samenvatting 
Sinds de herkenning van het syndroom van febris e causa ignota (е.с.i.), 
vormt de diagnostiek van deze categorie patiënten een geweldige uitdaging. 
Nadat Petersdorf en Beeson in 1961 een definitie van febris e.c.i. (een 
koortsende ziekte gedurende minimaal 3 weken, met minimaal 3 keer een 
rectale temperatuur van 38,3 °C (101 °F) of hoger, waarbij na 1 week 
opname en adequaat onderzoek geen diagnose gesteld is) introduceerden, 
werden epidemiologisch vergelijkende studies mogelijk waarvan er sindsdien 
vele zijn gepubliceerd. Er waren meerdere redenen om onze, in dit onderzoek 
beschreven, multicenter studie te ondernemen. Het spectrum van oorzaken 
van febris e.c.i. bleek afhankelijk van geografische factoren en er was in 
Nederland nog nooit epidemiologisch onderzoek naar febris e.c.i. gedaan. Ook 
bleek uit andere studies dat er een verschuiving optrad in de tijd in het 
spectrum van oorzaken en het leek wenselijk de kennis over febris eci over de 
jaren '90 bij te werken. De definitie van febris e.c.i. diende gemoderniseerd te 
worden door immuungecompromitteerde patiënten uit te sluiten. Deze 
patiënten bleken een geheel ander spectrum van oorzaken van febris e.c.i. te 
hebben waardoor een geheel andere diagnostische en therapeutische aanpak 
nodig was. Een uniforme epidemiologische fuik en een gestandaardiseerde 
diagnostische aanpak, nodig om onbedoelde selectie te voorkomen, waren 
nooit eerder gebruikt in studies naar febris e.c.i., waardoor het vergelijken van 
uitkomsten van studies bemoeilijkt werd. Ondanks het feit dat iedere expert 
op het gebied van febris e.c.i. het zoeken naar potentiële diagnostische clues 
(PDCs) benadrukte, was de waarde van individuele PDCs nooit prospectief 
bestudeerd. Ondanks het feit dat er meerdere pogingen waren ondernomen 
om te komen tot een eenduidige diagnostische aanpak van deze patiënten, 
was de diagnostische opbrengst van veel onderzoeken die in deze algoritmen 
werden genoemd nooit bepaald, zowel niet voor patiënten met als zonder 
PDCs. Voordat we een prospectieve studie wilden starten naar patiënten met 
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febris е.с.i., wilden we eerst inzicht krijgen het probleem en de diagnostische 
aanpak van dergelijke patiënten in Nederland. 
Hoofdstuk 2 
Gedurende 3,5 jaar, van augustus 1988 tot januari 1992, werden 53 
patiënten met klassieke febris e.c.i. retrospectief verzameld door 
gecombineerd gebruik van diverse zoektechnieken. Bij 11 (21%) patiënten 
werden infecties gevonden als oorzaak, bij 10 (19%) maligniteiten, bij 12 
(23%) niet-infectieuze ontstekingsziekten en in 16 (30%) patiënten kon geen 
diagnose gesteld worden. De groep patiënten zonder diagnose was 
toegenomen vergeleken met andere studies naar febris e.c.i. In geen van de 5 
patiënten zonder PDCs kon een diagnose gesteld worden. De aanwezigheid 
van PDCs leek belangrijk voor de uitkomst en prospectieve bestudering van 
deze PDCs leek interessant. In deze retrospectieve studie werd ook de 
diagnostische aanpak van dergelijke patiënten bestudeerd en het bleek dat 
veel onderzoeken screenend werden gebruikt zonder dat er specifieke PDCs 
waren wijzend in de richting van de gezochte diagnose. Een prospectieve 
studie naar de diagnostische waarde van deze onderzoeken leek de moeite 
waard. 
Hoofdstuk 3 
Bij 24 internisten, drie per academisch ziekenhuis, werd een diepte-interview 
verricht om inzicht te verkrijgen in de verschillen in diagnostische aanpak van 
patiënten met febris e.c.i. Negentien internisten vulden een vragenlijst in, 
bestaande uit twee delen. Het eerste deel bestond uit een beschrijving van 
een bestaande patiënt met febris e.c.i. met weinig PDCs en vragen over de 
aanpak van deze patiënt. Mediaan, met een spreiding van 2 tot 16, werden 
zes mogelijke diagnoses genoemd door de deelnemers. Veel onderzoeken 
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werden aangevraagd op basis van deze differentiaal diagnose. Het tweede 
deel bestond uit een meerkeuze vragenlijst, waarbij gevraagd werd de situatie 
te omschrijven waarin men, in het algemeen, elk van de 182 onderzoeken zou 
gebruiken. Veel onderzoeken werden screenend gebruikt, ondanks het feit dat 
informatie over de waarde van de betreffende technieken niet beschikbaar 
was ten tijde van het onderzoek. Met behulp van gegevens uit deze studie en 
de retrospectieve analyse van de aanpak van patiënten met febris e.c.i. in 
Nijmegen werd een gestandaardiseerd diagnostisch protocol, bestaande uit 
twee delen, ontwikkeld, welke gebruikt zou worden in een grote prospectieve 
multicenter studie. 
Hoofdstuk 4 
Voor de start van een prospectieve studie naar de diagnostisch waarde van 
de indium-111 gelabelde polyclonale humane IgG (111ln-lgG) scintigrafie, 
vergeleken we onze ervaringen met deze relatief nieuwe techniek met 
literatuur gegevens over scintigrafische technieken bij patiënten met febris 
e.c.i. Retrospectief bestudeerden we 24 patiënten die voldeden aan de criteria 
voor febris e.c.i., die in ons academisch ziekenhuis een 111ln-lgG scan hadden 
ondergaan. 
In 9 van de 13 patiënten met een positieve scan, hielp de scan bij het stellen 
van de diagnose. In 9 van de 11 patiënten met een negatieve scan werd 
ondanks uitgebreid onderzoek en langdurige fol low-up geen infectie als 
oorzaak van de koorts gevonden. 
De berekende sensitiviteit en specificiteit van de 111ln-lgG scan waren 8 1 % 
respectievelijk 6 9 % . Deze resultaten zijn goed vergeleken met de die van 
andere scintigrafische technieken zoals vermeld in de literatuur. Omdat er 
nogal wat voordelen zijn verbonden aan deze techniek, werd besloten een 
grotere prospectieve studie te verrichten naar de waarde van deze techniek bij 
patiënten met febris e.c.i. 
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Hoofdstuk 5 
Gedurende twee jaar, van januari 1992 tot januari 1994 werd op alle interne 
afdelingen van alle acht academische ziekenhuizen in Nederland een 
prospectieve studie naar febris e.c.i. verricht. Hierbij werden vaste 
epidemiologische toegangscriteria en een gestandaardiseerd diagnostisch 
protocol gebruikt om geen patiënten te missen, onbedoelde selectie te 
voorkomen en de diagnostische aanpak vergelijkbaar te maken. We pasten de 
definitie van klassieke febris e.c.i. aan door immuungecompromitteerde 
patiënten uit te sluiten en het tijdscriterium "1 week in het ziekenhuis zonder 
een diagnose" te vervangen door een kwaliteitscriterium waarin gesteld werd 
dat gedurende 1 week opname bepaalde screenende onderzoeken gedaan en 
adequaat geïndiceerd onderzoek naar aanleiding van PDCs zonder dat een 
diagnose gevonden was. 
Er werden 167 patiënten in het onderzoek ingesloten, waarvan er 43 (26%) 
infecties hadden, 21 (13%) maligniteiten en 40 (24%) niet-infectieuze 
ontstekingsziekten. In 50 (30%) patiënten werd de oorzaak niet achterhaald, 
van wie er 37 spontaan herstelden. In 11 van de 13 patiënten met 
persisterende koorts bleek een of andere vorm van periodieke koorts 
aanwezig te zijn, met volledig herstel tussen de koortsperioden. 
Het veranderende spectrum van oorzaken van febris e.c.i. werd in deze studie 
bevestigd. Er was een toename van de hoeveelheid patiënten zonder diagnose 
en meestal betrof het hier goedaardige, spontaan verdwijnende of periodieke 
koorts. Waarschijnlijk kon deze toename toegeschreven worden aan het 
toenemend gebruik van geavanceerde diagnostische technieken, vroeg in het 
diagnostisch proces waardoor een groep patiënten overbleef, welke voldeden 
aan de klassieke criteria, bij wie het veel moeilijker was om een diagnose te 
stellen met behulp van de tot onze beschikking staande technieken. 
Bij patiënten met periodieke koorts of koorts gedurende meer dan een half 
jaar, was de kans op het stellen van een diagnose significant lager. 
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Hoofdstuk 6 
Gedurende de periode januari 1992 tot januari 1994 gebruikten we een 
gestandaardiseerd diagnostisch protocol voor alle 167 ¡mmuuncompetente 
patiënten met febris e.c.i. opgenomen op alle interne afdelingen in alle 8 
academische ziekenhuizen in Nederland. Het protocol bevatte een formulier 
met een gestandaardiseerde anamnese en lichamelijk onderzoek. Een 
bepaalde hoeveelheid aanvullend onderzoek diende na een week opname 
verricht zijn en alle PDCs, op deze manier verkregen, moesten genoteerd 
worden. In de aanwezigheid van PDCs moesten specifiek gericht onderzoek 
aangevraagd worden, gebaseerd op een gemotiveerde differentiaal diagnose. 
Bij afwezigheid van PDCs of indien alleen misleidende PDCs aanwezig waren, 
ondergingen de patiënten een gestandaardiseerd onderzoeksprotocol. 
Bij 162 (97%) patiënten bleken er PDCs aanwezig te zijn na een week 
opname, bij 61 patiënten waren dit allemaal misleidende PDCs. De kans om te 
komen tot een diagnose was bij patiënten met PDCs niet significant groter 
dan bij patiënten zonder PDCs, waarschijnlijk door het hoge percentage 
misleidende PDCs. De kans om te komen tot een diagnose was significant 
lager ( < 10%) voor patiënten met periodieke koorts met normale bezinking en 
hemoglobine. Geen enkele andere PDC was significant verschillend in de twee 
groepen met en zonder diagnose. 
In 10 (23%) van de 43 patiënten bij wie het diagnostisch protocol gebruikt 
werd, bleek het protocol nuttig. Onderzoeken met screenende waarde waren, 
in een vroege fase: funduscopie, Western blot serologie voor Yersinia 
enterocolitis, serum cryoglobuline, arteria temporalis biopt bij patiënten 
ouder dan 55 jaar, in een late fase: cristabiopt, leverbiopt, CT-abdomen en 
CT-thorax. 
De screenende waarde van immunologische en microbiologische serologie en 
endocrinologisch onderzoek was nihil en waarschijnlijk moet dit onderzoek 
alleen gebeuren als er PDCs aanwezig zijn voor de ziekte waarnaar gezocht 
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wordt. Scintigrafische technieken, echocardiografie en ander afbeeldend 
onderzoek waren in ons onderzoek nooit behulpzaam bij het stellen van een 
diagnose in de afwezigheid van PDCs. Veel patiënten hadden aspecifieke 
anemie en gestoorde leverfuncties. In de aanwezigheid van deze PDCs alleen, 
zonder andere, meer specifieke, PDCs was de kans op het vinden van de 
diagnose met behulp van een beenmergaspiratie respectievelijk een leverbiopt, 
nihil. Biopten van dundarm waren nooit behulpzaam in onze patiëntengroep 
en huid-spier-fascie biopten waren nooit behulpzaam bij afwezigheid van 
PDCs. Indien patiënten alleen vergrote lymfomen hadden in de cervicale of 
inguinale regio (met negatieve X-Thorax en echografie van de buik) bleek een 
lymfeklier biopsie niet behulpzaam bij het stellen van een diagnose, in 
tegenstelling tot patiënten met gegeneraliseerde lymfadenopathie bij wie het 
onderzoek een hoge opbrengst had van 79%. 
In deze studie blijkt dat het zoeken naar PDCs een belangrijk instrument blijft 
bij het stellen van de diagnose bij patiënten met febris e.c.i., alhoewel ook 
blijkt dat veel PDCs misleidend bleken te zijn. Gericht diagnostisch onderzoek 
- met gebruik van PDCs gevonden door een grondige herhaalde anamnese en 
lichamelijk onderzoek - is nog steeds de meest efficiënte manier om het 
probleem van febris e.c.i. in de individuele patiënt op te lossen. 
Hoofdstuk 7 
In diverse studies werd gesuggereerd dat bepaling van het cytokine patroon 
behulpzaam zou kunnen zijn in de diagnostiek van febris e.c.i. De 
diagnostische waarde van cytokine bepalingen in patiënten met febris e.c.i. 
was nog nooit nagegaan. Sommige cytokinen zijn betrokken bij 
immunologische- en ontstekingsprocessen en hebben een directe werking op 
het thermoregulatiecentrum in de hypothalamus. Metingen van deze 
cytokinen zouden mogelijk kunnen leiden tot meer inzicht in de Pathogenese 
van koorts bij patiënten met febris e.c.i. 
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Bij 123 patiënten met febris e.c.i. werden zowel de hoeveelheid circulerend 
IL-1/?, TNFa, IL-6 en IL-1 ra als de ex-vivo productie van deze cytokinen 
bestudeerd. Na diagnostische evaluatie bleken 28 patiënten een infectie te 
hebben, 14 patiënten een maligniteit, 32 patiënten een niet-infectieuze 
ontstekingsziekte (NIIDs), 10 patiënten diverse andere ziekten terwijl in 39 
patiënten geen diagnose gesteld werd. 
Concentraties van circulerend IL-1£, IL-6 en IL-1 ra van patiënten met 
infecties, maligniteiten en NIIDs waren hoger dan bij normale controles. 
Patiënten met infecties hadden hogere concentraties JNFa dan normalen. 
De ex-vivo productie van IL-1/? en IL-1 ra was in geen enkele categorie 
patiënten met febris e.c.i. verschillend van normalen, productie van TNFff was 
lager in patiënten met maligniteiten en NIIDs, IL-6 productie was lager in 
patiënten met maligniteiten. 
In 35 patiënten met koorts tijdens en na het prikken, werd geen enkele 
verhoging van cytokinen gevonden. De mogelijke verklaringen voor dit 
fenomeen werden in dit hoofdstuk besproken. 
Ondanks het feit dat er significante verschillen gevonden werden tussen de 
verschillende subgroepen helpen deze bepalingen niet in het diagnostisch 
proces van patiënten met febris e.c.i. in verband met de grote overlap tussen 
alle subgroepen. 
Hoofdstuk 8 
Van januari 1992 tot januari 1994 werden 167 patiënten met febris e.c.i. 
prospectief bestudeerd, waarvan er 58 een indium-111 gelabelde polyklonaal 
Immunoglobuline G (111ln-lgG) scintigrafie ondergingen. Bij 23 patiënten werd 
de techniek gebruikt als screenend onderzoek, in de andere 35 patiënten 
waren er PDCs aanwezig wijzend in de richting van een lokale ontsteking. 
In 9 (26%) van de 35 patiënten met PDCs was het onderzoek behulpzaam bij 
het stellen van de diagnose, terwijl dit bij geen enkele patiënt zonder PDCs 
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het geval was. Infecties werden gevonden bij 10 (24%) van de 41 patiënten 
met een negatieve scan. Deze infecties waren focaal of gelokaliseerd in hart, 
lever of urinewegen, waar fysiologische opname een eventuele pathologische 
opname zou kunnen versluieren. 
In patiënten zonder PDCs voor lokale ontsteking of infectie dient 111ln-lgG 
scintigrafie niet routinematig gebruikt te worden. In patiënten met PDCs voor 
lokale ontsteking bleek de techniek behulpzaam in 25% van de patiënten. De 
meeste van de tot nu toe gebruikte scintigrafische technieken hebben een 
vergelijkbare opbrengst bij patiënten met klassieke febris e.c.i. 
Hoofdstuk 9 
Met behulp van de gegevens uit onze prospectieve studie wordt een 
diagnostische aanpak van patiënten met febris e.c.i. besproken. De nadruk 
ligt hierbij op een grondige zoektocht naar PDCs met behulp van een 
volledige, liefst gestandaardiseerde anamnese en lichamelijk onderzoek 
gecombineerd met een bepaalde verplichte onderzoeken zoals gebruikt in 
onze prospectieve studie (zie Addendum). 
De eerste stap in het diagnostisch proces bestaat uit het groeperen van PDCs 
en het maken van een lijst van meest waarschijnlijke diagnoses, gebaseerd op 
combinaties van PDCs. 
Alle medicatie moet gestopt of vervangen worden om medicamenteuze koorts 
uit te sluiten en ook dient manipulatie van de thermometer reeds in een vroeg 
stadium uitgesloten te worden. 
Bij patiënten met periodieke koorts worden slechts zelden infecties of 
maligniteiten als oorzaak gevonden. Bij deze patiënten dient het diagnostisch 
proces waarschijnlijk alleen te bestaan uit een grondige anamnese en 
lichamelijk onderzoek met de verplichte onderzoeken waarbij specifiek gelet 
moet worden op PDCs passend bij bepaalde periodieke syndromen. Alleen als 
er specifieke aanwijzingen zijn voor infecties, NIIDs of maligniteiten of als de 
189 
Samenvatting en conclusies 
klinische conditie verslechtert moet verdergaand onderzoek plaatsvinden. 
Bij patiënten met continue koorts zonder PDCs of met alleen misleidende 
PDCs zijn er weinig onderzoeken die in onze prospectieve studie screenende 
waarde hadden bij het stellen van de diagnose. Funduscopie, serologie 
(Western blot) voor Yersinia enterocolitica, serum cryoglobuline en een arteria 
temporalis biopt bij patiënten ouder dan 55 jaar bleken waardevol in de 
afwezigheid van PDCs, in een vroege fase van de diagnostiek. In een latere 
fase bleken crista biopsie, lever biopsie en CT thorax en CT abdomen soms 
waardevol. Het herhalen van een grondige anamnese en lichamelijk onderzoek 
en van sommige inclusie-onderzoeken in een speurtocht naar nieuwe PDCs is 
waarschijnlijk beter dan het aanvragen van allerlei screenend onderzoek in de 
hoop dat er ¡ets abnormaals gevonden wordt. Ondersteunende therapie met 
NSAIDs gecombineerd met zorgvuldige observatie, kan in deze fase nuttig 
zijn. Slechts zelden gaat de klinische toestand van patiënten achteruit tijdens 
het gebruik van NSAIDs zonder dat zich nieuwe PDCs presenteren. Alleen bij 
deze zeldzame patiënten dient nader screenend onderzoek plaats te vinden 
en/of empirisch gestart te worden met antibiotica, corticosteroïden of 
tuberculostatica. 
Conclusie 
Concluderend, het spectrum van oorzaken van febris e.c.i. is gedurende de 
afgelopen 30 jaar veranderd. Het meest valt op dat bij 3 0 % van de patiënten 
geen diagnose gesteld kon worden. Doordat geavanceerd onderzoek steeds 
vroeger in het diagnostisch proces gebruikt worden, worden klassieke 
oorzaken van febris e.c.i. binnen 1 week gediagnostiseerd. Er blijft een groep 
patiënten over met meestal goedaardige, spontaan verdwijnende of periodieke 
koorts, waarbij de diagnose veel moeilijker te stellen is met behulp van 
technieken die ons nu ter beschikking staan. 
We gebruikten in onze studie een gestandaardiseerd diagnostisch protocol en 
bestudeerden PDCs prospectief en met behulp van deze gegevens was het 
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mogelijk een algemeen voorstel te formuleren voor de aanpak van patiënten 
met febris e.c.i. 
Toekomstig onderzoek dient regelmatig plaats te vinden; de ontwikkeling in 
de diagnostiek gaat voort en blijft zijn invloed uitoefenen op de samenstelling 
van deze intrigerende groep patiënten. De nieuwe definitie dient in de 
toekomst gebruikt worden, met exclusie van immuungecompromitteerde 
patiënten en inclusie van poliklinische patiënten. Tevens dienen 
epidemiologische toegangscriteria geformuleerd te worden om onbedoelde 
selectie te voorkomen. Misschien dat nieuwe technieken (zoals 16S 
ribosomaal RNA amplificatie) nuttig kunnen zijn bij het stellen van de diagnose 
in de relatief grote groep van patiënten zonder diagnose. 
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Abbreviations 
ACE 
ANCA 
dsDNA 
DTPA 
ENA 
FUO 
Ga 67 
H M PAO 
IL-10 
IL-1ra 
IL-6 
111ln-lgG 
NIIDs 
PDCs 
JNFa 
99m T c 
WBC 
- angiotensin-converting enzyme 
antineutrophil cytoplasmic autoantibodies 
- double-stranded deoxyribonucleic acid 
- diethylene triamine pentaacetic bicyclic anhydride 
- extractable nuclear antigen 
- fever of unknown origin 
- gallium citrate 67 
- hexamethylpropyleneamineoxime 
- ¡nterleukin-1/? 
- interleukin-1 receptor antagonist 
- interleukin-6 
- indium-111-labeled polyclonal immunoglobulin G 
non-infectious inflammatory diseases 
- potentially diagnostic clues 
- tumor necrosis factor-σ 
- Technetium 99m 
- White blood cells 
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FEVER OF UNKNOWN ORIGIN (FUO). 
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STELLINGEN 
1. Epidemiologische studies naar febris e causa ignota kunnen sterk verbeterd 
worden door verandering van definitie, gebruik van protocollen en vaste 
epidemiologische toegangscriteria. 
dit proefschrift 
2. Het gebruik van scintigrafische technieken bij patiënten met febris e causa 
ignota is alleen zinvol als er aanwijzingen zijn voor lokale ontstekingen. 
dit proefschrift 
3. BIJ patiënten met periodieke koorts is de kans op het stellen van een 
diagnose significant lager dan bij patiënten met continue koorts 
dit proefschrift 
4. De kans op een diagnose bij patiënten met potentieel diagnostische 'clues' 
(PDCs) is niet groter dan bij patiënten zonder PDCs, waarschijnlijk door het 
hoge percentage misleidende PDCs. 
dit proefschrift 
5. BIJ 30% van de patiënten met febris e causa ignota wordt geen diagnose 
gevonden en is er een goedaardig verloop van de ziekte. De oorzaak is 
mogelijk selectie door het toenemend gebruik van geavanceerde 
diagnostische technieken vroeg in de diagnostiek van de patient met 
koorts. 
dit proefschrift 
6. Het zoeken naar potentieel diagnostische 'clues' (PDCs) blijft een belangrijk 
instrument in het diagnostisch proces van patiënten van febris e causa 
ignota omdat voor de meeste onderzoeken geldt dat ze alleen zinvol zijn als 
er specifieke PDCs voor de gezochte diagnose aanwezig zijn. 
dit proefschrift 
7. Het meten van circulerend IL-1/?, IL-6, TNFa en IL-1 ra en de bepaling van 
de ex-vivo productie van deze cytokinen draagt niet bij aan het 
diagnostisch proces van patiënten met febris e causa ignota. 
dit proefschrift 
8. Bij oudere patiënten met febris e causa ignota dient - ook bij afwezigheid 
van lokale klachten - voor de start van een proefbehandeling met 
corticosteroïden een arteria temporalis biopsie verricht te worden. 
9. De hoeveelheid technisch onderzoek bij een patiënt is omgekeerd evenredig 
met de kwaliteit van anamnese en lichamelijk onderzoek. 
eigen waarneming 
10. Door fusering van ziekenhuizen, wordt het voor specialisten-echtparen 
steeds moeilijker binnen dezelfde regio een baan te vinden. 
11. De opvatting dat het werken als internist wel gecombineerd kan worden 
met onderzoekstaken en managementtaken maar niet met zorgtaken thuis, 
is discriminerend. 
12. Bij de "inverdienregeling voor de jonge specialist" zoals geformuleerd door 
de commissie Biesheuvel wordt er ten onrechte van uitgegaan dat de 
intredende specialist jong is. 
13. Bij de poging een stelling te formuleren, blijkt het omgekeerde vaak ook 
waar te zijn. 
14. Drukfouten vallen gemakkelijker op dan denkfouten. 
15. Het bedrijven van topsport is een goede training van doorzettings-
vermogen en frustratietolerantie, en dus een goede voorbereiding op het 
schrijven van een proefschrift. 
16. Omdat niets of niemand volmaakt is, heeft klonen geen zin. 
17. Wie met open kaart speelt, heeft meestal alle troeven in handen. 



